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Abstract  I 
Abstract  
The neuronal high affinity L-proline transporter (PROT) is a putative neurotransmitter 
transporter whose contribution to neurotransmission is still unknown. PROT is expressed 
exclusively in brain by subpopulations of glutamatergic neurons and is assumed to conduct 
the reuptake of L-proline, which is released upon depolarization. Since to date no specific 
high-affinity receptor for L-proline has been discovered, the amino acid has been suggested 
to play a role regulating glutamatergic neurotransmission. To uncover the in vivo 
modulatory function of PROT, a mouse strain lacking functional PROT was generated and 
confirmed. The analysis of these PROT-knockout mice provided new insights into the 
modulatory functional roles of this transporter. Biochemical alterations within the central 
nervous system of PROT lacking mice were identified. Thus, PROT-deficient mice exhibit 
increased expression levels of N-methyl-D-aspartic acid (NMDA), α-amino-3-hydroxy-5 
methylisoxazolepropionic acid (AMPA) and kainate (KA) receptor subunits. Furthermore, 
levels of the dopamine receptor D2 (DRD2) as well as levels of the dopamine synthesizing 
enzyme tyrosine hydroxylase (TH) are elevated. Behavioral analyses of PROT-knockout 
mice unveiled decreased locomotor activity, increased anxiety like behavior, and better 
learning abilities compared to wild-type littermates. The changes in behavioral profiles of 
analyzed PROT-deficient animals are in line with the observed biochemical adaptive 
alterations. Collectively, the presented studies indicate that the functional role of PROT 
within neurotransmission is primarily the modulatory fine tuning of glutamatergic signaling, 
by controlling the levels of L-proline in synaptic clefts.  
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Zusammenfassung  III 
Zusammenfassung 
Bei dem neuronalen hochaffinen L-Prolin-Transporter (PROT) handelt es sich vermutlich 
um einen Neurotransmitter Transporter, dessen Einfluß auf die Neurotransmission bislang 
kaum erforscht ist. Dieser Transporter wird ausschließlich im Gehirn von einer 
Teilpopulation glutamaterger Neurone exprimiert und es wird angenommen, dass er der 
Wiederaufnahme von depolarisations-abhängig ausgeschüttetem L-Prolin dient. Da bisher 
noch kein spezifischer L-Prolin-Rezeptor im ZNS nachgewiesen werden konnte, wird 
vermutet, dass diese Aminosäure eine Funktion bei der Regulation der glutamatergen 
Neurotransmission ausübt. Um die modulatorische Funktion von PROT in vivo 
aufzuklären, wurde eine Mauslinie generiert, der das funktionsfähige PROT-Protein fehlt. 
Durch die Analyse dieser PROT-Knockout Mäuse konnten neue Erkenntnisse über die 
modulatorische Funktion dieses Transporters gewonnen werden. Zahlreiche biochemische 
Veränderungen konnten im ZNS von PROT-defizienten Tieren identifiziert werden. 
PROT-Knockout Mäuse weisen eine erhöhte Expression von N-methyl-D-aspart 
(NMDA), α-amino-3-hydroxy-5 methylisoxazolepropionsäure (AMPA) und Kainat (KA) 
Rezeptor Untereinheiten auf. Weiterhin sind die Expressions-Level des Dopamin 
Rezeptors D2 (DRD2), sowie des Dopamin synthetisierenden Enzyms Tyrosin 
Hydroxylase (TH) erhöht. Darüber hinaus zeigen PROT-defiziente Tiere veränderte 
Verhaltensprofile. PROT-Knockout Mäuse zeichnen sich im Vergleich zu Wild-Typ Tieren 
durch eine verminderte lokomotorische Aktivität, ein erhöhtes Angst-Verhalten und eine 
bessere Lernfähigkeit aus. Diese veränderten Verhaltensphänotypen der PROT-defizienten 
Tiere passen zu den beobachteten adaptiven Veränderungen der Glutamat Rezeptor 
Expression. Insgesamt deuten die dargestellten Studien darauf hin, dass die Funktion, die 
PROT in der Neurotransmission ausübt, in erster Linie der modulatorischen 
Feinabstimmung der glutamatergen Signalgebung dient, indem dieses Protein die L-Prolin-
Level im synaptischen Spalt kontrolliert. 
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1 Introduction 
1.1 Synaptic Transmission in the Central Nervous System 
The activities of the nervous system operate through ongoing electrical and chemical 
signals. These alternations are based on the process of synaptic transmission, also called 
neurotransmission. Synaptic transmission is a process reporting the intercellular 
communication of neuronal cells through signal transduction at specialized junctions 
(synapses). At these synapses, signaling molecules (neurotransmitters) are released from the 
presynaptic neurons into the synaptic cleft to activate corresponding receptors of 
postsynaptic cells upon binding. The activation of these neurotransmitter receptors leads to 
conformational changes, which either result in induction of intracellular signal transduction 
cascades or in the diffusion of ions through molecular pores (ion channels), which can be 
part of receptors and play a central role in membrane excitation. Synaptic transmission 
arises when signaling through neurotransmitters causes the development of an electric 
current (action potential) in the postsynaptic neuronal cell. It can be either excitatory or 
inhibitory, depending on the ion-selectivity of the activated receptor. This is because 
neuronal cells have a negative membrane potential, or in other words, the cytoplasm is 
electrically more negative than the external fluid, leading to a potential drop across the 
plasma membrane. Incoming ions that make the cytoplasm more positive depolarize the 
membrane, and vice versa, those making it more negative are said to hyperpolarize the 
membrane. If a receptor is selectively permeable for positive charged ions, activation 
induces an excitatory postsynaptic potential (EPSP). On the other hand, selectivity for 
negatively charged ions leads upon activation of the respective receptors to an inhibitory 
postsynaptic potential (IPSP). Thereby, the development or abortion of an action potential 
is triggered. The main neurotransmitter activating excitatory receptors is glutamate, and 
main inhibitory neurotransmitters are gamma-aminobutyric acid (GABA) and glycine. To 
terminate the synaptic transmission induced upon neurotransmitter release from the 
presynaptic neuron, neurotransmitters have to be inactivated. This is achieved either by 
enzymatic degradation or by active transport back into neuronal cells (or into glial cells) 
through membrane located neurotransmitter transporters. These transporters are highly 
selective and bind their substrates with high affinity. Neurotransmitter transporters use the 
electrochemical gradient across the cell membrane as a driving force to carry their 
substrate. This means that the energy is obtained by cotransport of ions like sodium and 
chloride, or antiport of potassium. 
2 1 Introduction 
1.2 An Overview about the Amino Acid L-Proline  
L-proline (shown in Figure 1) is an exceptional amino acid; it differs from others in its 
imino group instead of a primary amino group. Its side chain is bound to both nitrogen 
and α-carbon atoms resulting in a special molecule that exhibits conformational rigidity. 
Therefore, L-proline has an important role for the structure of proteins and is as well 
excluded from the regular amino acid metabolism, namely the pyridoxal 5-phosphate 
coenzyme catalyzed decarboxylation and transamination reactions. Besides the abundant 
presence of L-proline in regular food, pathways exist for its synthesis from glutamate or 
ornithine as precursors (Hu et al. 2008). As shown in Figure 2, the initial reactions of these 
pathways occur in the mitochondria. The common intermediate is glutamic-γ-semialdehyde 
that spontaneously cycles to ∆1-pyrroline-5-carboxylate (P5C) (Adams 1970; Phang et al. 
1979). The enzymes required for synthesis are ornithine-aminotransferase (OAT) and  
P5C-synthase, respectively. P5C is then released to the cytoplasm and converted to  
L-proline by P5C-reductase (Pycr). L-proline is reshuttled into the mitochondria and there 
degraded by the enzyme L-proline dehydrogenase (PRODH) that converts L-proline back 
to P5C. Subsequently, P5C is non-enzymatically converted back to glutamic-gamma-
semialdehyde, which can be transformed into glutamate (by ∆1-pyrroline-5-carboxylate 
dehydrogenase) or ornithine (by ornithine-aminotransferase). 
 
 
 
Figure 1 Chemical structure of L-proline 
Image was designed with the help of Symyx® Draw 3.3 (Symyx Solutions, Inc.) 
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Figure 2 Schematic depiction of the L-proline cycle (modified from Wyse and Netto 2011) 
Abbreviation: P5C = ∆1-pyrroline-5-carboxylate 
 
Dysfunctions of the described primary metabolism of L-proline are known to be associated 
with various diseases (Mitsubuchi et al. 2008). The disorder hyperprolinemia is an 
autosomal recessive inherited disease caused by insufficient L-proline catabolism and 
present in two forms. Hyperprolinemia type I (HPI) results from the hepatic deficiency of 
the enzyme proline dehydrogenase (PRODH) with subsequent tissue accumulation of  
L-proline. Plasma L-proline levels of patients suffering from HPI are elevated from five- to 
ten times (700 to 2400 µM) above normal values (51 to 271 µM) (Wyse and Netto 2011). 
Hyperprolinemia type II (HPII) is characterized by insufficiency of P5C-dehydrogenase 
activity again resulting in accumulation of L-proline (Flynn et al. 1989). This form of 
hyperprolinemia leads to higher increase in L-proline plasma concentrations (1500 to 
3700 µM) compared to HPI. In state of hyperprolinemia, concentrations of L-proline are 
increased in all tissues, thus as well in the cerebrospinal fluid. As a result, the disease is 
associated with cognitive symptoms like hyperactivity, amnesia, epilepsy and deafness 
(Mitsubuchi et al. 2008). In addition, there is evidence for association of hyperprolinemia 
with schizophrenia (Clelland et al. 2011). In mouse models of hyperprolinemia the animals 
are found to exhibit learning deficits in short-term memory examining tasks like T-maze as 
well as in aversive learning tasks (Baxter et al. 1985; Davis et al. 1987). Furthermore, 
chronic hyperprolinemia provokes a long-term memory deficit, shown by Morris water 
maze test analysis (Bavaresco et al. 2005). 
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1.3 The Role of  L-Proline in the Brain 
There is a long history of evidence suggesting that certain amino acids or their metabolites 
are able to modulate synaptic transmission in the central nervous system  
(Snyder et al. 1973; Yoneda and Roberts 1982; Fremeau et al. 1992; Gogos et al. 1999). 
While L-glycine and L-glutamate are well established as neurotransmitters, little is known 
about the role of the non-essential amino acid L-proline in the CNS. However, in addition 
to its essential roles in primary metabolism and protein synthesis L-proline fulfills several 
criteria of well characterized amino acid neurotransmitters.  
First, the neurotransmitter candidate L-proline shows a heterogeneous regional distribution 
in brain. By using an L-proline conjugated antibody, L-proline was observed in areas 
corresponding to the amygdala, piriform cortex and hippocampus as well as in a group of 
fibers and neuronal cell bodies in the brainstem and hypothalamus (Takemoto and Semba 
2006). Furthermore, a differential distribution of radioactivity can be found after injection 
of 3H-leucine and 3H-proline into cortex (Felix and Kunzle 1974). 
A synaptosomal biosynthetic pathway from ornithine has been found in the rodent brain, 
where L-proline is synthesized by the enzymes ornithine-δ-aminotransferase and pyrroline 
5-carboxylate reductase (Yoneda and Roberts 1982). However, this synthetic pathway is 
not required to offer substrate for protein synthesis because L-proline is sufficiently 
present in conventional food. Furthermore, L-proline is one of the most abundant amino 
acids in any tissue, being readily available from decomposition of the extracellular matrix, 
which is built-on predominately of collagen, which in turn contains 25% L-proline and its 
derivative hydroxyproline. 
Another piece of evidence of the transmitter role of L-proline arises from experiments in 
which intrahippocampal injections of L-proline at high doses produce lesions at the 
injection site similar to those appearing after injections of L-glutamate (Nadler et al. 1988). 
The neurodegenerative activity of L-proline could result directly from a putative ability to 
depolarize affected cells.  
An additional hint to the possible role of L-proline as a neurotransmitter comes from the 
observation that in rat cerebral cortex and spinal cord slices, radiolabeled L-proline is 
released from neurons by potassium-induced depolarization in a Ca2+-dependent manner 
(Snyder et al. 1973). Furthermore, a Ca2+-dependent release of exogenously loaded 
radiolabeled L-proline was also described in synaptosomes prepared from rodent brain 
cortex (Nickolson 1982). Such a Ca2+-dependent release is a typical hint for 
neurotransmitters. 
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Although specific sodium-independent binding of radiolabeled L-proline to rodent brain 
synaptic membranes has been described (Greene et al. 1986; Cordero et al. 1991), so far no 
specific high-affinity receptor has been found for L-proline in the CNS, suggesting that it is 
a neuromodulator rather than a neurotransmitter (Shafqat et al. 1995). Indeed, the amino 
acid L-proline reportedly plays a role in regulating synaptic transmission, which is the most 
striking remark for its neuromodulatory function. Already in 1976 it was published that 
intracerebral administration of L-proline selectively disrupts memory formation and recall 
in chicks (Cherkin et al. 1976). Another study about the contribution of L-proline to 
synaptic transmission displayed that high concentrations of this amino acid could be shown 
to activate N-methyl-D-aspartic acid (NMDA) receptors, α-amino-3-hydroxy-5 
methylisoxazolepropionic acid (AMPA) receptors and kainate (KA) receptors in mouse 
brain slices (Ault et al. 1987; Henzi et al. 1992; Martin et al. 1992). As well it was reported 
that more physiological concentrations of L-proline potentiate the transmission mediated 
by NMDA-receptors (Cohen and Nadler 1997b). Different studies showed that L-proline 
applied to neurons can exhibit excitatory actions (Ault et al. 1987; Henzi et al. 1992; Martin 
et al. 1992; Felix and Kunzle 1974). Furthermore, it was observed that in chicks under 
acute stressful conditions the amount of L-proline in brain was reduced whereas 
intracerebroventricular injection of L-proline induced sedative and hypnotic effects 
(Hamasu et al. 2009; Hamasu et al. 2010). 
Another important piece of evidence that L-proline is a neurotransmitter or 
neuromodulator candidate is displayed through the interesting finding that a high affinity 
sodium-dependent transporter for L-proline (PROT) was detected in the CNS (Cohen and 
Nadler 1997c; Fremeau et al. 1992; Renick et al. 1999). In general, neurotransmitter systems 
have mechanisms to terminate signaling through removing the ligands via rapid reuptake 
by sodium-dependent transporters. Typically, for high affinity uptake of amino acids into 
obvious neurotransmitter pools, sodium-dependency is more characteristic than for low 
affinity uptake of the same amino acids, particularly in metabolic processes through 
different types of transporters (Mulder and Snyder 1974). 
6 1 Introduction 
1.4 The Neuronal High Affinity L-Proline Transporter PROT 
Although already in 1976 a high affinity sodium-dependent L-proline uptake was described 
in rodent brains (Balcar et al. 1976), it was not before 1992 that this could finally be related 
to the neuronal high affinity sodium-dependent L-proline transporter (PROT) (Fremeau et 
al. 1992). First, PROT was cloned and characterized using rat brain cDNA (Fremeau et al. 
1992) and later on as well using human sources (Shafqat et al. 1995). Sequence analysis 
revealed that PROT belongs to the family of sodium-dependent neurotransmitter 
transporters, which enclosed among others the transporters for dopamine, serotonin, 
glycine, norepinephrine or GABA (Fremeau et al. 1992). These transporters use 
transmembrane electrochemical ion gradients to drive active transport of substrates across 
the plasma membrane (Amara and Kuhar 1993; Kanner 1989). The structural properties of 
this transporter family are the existence of 12 hydrophobic transmembrane domains, 
intracellular amino- and carboxy-termini, and N-glycosylation sites between 
transmembrane domains 3 and 4. PROT shares with its family of sodium-dependent 
neurotransmitter transporters an overall sequence identity of 45% (Fremeau et al. 1992; 
Shafqat et al. 1995). 
 
Figure 3 Snake plot of murine high affinity L-proline transporter PROT 
The schematic representation of PROT as a serpentine model demonstrates conserved structural features 
with other members of the sodium-dependent neurotransmitter transporter family by exhibiting an 
intracellular N-terminus, 12 transmembrane domains linked by 5 intracellular and 6 extracellular loops as well 
as an intracellular C-terminus. Cysteine residues are highlighted as yellow circles and potentially 
phosphorylation sites are highlighted as red circles (threonine-residues) and blue circles (serine-residues).  
Plot was designed with the help of an online available TM prediction server and a snake plot construction program from 
http://www.enzim.hu/hmmtop/html/submit.html (HMMTOP prediction of TM helices) and 
http://www.sacs.ucsf.edu/TOPO (TOPO2 Transmembrane Protein Display Page).  
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Northern blot analysis detected for both human and rat origins a ~4 kb mRNA transcript 
[murine PROT: NCBI accession no. NM 201353.1, mRNA =3362 bp, cDNA = 1914 bp] 
coding for the transporter. Immunoblots of rat and human brain tissues identified a  
68 kDa glycosylated protein. As deduced from treatment with peptide-N-glycosidase F, the 
molecular mass of the primary translation product is 53 kDa (Velaz-Faircloth et al. 1995). It 
was shown that human PROT (hPROT) exhibits 636 amino acids, lacking one of the 
glutamate residues present at positions 630-634 in the carboxy-terminus, compared to 637 
amino acids of rat PROT (rPROT) and murine PROT (mPROT) (Shafqat et al. 1995). 
Expression of the corresponding cDNAs in HeLa cells revealed the characteristics of high 
affinity transport for L-proline with apparent Michaelis constants (Km) of 9.7 µM for the 
rPROT and 6.2 µM for hPROT (Shafqat et al. 1995). Moreover, PROT shows a 
stoichiometry of one L-proline molecule to two sodium ions and one chloride ion per net 
transport (Galli et al. 1999). 
PROT is expressed in the hippocampal formation, the cerebral cortex (Velaz-Faircloth et 
al. 1995), corpus striatum, hypothalamus, amygdala, thalamus and subthalamic nucleus 
(Shafqat et al. 1995) of the brain. In these regions PROT is localized in a subset of 
neuronal cells, mainly in glutamate pathway fibers (Nadler 1987; Nadler et al. 1992) and 
within synaptic terminals (Fremeau et al. 1992; Velaz-Faircloth et al. 1995). Labeling of 
PROT revealed that this transporter is localized both in membranes of small synaptic 
vesicles (SSVs) and in the plasma membrane of axon terminals (Renick et al. 1999). 
Furthermore, the topology of PROT in synaptic vesicles was found to be inverted with 
respect to the plasma membrane. This orientation suggests that PROT-containing vesicles 
are generated by a process involving endocytosis from the plasma membrane  
(Renick et al. 1999).  
PROT-function has been found to be regulated by calcium (Ca2+) and  
Ca2+-dependent protein kinases (Jayanthi et al. 2000). These authors reported that Ca2+ acts 
as an acute activator of PROT, suggesting that this ion is involved not only in the release of 
transmitters but also in its fast removal from the synaptic cleft. On the other hand, it was 
observed that calcium acts indirectly and more slowly by down-stream events inhibiting 
PROT-function through Ca2+-dependent protein kinases, maybe due to long-term 
modulation of synaptic transmission (Jayanthi et al. 2000). In addition, PROT was found to 
be potently inhibited by exogenously applied enkephalins in both rat brain synaptosomes 
and HeLa cells recombinantly expressing PROT (Fremeau et al. 1996; Galli et al. 1999), 
which suggests a potential role for PROT in analgesia.  
8 1 Introduction 
In summary, all data strongly support an important role of L-proline as neuromodulator of 
synaptic neurotransmission in brain. In addition, PROT codes for the brain-specific high-
affinity L-proline transporter previously described in rat brain synaptosomes and slices. 
Moreover, its pattern of expression in glutamatergic neuronal cells suggests that PROT 
does not represent a ubiquitous transporter that might have a general function, but rather 
supports a specific role for L-proline and its transporter in neurotransmission, particularly 
at glutamatergic synapses. 
1.5 An Overview about Glutamatergic Neurotransmission 
As mentioned above, it was published that L-proline can modulate glutamatergic synaptic 
transmission either by potentiating it at physiological concentrations or by directly 
activating N-methyl-D-aspartic acid (NMDA) receptors, α-amino-3-hydroxy-5 
methylisoxazolepropionic acid (AMPA) receptors and kainate (KA) receptors at high 
concentrations (Ault et al. 1987; Henzi et al. 1992; Martin et al. 1992). 
Glutamate-receptors are classified into two groups: ionotropic glutamate-receptors, which 
are ligand-gated ion channels, and metabotropic glutamate-receptors that work through a 
signaling cascade, which involves G proteins (Nakanishi 1992). Ionotropic glutamate-
receptors can be further divided into three major subtype families as a result of their ability 
to bind specific chemicals more selectively than glutamate, their native ligand (Watkins and 
Evans 1981). Therefore, glutamate-receptors are rationed into NMDA-, AMPA- and KA-
receptors.  
Functional NMDA-receptors are heteromeric complexes that consist of two obligatory 
NR1 subunits and two identical or different NR2 (NR2A, NR2B, NR2C and NR2D) 
subunits and possibly the NR3A subunit (Dingledine et al. 1999). AMPA-receptors are 
tetramers made up of four subunits, GluR1-GluR4 (encoded by Gria1-4). Kainate-receptors 
as well form tetrameric complexes built of one dimer out of GluR5-GluR7 (Grik1-Grik3) 
subunits and one dimer of KA1 (Grik4) or KA2 (Grik5), which is the main KA-receptor 
subunit expressed all over the brain (Ozawa et al. 1998). 
The class of the ionotropic glutamate-receptors conveys most excitatory neurotransmission 
in the mammalian CNS (Dingledine et al. 1999). Most ionotropic AMPA- and  
KA-receptors allow, upon activation through glutamate, Na+-entry but little Ca2+-influx 
into the neuronal cells. In contrast, NMDA-receptors allow the slipping of Na+ and Ca2+ 
(Dingledine et al. 1999). Furthermore, NMDA-receptors require an additional stimulus to 
become activated together with glutamate-binding, like depolarization by a previously 
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activated AMPA-receptor (Angulo et al. 1999). Therefore, NMDA-receptors act as 
“coincidence detectors” (Tsien et al. 1996) that contribute to Ca2+ mediated synaptic 
plasticity, which is suggested to be important for learning and memory formation  
(Clayton and Browning 2001).  
Rapid excitatory neurotransmission is only mediated by ionotropic glutamate-receptors 
(Collingridge and Lester 1989). AMPA-receptors contribute to the fast component of the 
rapid excitatory postsynaptic currents (time to peak 200 µs or less, decay time 1-3 ms) 
whereas the slower component of the rapid excitatory postsynaptic currents (time to peak 
10 ms or less, decay time 100 ms or more) is mediated by NMDA-receptor channels 
(Sprengel and Single 1999). Moreover, presynaptically localized KA-receptors can act as 
conditional amplifiers of preexisting glutamatergic neurotransmission by facilitating 
subsequent transmitter release (Lerma 2006). These presynaptic KA-receptors regulate 
transmitter release at both inhibitory and excitatory synapses (Rodriguez-Moreno et al. 
1997; Kamiya and Ozawa 2000), thus modulating neuronal network activity throughout the 
CNS. 
1.6 An Overview about Knockout Mice 
Evans, Kaufman and Martin (Evans and Kaufman 1981; Martin 1981) were the first to 
report the isolation and culture of murine pluripotent embryonic stem cells, thus becoming 
pioneers for the generation of genetically engineered animals. Arise of this technology to 
manipulate genomes of mammalian model organisms by mutating a selected gene (Shastry 
1994) is an effective and powerful method to investigate functions of the encoded 
protein(s) in vivo. By this technology, manipulated artificial DNA acquires the opportunity 
to recombine with the genome of ES cells and thereby knocks out a user-defined DNA 
locus. This technique facilitates to relate a particular gene directly with a particular 
behavior. Moreover, the phenotypically screening of knockout mice can help to delineate 
valuable new targets for pharmaceutical development. An advantage of knockout animals is 
that they can be used as “filters” for the physiological significance of potentially new drug 
targets when their deletion in the mouse modulates mammalian physiology in a 
therapeutically relevant manner (Zambrowicz and Sands 2003). 
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1.7 Intention of  this Work 
Taken together all the given information, little is known about the particular role that  
L-proline and the high affinity transport of L-proline by PROT play in neurotransmission. 
In order to uncover the in vivo role of PROT, it is the goal of this doctoral thesis to 
generate mice that lack the expression of a functional PROT-protein. Initially, the 
recombinant mouse strain should be analyzed in order to evaluate whether deletion of 
PROT has effects on brain morphology and to examine the contribution of PROT on  
L-proline uptake. Moreover, as described above, it is known that PROT is localized 
primarily at glutamatergic synapses (Nadler et al. 1992). Thus, it should be investigated if 
PROT-deficient animals display changes in the expression of specific components of 
glutamatergic neurotransmission. Existing association studies observe a relationship of  
L-proline levels in CNS with some diseases, including prevalent ones like schizophrenia 
(Clelland et al. 2011; Jacquet et al. 2002; Willis et al. 2008). Hence, PROT-/- mice should be 
consequently investigated to identify potential behavioral alterations within nociception, as 
it has previously been proposed that L-proline might play a role in analgesia (Fremeau et al. 
1996; Galli et al. 1999). Since it has been reported that animals possessing reduced proline 
oxidase activity and high plasma L-proline levels exhibit sluggish behavior (Kanwar et al. 
1975; Hayward et al. 1993) as well as altered locomotor activity (Paterlini et al. 2005), 
PROT-/- mice should be also analyzed in order to look for possible changes in their 
locomotor abilities. Furthermore, it would be of interest to investigate potentially modified 
prepulse inhibition in PROT-mutants, since abnormalities in sensorimotor gating have also 
been reported for proline dehydrogenase knockout mice (Gogos et al. 1999). In summary, 
via these investigations, it would be analyzed whether PROT-deficient animals exhibit CNS 
symptoms similar to those found in human metabolic diseases related to altered levels of  
L-proline.  
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2 Materials 
Contact information of the listed manufacturers is given in the annex (9.3). 
2.1 Enzymes and Molecular Weight Markers 
Enzyme Product Number Manufacturer 
Antarctic Phosphatase M0289S NEB 
BamHI R0136S NEB 
EcoRI R0101S NEB 
GoTaq Flexi DNA 
Polymerase 
M8305 Promega 
HindIII R0104S NEB 
KpnI R0142S NEB 
NheI R0131S NEB 
NotI R0189S NEB 
1 kb DNA Ladder N3232 NEB 
100 bp DNA Ladder N3231 NEB 
Pfu DNA Polymerase M7741 Promega 
Proteinase K 82560 Fluka 
Revertaid Reverse 
Transkriptase 
EP0442 Fermentas 
Ribolock RNase Inhibitor EO0382 Fermentas 
SpeI R0133S NEB 
SYBR® Green JumpStart™ 
Taq ReadyMix™ 
S4438 Sigma 
T4 DNA Ligase M0202S NEB 
XbaI R0145S NEB 
XhoI R0146S NEB 
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2.2 Antibodies 
Antigen Type Species Product 
Number 
Manufacturer 
Goat IgG polyclonal rabbit NB710-H Novus 
Biologicals 
Gria2 / GluR2 polyclonal rabbit PAB9628 Biozol 
Grik3 / GluR7 polyclonal mouse ABIN302159 antibodies-
online 
KA2 / Grik5 polyclonal rabbit 06-315 MilliporeTM 
Mouse IgG polyclonal goat A 4416 Sigma 
NR1 monoclonal mouse 556308 BD 
PharmingenTM 
NR2A polyclonal rabbit 4205 Cell Signaling 
NR2B polyclonal rabbit 4207 Cell Signaling 
PROT polyclonal rabbit - AG Milenz 
PSD95 monoclonal rabbit 04-1066 MilliporeTM 
Rabbit IgG polyclonal goat A 6154 Sigma 
Tubulin polyclonal goat 3708-100 BioVision 
 
2.3 Molecular and Cellular Biological Kits 
Kit Product Number Manufacturer 
QIAquick® Gel Extraction 
Kit 
28706 QIAGEN GmbH 
QIAprep® Spin Miniprep 
Kit 
27106 QIAGEN GmbH 
NucleoBond® Xtra Maxi 740414.50 Macherey-Nagel 
G-50 Micro Column Kit 27-5335-01 Amersham 
RNeasy® Micro Kit 74004 QIAGEN GmbH 
InnuPREP DNA Mini Kit 845-KS-1040050 Analytik Jena 
Random Primed DNA 
Labeling Kit 
11004760001 Roche 
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2.4 Oligonucleotides 
All oligonucleotide primers applied in this thesis were synthesized either by Promega or 
Invitrogen and reconstituted in UltraPureTM distilled water to obtain 100 µM stock 
solutions.  
Name Acc.-No Primer Sequence [5´-3´]  bp 
ProT Exon7S NM_201353.1 TCT CTA GGA GTG GGC TTT GG 20 
ProT Exon8AS  NM_201353.1 CTG AGA CAT GTA GCC CAG CA 20 
b-Actin Forward NM_007393.3 TGT TAC CAA CTG GGA CGA CA 20 
b-Actin Reverse NM_007393.3 GGG GTG TTG AAG GTC TCA AA 20 
GAPDH 
Forward 
NM_008084.2 ACC CAG AAG ACT GTG GAT GG 20 
GAPDH 
Reverse 
NM_008084.2 CAC ATT GGG GGT AGG AAC AC 20 
neoS XM_001387562.
1 
CAG CTC ATT CCT CCC ACT CAT GAT 24 
WTAS NM_201353.1 GCT ATC CCC CAT CTT GCC TG 20 
WTSIII NM_201353.1 AGA ACA TCT ACA GGT CAG TG 20 
PRODH-
Forward 
NM_011172.2 AGC AGG ACC CGG CTC TCC AG 20 
PRODH-Reverse NM_011172.2 GGT CAG GCG GCT GAT GGC TG 20 
Pycr1 Forward NM_144795.3 AGC TAC GGT CTC GGC CCT CC 20 
Pycr1 Reverse NM_144795.3 GAT GGT GAC CCC TGC CGC AC 20 
Gria1 Forward NM_001113325.
1 
GGG AAT GTG GAA GCA AGG ACT 
CCG 
24 
Gria1 Reverse NM_001113325.
1 
CCG CTT CGA CTC GCT ACG GG 20 
Gria3 Forward NM_016886.3 ACA GCG CTG GGT GAG ACT GG 20 
Gria3 Reverse NM_016886.3 CTC CAG CAC TGC CTC TGC GG 20 
Grin2A Forward NM_008170.2 CAA CCA CCT CAG CAT TGT C 19 
Grin2A Reverse NM_008170.2 ACT TCT TCA CAT TCA TCC CTT C 22 
PSD95 Forward Q62108 ACA ACC AAG AAA TAC CGC TAC 21 
PSD95 Reverse Q62108 TCC TCA TAC TCC ATC TCC CC 20 
14 2 Materials 
Name Acc.-No Primer Sequence [5´-3´] bp 
SR Forward NM_001163311 GCT GCT GAG CCC TCG AAT GCA 21 
SR Reverse NM_001163311 CTC CCC CAC ACC AGC TGG GT 20 
DRD1 Forward NM_010076 GGC CTG CCA GTG GAG AGG GA 20 
DRD1 Reverse  NM_010076 ACC TTG GAC CGC AGG TGT CG 20 
DRD2 Forward  NM_010077 GCT CAC CCT CCT CAT CTT TAT C 22 
DRD2 Reverse  NM_010077 ATT TCC ACT CAC CCA CCA C 19 
COMT Forward  NM_001111062 AAG ACC GCT ACC TTC CAG AC 20 
COMT Reverse  NM_001111062 TAG ACT GCC TTC TCC AAG CC 20 
TH Forward  NM_009377.1 TGA AGC CAA AAT CCA CCA C 19 
TH Reverse  NM_009377.1 GAC ACT TAT CCA ACT CTG ACA C 22 
GlyT1 Forward NM_008135 GTG GAT GAG GTA GGG AAT GAG 21 
GlyT1 Reverse NM_008135 GAG ATG ACA ACC AAG GAG AAG 21 
ProT Forward NM_201353.1 TCT TAA CCT CAG CAG CAC C 19 
ProT Reverse NM_201353.1 GAA ATA CAC CAC CTT GCC C 19 
ProT Reverse NM_201353.1 GAA ATA CAC CAC CTT GCC C 19 
3´-PHext F. NM_201353.1 GGG GAC TAA GTG GTG AAT GT  20 
3´-PHext R.  NM_201353.1 TGT CCC TTC CTG CTT CCC AG 20 
5´-probe 
Forward 
NM_201353.1 TTT GGT ACC CTG GCT TCT TCC CTC 24 
5´-probe 
Reverse 
NM_201353.1 TTA GAA TTC CAG ACA TTT CCC 
AAG CCC AC 
29 
Ex2 Forward NM_201353.1 TTT GCG GCC GCT TTC CCT ACC 
GAG CCT AC 
29 
Ex6 Reverse NM_201353.1 TTA CTC GAG GAT GAG GTA GGG 
AAA GGT 
27 
Ex8 Forward NM_201353.1 CGC GGA TCC AGA CAC CTT CAT 
TGT CAC TC 
29 
Ex10 Reverse NM_201353.1 TTA GAA TTC TCA TCA GTC ACT 
GCA GTC AC 
29 
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2.5 Chemicals 
Substance / Reagent Product Number Manufacturer 
Agar 05040 Fluka 
Agarose UltraPure 15510027 Invitrogen™ 
Albumin, bovine A6003 Sigma 
Ampicillin K029.1 Roth 
Ammonium Persulphate A3678 Sigma 
Bromophenol blue 18030 Fluka 
Calcium chloride, dihydrate 21097 Fluka 
DMSO A1584 AppliChem 
D-glucose G7021 Merck 
Ethylendiamine tetra acetic 
acid (EDTA) 
CN06.3 Roth 
Ethanol absolute 08-205 KMF 
Ethidiumbromide 2218.1 Roth 
Enhanced 
Chemoluminescence 
Reagent 
RPN2132 GE Healthcare 
Gelatine G2500 Sigma 
Glycine 11016 Grüssing 
Glucose G7021 Merck 
Glycerol 11052 Grüssing 
HEPES (4-(2-hydroxyethyl)-
1-piperazineethanesulfonic 
acid) 
54457 Fluka 
Hydrochloric acid  08-721 KMF 
Kaleidoscope Marker 161-0324 Bio-Rad 
MagicMark XP Protein 
Standard 
LC5602 Invitrogen 
Magnesium chloride 63072 Fluka 
Magnesium Sulfate 0261.1 Roth 
Methanol 20847.307 VWR International 
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Substance / Reagent Product Number Manufacturer 
NuPage Antioxidant NP0005 Invitrogen 
NuPage Sample Buffer NP0007 Invitrogen 
NuPage Sample Reducing 
Agent 
NP0004 Invitrogen 
NuPage Transfer Buffer NP0006-1 Invitrogen 
Potassium acetate 1.04820.1000 Merck 
Potassium chloride 12008 Grüssing 
Potassium dihydrogen 
phosphate 
1.04873.5000 Merck 
Propan-2-ol P-7507-15 Fisher Scientific 
Roti-Block A151.2 Roth 
Rotiphorese Gel 40 (19:1) A515.1 Roth 
Rubidium chloride R-2252 Sigma 
Sodium acetate anhydrous 4555 Applichem 
Sodium chloride 12123 Grüssing 
Sodium dodecyl sulfate CN30.0 Roth 
Di-sodium hydrogen 
phosphate 
71640 Fluka 
Sodium hydroxide 12156 Grüssing 
Sucrose 84105 Fluka 
Sulfuric acid 00731.2511 Merck 
Tetramethylethylenediamine T9281 Sigma 
Tris A2264 AppliChem 
Tris-HCl 90.90.3 Roth 
Triton X-100 93420 Fluka 
Tryptone A1553 AppliChem 
Tween 20 P1379 Sigma 
Yeast extract 2363.3 Roth 
β-Mercaptoethanol 31350 Invitrogen 
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2.6 Solutions and Buffers for Molecular Biology 
If not indicated differentially, all buffers and solutions were prepared with purified 
demineralized (dH2O) water. 
 
Lysis buffer (for DNA isolation from murine stem cells) 
Constituent Amount  Final Concentration 
1 M Tris-HCl 10 ml 0.1 M 
0.25 M EDTA 2 ml 0.025 M 
10% SDS 2 ml 1% 
1 M NaCl 20 ml 0.1 M 
Chemicals were dissolved in 100 ml dH2O, pH adjusted to 7.2 with NaOH, and afterwards 
the solution was sterilized via sterile filtration and stored as 10 ml aliquots at -20°C. 
 
Phosphate buffered saline (1X PBS) 
Constituent Amount Final Concentration 
KCl 0.2 g 2.7 mM 
KH2PO4 0.2 g 1.76 mM 
NaCl 8.0 g 137 mM 
Na2HPO4 2.88 g 10.0 mM 
Chemicals were dissolved in 1000 ml dH2O, pH adjusted to 7.4 with HCl, and the solution 
was sterilized by autoclaving.  
 
3 M Sodium acetate (for precipitation of linearized plasmid DNA) 
Constituent Amount  Final Concentration 
Sodium acetate anhydrous 2.46 g 3 M 
Sodium acetate was dissolved to a final volume of 10 ml with dH2O, the pH was adjusted 
up to 5.1 with glacial acetic acid and the solution was sterilized via sterile filtration. 
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DNA Loading Buffer 
Constituent Amount Final Concentration 
Bromophenol blue 25 mg 0.25% 
Xylene cyanol 25 mg 0.25% 
Sucrose 4 g 4% 
 
Tris-Acetate-EDTA (50X TAE-buffer) 
Constituent Amount Final Concentration 
Tris 242 g 2 M 
Glacial acetic acid 57.1 ml 5.71% 
0.5 M EDTA (pH 8.0) 100 ml 0.05 M 
Chemicals were dissolved in 1000ml dH2O.  
 
TE-Buffer  
Constituent Amount Final Concentration 
1M Tris 1 ml 10 mM 
0.5 M EDTA (pH 7.4) 0.2 ml 1 nM 
 
2.7 Solutions and Buffer for Southern-Blotting 
Depurination-Solution  
Constituent Amount Final Concentration 
HCl - 250 mM 
 
Denaturation-Solution  
Constituent Amount Final Concentration 
NaOH 19.99 g 500 mM 
NaCl 87.66 g 1.5 M 
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Neutralisation-Solution  
Constituent Amount Final Concentration 
Tris/HCl 60.57 g 500 mM 
NaCl 87.66 g 1.5 M 
 
20x SSC  
Constituent Amount Final Concentration 
Na-citrat dihydrate 88.23 g 300 mM 
NaCl  175.32 g 3 M 
 
Maleic Acid-Buffer  
Constituent Amount Final Concentration 
Maleic acid 11.6 g 100 mM 
NaCl  8.76 g 150 mM 
 
10x Blocking Solution  
Constituent Amount Final Concentration 
Blocking reagent  10 g 10% 
Maleic acid buffer 90 ml - 
Solution was autoclaved at 121°C for 20 min. 
 
Hybridization Buffer 
Constituent Amount Final Concentration 
20x SSC 25 ml 25% 
10x Blocking solution 10 ml 10% 
SDS 0.2 g 0.2% 
N-lauroylsarcosine 1 g 1% 
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Washing Buffer 
Constituent Amount Final Concentration 
Maleic acid buffer 997 ml - 
Tween 20 3 ml 0.3% 
 
2.8 Chemicals, Solutions and Media for Cell Culture 
Media & Additives Product Number Manufacturer 
Dulbecco’s Modified Eagle Medium 
(DMEM) 
41965 Gibco/Invitrogen™ 
ES Cell Qualified Fetal Bovine Serum 
(Mexiko) 
10439024 Gibco/InvitrogenTM 
ESGRO® (107 Units) = leukemia 
inhibitory factor (LIF) 
ESG1107 Chemicon® 
FIAU (1-(2-Deoxy-2-fluoro-ß-D-
arabinofuranosyl)-5-iodouracil) 
M251 Moravek Biochemicals 
G418, liquid (Geneticin) Ant-gn-5 InvivoGen 
Hank’s balanced salt solution (HBSS) 14025050 Gibco/InvitrogenTM 
L-Glutamine, 200 mM, liquid 25030 Gibco/InvitrogenTM 
2-Mercaptoethanol, 50 mM 31350010 Gibco/InvitrogenTM 
Minimum Essential Medium (MEM) 31095029 Gibco/InvitrogenTM 
MEM Non Essential Amino Acids 
Solution 
11140035 Gibco/InvitrogenTM 
Penicillin-Streptomycin solution 15140130 Gibco/InvitrogenTM 
Sodium Pyruvate, 100 mM, liquid 11360 Gibco/InvitrogenTM 
Trypsin / EDTA (0.05%/0.02%) P10-02318P PANTM Biotech 
GmbH 
Trypsin, 0.25% (1x) with EDTA 4Na, 
liquid 
25200 Gibco/InvitrogenTM 
UltraPureTM Distilled water 10977 Gibco/Invitrogen™ 
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ES Cell Medium 
Constituent Volume [ml] Final Concentration 
Dulbecco’s Modified Eagle Medium 
(DMEM) 
500 - 
Fetal Bovine Serum (ES Cell approved) 56 10% 
L-Glutamine, (200 mM) 5.6 2 mM 
Penicillin-Streptomycin 5.6 
0.6% 
Sodium pyruvate (100 mM) 5.6 
2 mM 
Non-Essential Amino Acids 5.6 
0.1 mM 
2-Mercaptoethanol, (50 mM) 1.1 0.1 mM 
ESGRO® (107units/ml) 0.05 1000 units/ml 
 
ES Cell Selection Medium 
Constituent Volume [ml] Final Concentration 
Dulbecco’s Modified Eagle Medium 
(DMEM) 
500 - 
Fetal Bovine Serum (ES Cell approved) 56 10% 
FIAU 0.5 0.2 µM 
G418 4 600 µg/ml 
L-Glutamine, (200 mM) 5.6 2 mM 
Penicillin-Streptomycin 5.6 
0.6% 
Sodium pyruvate (100 mM) 5.6 
2 mM 
Non-Essential Amino Acids 5.6 
0.1 mM 
2-Mercaptoethanol, (50 mM) 1.1 0.1 mM 
ESGRO® (107units/ml) 0.05 1000 units/ml 
 
ES Cell Freezing Medium (2x) 
Constituent Volume [ml] Final Concentration 
Dulbecco’s Modified Eagle Medium 
(DMEM) 
50 - 
Fetal Bovine Serum (ES Cell approved) 40 40% 
DMSO 10 10% 
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Fibroblast Medium 
Constituent Volume [ml] Final Concentration 
Dulbecco’s Modified Eagle Medium 
(DMEM) 
500 - 
Fetal Bovine Serum 56 10% 
L-Glutamine, (200 mM) 5.6 2 mM 
Sodium pyruvate (100 mM) 5.6 
2 mM 
Penicillin-Streptomycin 5.6 
0.6% 
 
Gelatin was dissolved in cell culture grade water (UltraPureTM Distilled water), autoclaved 
twice (second time on the following day) and stored at 4-8°C. For usage a working dilution 
(0.1% in UltraPureTM Distilled Water) was prepared. 
 
FIAU (1-(2-Deoxy-2-fluoro-ß-D-arabinofuranosyl)-5-iodouracil, 0.2 mM) 
Constituent Amount Final Concentration 
FIAU 1.0 mg 0.2 mM 
UltraPureTM Distilled water Ad 13.4 ml - 
FIAU solution was always sterilized by filtration, divided in aliquots (500 µl) and stored at  
-20°C. 
 
10X HBS (ES cell electroporation) 
Constituent Amount Final Concentration 
D-Glucose 2.0 g 1% 
HEPES 10.0 g 20 mM 
KCl 0.74 g 50 mM 
NaCl 16 g 280 mM 
Na2HPO4 0.252 g 1.5 mM 
UltraPureTM Distilled water Ad 200 ml - 
Chemicals were dissolved in water; the pH was adjusted to 7.2 and solution was sterilized 
via sterile filtration. 
Gelatin Solution (for ES Cell Cultivation) 
Constituent Amount Final Concentration 
Gelatin 2.0 g 1% 
UltraPureTM Distilled Water Ad 200 ml - 
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2.9 Media and Solutions for Bacteria Culture 
Rubidium Chloride Solution 1 
Constituent Amount Final Concentration 
KAc 0.088 g 30 mM 
MnCl2  (x 4 H2O) 0.297 g 50 mM 
RbCl 0.363 g 100 mM 
CaCl2 (x 2 H2O) 0.044 g 10 mM 
Glycerol 4.5 ml 15% 
Chemicals were dissolved in 4.5 ml water; the pH was adjusted to 5.8 with HCl and 
solution sterilized via sterile filtration.  
 
Rubidium Chloride Solution 2 
Constituent Amount Final Concentration 
RbCl 0.012 g 10 mM 
CaCl2 (x 2 H2O) 0.110 g 75 mM 
MOPS 0.021 g 10 mM 
Glycerol 1.5 ml 15.0% 
dH2O ad 10 ml - 
Chemicals were dissolved in 10 ml water, the pH was adjusted to 6.8 with HCl and the 
solution was sterilized via sterile filtration. 
 
Super Optimal Broth (SOB Medium) 
Constituent Amount Final Concentration 
Tryptone 6.0 g 2.0% 
Yeast extract 1.5 g 0.5% 
NaCl 0.175 g 10 mM 
KCl 0.055 g 2.5 mM 
1 M MgCl2 3.0 ml 10 mM 
1 M MgSO4 3.0 ml 10 mM 
All constituents were dissolved in Milli-Q water up to a final volume of 300 ml and 
sterilized by autoclaving. MgCl2 and Mg2SO4 solutions were added directly before usage. 
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LB Agar 
Constituent Amount Final Concentration 
Agar 15 g 1.5% 
NaCl 10 g 1% 
Tryptone 10 g 1% 
Yeast extract 5 g 0.5% 
Constituents were dissolved in Milli-Q water up to a final volume of 1000 ml, and the pH 
was adjusted to 7.5 with NaOH. The solution was heated to dissolve the agar and sterilized 
by autoclaving. 
 
LB Medium 
Constituent Amount Final Concentration 
NaCl 10 g 1% 
Tryptone 10 g 1% 
Yeast extract 5 g 0.5% 
Constituents were dissolved in Milli-Q water up to a final volume of 1000 ml, the pH was 
adjusted to 7.4 with NaOH, and the solution was sterilized by autoclaving. 
2.10 Water Purification 
All solutions were prepared with purified demineralized (dH2O) water obtained from a 
Milli-Q® Water System (Millipore, Eschborn) or with sterile UltraPureTM Distilled Water 
(Gibco/InvitrogenTM). 
2.11 Sterilization Method 
For molecular and cellular biological experiments all heat stable materials, equipments, 
solutions and media were autoclaved in a Varioklav® (H+P Labortechnik AG, 
Oberschleißheim) at 121°C and 1.2 bar for 21 min. Sterilization of heat sensitive solutions 
and buffers was accomplished by the use of sterile filters (pore wide 0.2 µm).  
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2.12 Plasmids, Bacterial Strains and Cell-Lines 
XpPNT: Targeting vector for the mutation of the murine ProT gene locus. The XpPNT- 
vector is described in detail (9.1) and pictured in the annex (Figure 41). It was kindly 
provided by Prof. Dr. Jesús Gomeza. 
pBS: pBluscript II KS (+/-) vector was used for the amplification of parts of the ProT 
gene. This vector (2961 bp) consists of an origin of replication in E.coli, a multiple cloning 
site (MCS), and an ampicillin resistance gene (amp).  
XL1-Blue: This E.coli strain obtained from Agilent Technologies (200249) was used for the 
amplification of recombinant plasmids. 
HM1: This embryonic stem cell line was derived from mice strain Ola/SV129. These cells 
were kindly provided by Prof. Dr. Volkmar Gieselmann (Institute of Physiological 
Chemistry, University of Bonn) (Magin et al. 1992). 
2.13 Consumables 
Consumables Product Number Manufacturer 
Cell culture flasks 430168 / 430729 / 431079 Corning 
Centrifuge tubes 430791 / 430829 Corning 
Combitips plus 0030 069. 447/455/463/390 Eppendorf 
Costar® 6 / 12 / 24 well 
plates 
3506 / 3512 / 3527 / 3548 Corning 
Cryogenic vials 5000-1020 Nalgene® 
Culture dishes 430166 / 430167 Corning 
Disposable filter unit 0.2 µl FB30/0.2 CA-s Whatman® 
ELISA microplate (96 well) 9017 Corning 
Filter tips SSNC B95012 / B95020 / B 90222 
/ B95210 
Bioplastics BV 
Gene Pulser® cuvette 165-2088 Bio-Rad 
Incubation tubes 294718727 Labomedic 
1.5 ml 115105 Labomedic 
2.0 ml 115106 Labomedic 
Nitrocellulose membranes RPN203E GE Healthcare 
ParafilmTM 1447011 Labomedic 
Pasteur pipettes, glass 447016 Labomedic 
Pasteur pipettes, PP, sterile 297804239 Labomedic 
PCR tubes 0030 124.332 Eppendorf 
Oxygen crystal tips 10 µl 110727 Labomedic 
Whatman paper GB005 Biometra 
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Consumables Product Number Manufacturer 
Yellow 200 µl tips 70.760.002 Sarstedt 
Blue 1000 µl tips 686290 Greiner bio-one 
Stripette® serological pipettes 4486 – 4490 Corning 
 
2.14 Laboratory Instruments and Equipment 
Type Format Manufacturer 
Autoclave Varioklav® H&P Labortechnik 
Balance TE64 Sartorius 
Balance TE6101 Sartorius 
Balance BL310 Sartorius 
Camera CoolSNAPHQ2 Roper Scientific 
Centrifuge MiniSpin Eppendorf 
Centrifuge Galaxy Mini VWR 
Centrifuge Centrifuge 5810 Eppendorf 
CO2 incubator Heraeus
®HERAcell® 240 Thermo Fisher 
Scientific 
Counting chamber Fuchs-Rosenthal Labomedic 
Dry block heater Thermomixer® comfort Eppendorf 
Dry block heater QBT2 Grant Instruments 
Electronic pipet filler Easypet® Eppendorf 
Electrophoresis chamber Mini-Sub® cell GT Bio-Rad 
Electrophoresis chamber Wide Mini-Sub® cell GT Bio-Rad 
Freezer (-80°C) Heraeus®Herafreeze® Thermo Fisher 
Scientific 
Freezer (liquid nitrogen) MVE 815P-190 Chart BioMedical 
Ltd. 
Microplate reader Sunrise-Basic Tecan Tecan Austria 
GmbH 
Microscope CKX31SF Olympus 
Microscope Leica DM IL LED Fluo Leica 
Microwave Intello Wave LG 
PCR cycler GeneAmp® PCR System 
9700 
Applied Biosystems 
PCR cycler 2720 Thermal Cycler Applied Biosystems 
qPCR cycler Realplex2 S Eppendorf 
pH-meter SevenEasy™ Mettler Toledo 
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Type Format Manufacturer 
Photo documentation system De Vision DBOX Decon Sience Tec 
Pipettes 0.5-10 µl; 10-100 µl; 100-
1000 µl 
Eppendorf 
Power supplie PowerPac HC™ Bio-Rad 
Safety cabinet HeraSafe HS12 Thermo Electron 
Shaking water bath Herlev Buch& Holm 
Sponge Pad Sponge InvitrogenTM 
UV/VIS spectrophotometer SmartSpecTM Plus Bio-Rad 
Vacuum pump system AP 15 HLC BioTech 
Vortex Milli-Q® Water System Millipore 
Water purification system Reax Top Heidolph 
Infrared-tracking system Actimot TSE Systems 
Liquid scintillation counter Wallac 1409 Wallac 
Detection system DeVision DBOX Decon Science Tec 
Blotting module XCell II Blot Module InvitrogenTM 
Blotting chamber XCell SureLock™ Mini-Cell InvitrogenTM 
 
2.15 Software 
Name Company 
Actimot TSE Systems 
Citavi v3.0 Swiss Academic 
DeVision G v1.0 Decon Science Tec GmbH 
Gel Pro Analyzer Media Cybernetics 
Gel Scan Software BioSciTec 
Office Excel 2007 Microsoft® Corporation 
Office PowerPoint® Microsoft® Corporation 
Office Word 2007 Microsoft® Corporation 
Prism® 4.02 GraphPad Software 
Symyx® Draw 3.3 Symyx Solutions, Inc. 
Vector NTI 8 InvitrogenTM 
Quantity One Bio-Rad 
XFluor4 Microsoft® Corporation/Tecan sunrise 
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3 Methods 
3.1 Cell Culture Methods 
3.1.1 Cultivation of Cells 
All cells were cultivated at 37°C in an incubator with 5% CO2 and humid atmosphere  
(96% humidity). Every operation was carried out under aseptic conditions in safety 
cabinets with laminar air flow. HM1-embryonic stem (ES) cells, which derive from 
Ola/SV129 mice strain (Magin et al. 1992), were kindly provided by Prof. Dr. Volkmar 
Gieselmann (Institute of Physiological Chemistry, University of Bonn). These cells where 
cultured on monolayers of mitotically inactivated mouse embryonic fibroblasts (MEF) as 
feeder cells. ES cells were passaged three times a week, splitted at a ratio of 1:3 to 1:10, 
depending on their growth rate, to reach approximately 70% confluence. For trypsinization 
growth medium was removed from the flask and cells were washed with pre-warmed PBS 
(2.8). Afterwards, cells were incubated with ES cell trypsin at 37°C for up to 3 min until 
cells were detached. Trypsinization was stopped by adding ES cell medium (2.8). After 
trypsinization, cells were dispensed on fresh feeder plates, which had been prepared in 
advance. Medium exchange was performed daily.  
3.1.2 Generation of Embryonic Mouse Fibroblasts (Feeder Cells) 
Mouse Embryonic Fibroblast (MEF) were derived from mouse embryos carrying a 
neomycin resistance gene and required to support the growth of undifferentiated ES cells 
by releasing cytokines such as LIF to the culture media. These cells were kindly provided 
by Dr. Jesús Gomeza (Institut für Pharmazeutische Biologie, AK Kostenis, University of 
Bonn).  
3.1.2.1 Gamma Ray Treatment of Embryonic Mouse Fibroblasts 
Feeder layer fibroblasts need to be mitotically inactive in order to seed a monolayer with a 
defined cell number. Therefore, cells were treated by irradiation to stop mitosis, while 
maintaining the ability to secrete growth factors. The irradiation was performed by  
Dr. Stefan Garbe (Radiology, University Medical Center of Bonn) by treating the 
fibroblasts with gamma rays (96 Gray for 5 min). The same day feeder cells became 
cryopreserved (3.1.3). Usually, one day before ES cell plating was conducted, cell culture 
dishes were gelatinized with 10 ml of a gelatin working solution (0.1%) and incubated for 
10 min. After aspiration of gelatin solution, a calculated amount of feeder cells was seeded 
on these plates, which were used for up to four days.  
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3.1.3 Cryopreservation and Re-Cultivation of Cell Lines 
In order to prepare permanent cell line stocks, cells were frozen at – 80°C, and after 1–2 
days they were transferred into liquid nitrogen (-180°C) for long-term storage. For this 
purpose, cells were trypsinized, dispersed in freezing medium (+20% FCS and 10% 
DMSO), and stored in cryotubes. For thawing cells after long-term storage, they were 
unfrozen rapidly in a 37°C water bath, diluted in medium, and after resuspension spun 
down at 800 g (4 min). Afterwards, the supernatant was discarded in order to remove 
DMSO, and cells were resuspended in fresh medium before being transferred to cell 
culture flasks or dishes.  
3.1.4 Electroporation of Murine Embryonic Stem Cells 
For electroporation, a culture of densely grown early-passage ES cells (55cm2 cell culture 
dishes) was used. The medium was changed 1–2 hours before harvesting the cells. ES cells 
were trypsinized, and centrifuged twice (4 min, 800 rpm) in order to reduce the amount of 
feeder cells. After final resuspension in 10 ml of fresh ES medium, the cell number was 
determined in a hemacytometer in order to utilize ~10-20x106 ES cells per electroporation. 
The appropriate amount was again spun down and resuspended in 980 µl of 
electroporation buffer (1x HBS). This suspension and 20 µl of the linearized targeting 
DNA construct (2 µg/µl) were transferred to an electroporation cuvette (0.4 cm) and 
incubated for 5 min (RT). Electroporation was carried out with one pulse of 230 V and  
500 µF with a time constant of 118 ms. The short high voltage pulse of the electroporator 
disturbs the membrane potential with subsequent formation of pores across the 
membranes to allow incorporation of the DNA (Sukharev et al. 1992). After a further  
10 min, cells were resuspended in an appropriate volume of ES medium (1-2x106 cells per 
10 ml per 55 cm2) and transfered to feeder cell covered plates. 
Selection of cells harboring the desired construct was initiated 24 hours later by first 
switching to selection medium containing G418 (600 µg/ml), and from the following day 
on G418 (600 µg/ml) as well as FIAU (0.2 µM) were used. Whereas the neomycin analog 
G418 serves for the maintenance of cells with stably integrated neo resistance gene of the 
targeting construct, FIAU selects for cells that do not exhibit an integration of the  
HSV-TK gene. Medium was changed daily over a selection time of 9 days. Thereafter, 
single colonies appearing on the plates were isolated. For this purpose, selection medium 
was replaced by prewarmed PBS, and cell clones were picked by use of a 200 µl pipette 
already containing 100 µl ES cell trypsin/EDTA. The suspensions were transferred into  
24-well plates. After trypsinization, cells were singularized by pipetting, dispersed in 1 ml of 
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ES cell medium, and transferred into new 24-well cell culture dishes, already coated with 
monolayers of feeder cells. After 24 hours, medium was renewed, and cells were grown 
until they reached a confluence of approximately 80-90%. For storage, two-thirds of these 
cells were cryopreserved. The remaining cells were kept in culture until they reached full 
confluence to obtain highest rates of DNA yields. 
3.2 Methods in Molecular Biology 
3.2.1 Transformation of Chemical Competent Bacteria 
Transformation of bacteria with plasmid DNA was performed in order to increase plasmid 
amount in relation to the genomic DNA. This was achieved by chemical pretreatment with 
rubidium chloride and a subsequent heat shock.  
3.2.1.1 Preparation of Rubidium Chloride Competent E.coli Cells 
An initial culture was prepared by inoculating 5 ml of SOB medium with 5 µl of XL-1 blue 
bacteria. The suspensions were grown over-night at 37°C and 220 rpm. The next day,  
100 ml of SOB medium were inoculated with 1 ml of the over-night culture and grown at 
37 C° and 220 rpm until the OD550 reached 0.5. Afterwards, cells were put on ice for  
10 min and subsequently pelleted at 2800 g for 10 min in pre-cooled tubes at 4 C°. 
Thereafter, the supernatants were removed, and the bacteria pellets were resuspended in  
25 ml of ice-cold rubidium chloride solution 1 (2.9). The suspension was incubated on ice 
for 10 min followed by centrifugation at 2800 g (4°C). Finally, bacteria became 
resuspended again in 8 ml of rubidium chloride solution 2 (2.9), were aliquoted, 
immediately frozen in liquid nitrogen, and stored at -80°C until usage. 
3.2.1.2 Transformation by Heat Shock 
For the transformation procedure, aliquots (100 µl) of rubidium chloride competent 
bacteria were thawed on ice, and after unfreezing an appropriate amount of plasmid DNA 
(~0.05-100 µg) was added and mixed by pipetting up and down. This solution of XL1-blue 
bacteria was incubated 30 min on ice, followed by a 30 seconds heat-shock at 42°C in a 
block heater. After the heat-shock, the suspension was placed on ice again and incubated 
for a further 2 min. Thereafter, 300 µl of SOC medium were added, and suspension was 
incubated at 37°C and 220 rpm for 60 min (allowing formation of antibiotic resistance 
encoded on the plasmid DNA). After that, the bacteria suspensions were distributed  
(50-200 µl) on prewarmed LB agar plates containing the appropriate selective antibiotic 
(usually ampicillin), and incubated over-night at 37°C. 
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3.2.2 Isolation of Plasmid DNA 
Plasmid DNA was isolated according to the required amount of DNA using special 
commercial available kits QIAprep® Spin Miniprep Kit or NucleoBond® Xtra Maxi as 
recommended by the manufacturer. 
3.2.3 Isolation of Genomic DNA 
To isolate genomic DNA from mouse tail biopsies, a commercially available kit was used 
(InnuPREP DNA Mini Kit).  
For isolation of genomic DNA from ES cells cultured in 24-well cell culture dishes the 
following protocol was applied. After the medium was aspirated, cells were incubated in  
300 µl of lysis buffer (10 mM Tris-HCl pH 8.0, 5 mM EDTA, 0.2 % SDS, 200 mM NaCl) 
at 55°C with agitation (600 rpm), for two hours up to over-night. Afterwards, a 
centrifugation step was carried out to pellet the non-soluble material. The DNA of the 
supernatant was purified via ethanol and NaCl ion precipitation. Therefore, 150 µl of 
saturated NaCl-solution and 900 µl of absolute ethanol were added, and the resulting 
DNA-filaments were transferred into reaction tubes, prefilled with 500 µl of 70% ethanol. 
Subsequent, DNA was spun down (12000 rpm for 5 min), the pellet was air-dried, and 
dissolved in 100 µl of UltraPureTM distilled water or TE-buffer. 
3.2.4 Cryoconservation of Bacterial Strains 
In order to prepare permanent stocks of bacterial strains containing favored plasmids and 
thereby saving retransformation, the respective bacteria were cryopreserved. This was done 
by addition of 200 µl glycerol to 800 µl of the respective bacterial suspension and 
subsequent storage at -80°C. 
3.2.5 Ethanol Precipitation 
Ethanol precipitation was performed in order to concentrate nucleic acids, or to transfer 
them into a new set of buffer and salts. The (cleaved) DNA was well mixed with 1/10 
volume of sterile 3 M sodium acetate (pH 5.1) and with 2 volumes of absolute ethanol. 
Afterwards, the DNA was pelleted for 5 min at 13000 rpm. After decantation of the 
supernatant, the pellet was washed with 500 µl of 70% ethanol and spun down once more 
for 5 min at 13000 rpm. The supernatant was discarded and after the DNA pellet was air-
dried, it was dissolved in the desired amount of buffer (e.g. TE buffer) or UltraPureTM 
distilled water. 
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3.2.6 Determination of Nucleic Acid Concentration 
The concentration of nucleic acids was determined photometrically by measurement of the 
absorption at a wavelength of 260 nm. To calculate nucleic acid concentrations (µg/ml), 
the following formula was used:  
C [µg/ mL] = A260 x D x F 
c concentration 
A260 Absorption at 260 nm 
D Dilution factor 
F Multiplication factor (for DNA 50)  
1 absorbance corresponds to 50µg DNA per ml water 
The quotient of A260/A280 is a determinant of the purity and should range between 1.6 and 
2.0 (in water) so as to protein impurities can be disregarded.  
3.2.7 Agarose Gel Electrophoresis 
For agarose gel electrophoresis varying concentrations of agarose (0.5-1.5% agarose) were 
diluted in 100 ml of electrophoresis buffer (1xTAE, pH 8; 2.6) and boiled to form a matrix. 
After cooling down, ethidium bromide (0.5 µg/ml) was added to the solution to enable 
visualization of the separated DNA fragments by fluorescence in UV light (302 nm). 
Electrophoresis was carried out at 20-120 V. For determination of the size of the applied 
fragments, a DNA size marker was always loaded in parallel. Prior to loading, the samples 
were always supplemented with loading buffer (2.6). 
3.2.8 Purification of DNA-Fragments 
DNA-fragments were purified using a commercial Gel Extraction-Kit (Qiagen) following 
the manufacturer’s instructions. For that purpose, a gel slice containing the DNA fragment 
of interest was cut off and solubilized by mixing it with the appropriate buffer and thermal 
heating. Afterwards, the solution was applied to a spin column where the DNA binds to 
the silica gel membrane and impurities were washed away. Finally, the pure DNA was 
eluted in 30 µl of UltraPureTM distilled water or TE-buffer. 
3.2.9 Restriction Endonuclease Cleavage of DNA  
Sequence-dependent cleavage of DNA was carried out using commercially available 
restriction endonucleases and the appropriate buffers (and if needed BSA) at the required 
temperature. Restriction of DNA was performed for analytical purpose (e.g. identification 
of plasmid or a targeting event in genomic DNA) or for preparative purpose (e.g. isolation 
of a fragment for cloning). For analytical purposes up to 1 µg of plasmid DNA was cleaved 
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with one or more restriction enzymes (1-10 units each) in a volume of 10-20 µl for at least 
one hour. For preparative purposes vector DNA and/or PCR products were cut with 
similar restriction enzymes to obtain compatible, sticky ends. 
3.2.10  Dephosphorylation of Cleaved Vector DNA 
Antarctic Phosphatase was used to catalyze the removal of 5´phosphate groups from 
restriction enzyme cleaved products of vector DNA prior to ligation reactions. The cleaved 
vector DNA was incubated in a mixture of 1 x Antarctic Phosphatase reaction buffer and  
5 U of Antarctic Phosphatase at 37°C for 15 min. Afterwards, the enzyme was heat-
inactivated at 65°C for 5 minutes. 
3.2.11  Ligation of DNA Fragments 
DNA ligase of the phage T4 was used to catalyze the formation of phosphodiester bonds 
between 5'-phosphate and 3'-hydroxyl termini for ligation reactions. For this purpose, 
fragments with sticky ends of digested and dephosphorylated vector DNA (50-500 ng) and 
the respective insert DNA were mixed in a molecular ratio of 1:5 (vector to insert). This 
reaction mixture was supplemented with ligation buffer; UltraPureTM distilled water and  
2 U of T4 DNA Ligase to a total volume of 10 µl and incubated over-night at 16°C. 
3.2.12  Sequencing of Cloned DNA Constructs 
Sequencing reactions were conducted by GATC Biotech AG (Konstanz). Thus, the correct 
sequence and especially the absence of point mutations (in PCR products) were ensured.  
3.2.13  RNA-Isolation 
After tissue sample preparation (3.3.2), RNA was isolated either by the RNeasy® Micro Kit 
(Qiagen) or through the following protocol: Tissue (~50 mg) was homogenized 
(20 strokes) in 800 µl of denaturating solution (4 M guanidinium-thiocyanate, 25 mM 
sodium citrate, 0.5% sarcosyl, and 0.1 M 2-mercaptoethanol in RNase-free water, 
autoclaved, pH 7.0) on ice. Subsequently, 80 µl of sodium acetate (2 M, pH 4.1), 800 µl of 
Phenol (water saturated) as well as 160 µl of a chloroform-isoamylalcohol mixture (49:1) 
were added to the homogenates, mixed well, and samples were incubated 15 min on ice 
before centrifugation (20 min, 13000 rpm, 4°C). The upper aqueous phase was mixed with 
one volume of isopropanol in a new cap, spun down shortly and incubated at -20°C for 1 h 
to over-night to precipitate the RNA.  
Then, samples were centrifuged (20 min, 13000 rpm, 4°C), and the supernatants were 
discarded. Pellets were dissolved again in denaturating solution (300 µl) and mixed with one 
volume of isopropanol and incubated at -20°C for 1h to overnight. After a subsequent 
centrifugation step (20 min, 13000 rpm, 4°), the pellets became dissolved in 70% ethanol 
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spun down once more (20 min, 13000 rpm, 4°), and finally dissolved in 30 µl RNase free 
water. 
3.2.14  Reverse Transcription 
For the cDNA synthesis, Revert Aid reverse transcriptase (Fermentas) was incubated for  
1 h at 37°C together with 200 ng of RNA, the RiboLockTM RNase Inhibitor (Fermentas) 
and 250 pmol of random hexamer primer (Invitrogen) in a final volume of 20 µl. “No-
reverse transcriptase” controls were performed by omitting reverse transcription, and “no-
template” controls were carried out by addition of ultra-pure water instead of the DNA 
template. For qPCR experiments the cDNAs were diluted 1:4 with ultra-pure water. 
3.2.15  Polymerase Chain Reaction (PCR) 
The temperature profiles and reaction outlines of the different PCRs, performed in the 
scope of this thesis, were specifically adjusted according to the thermodynamic properties 
of the oligonucleotide primer and the lengths of the amplified PCR products. In the 
following, all PCR-setups used in the scope of this thesis are listed in detail.  
3.2.15.1 PCR-Setup for Isolation of the DNA for the Generation of the Targeting 
Vector 
 
 
Reaction Mixture Program 
2.0 µl Template (genom. DNA)  Time Temperature 
1.0 µl Sense primer, halfext., 100 µM  [min] [°C] 
1.0 µl Antisense primer, halfext., 100 µM Initial denaturation 
40 cycles of 
2:30 95 
 
10.0 µl 5x GoTaq buffer (with MgSO4, 
Fermentas) 
     Denaturation 0:30 95 
2.0 µl dNTP-Mix, 2.5 mM each      Hybridization 1:00 62 
0.5 µl GoTaq Flexi® DNA Polymerase  
(2-3 U/µl) 
     Extension 2:00 72 
2.0 µl DMSO Final extension 10:00 72 
31.5 µl  UltraPureTM distilled water    
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3.2.15.2 PCR Setup for Maintaining the Southern Probe Template 
 
3.2.15.3  Setup for the Southern Probe for Detection of Targeted ES Cells 
For the generation of the radiolabeled probe used for Southern-blot experiments  
(3´-southern-probe, 2.4) 7 µl of the isolated (QIAquick® Gel Extraction Kit) template 
(3.2.15.2) was mixed with 3 µl UltraPureTM distilled water, incubated 5 min at 97°C, and 
then was put immediately on ice for 2 min. Subsequently, random hexamer primer, dNTPs, 
5 µl dCTP32, and 2U Klenow fragment of DNA polymeraseI were added (Random 
Primed DNA Labeling Kit, Roche), and the mixture was incubated for 1 h at 37°C. 
Afterwards, 30 µl of STE-buffer (10 ml TE, 300 µl 5 M NaCl) were added, and the probes 
were cleaned up with the ProbeQuantTM-Kit according to the manufacturer’s 
recommendations. 15 µl of the flow-through were used for the Southern-blot detection. 
3.2.15.4 PCR-Setup for the qPCR-Primer Validation 
Reaction Mixture Program 
1.5 µl cDNA-template (3.2.14)  Time Temperature 
1.0 µl Respective "sense" primer, 40 pmol  [min] [°C] 
1.0 µl Respective"antisense" primer, 40 pmol Initial denaturation 
40 cycles of 
2:00 95 
 
5.0 µl 5x GoTaq buffer (Fermentas)      Denaturation 0:30 95 
0.5 µl dNTP-Mix, 10 mM      Hybridization 0:30 55 
0.5 µl GoTaq Flexi® DNA Polymerase  
(2-3 U/µl, Fermentas) 
     Extension 0:30 72 
0.7 µl MgCl2 Final extension 1:00 72 
15 µl  UltraPureTM distilled water    
 
Reaction Mixture Program 
2.0 µl Template (genom. DNA, 3.2.3)  Time Temperature 
1.0 µl Sense primer, halfext., 100 µM  [min] [°C] 
1.0 µl Antisense primer, halfext., 100 µM Initial denaturation 
40 cycles of 
2:30 95 
 
10.0 µl 5x GoTaq buffer (with MgSO4, 
Fermentas) 
     Denaturation 0:30 95 
2.0 µl dNTP-Mix, 2.5 mM each      Hybridization 1:00 62 
0.5 µl GoTaq Flexi® DNA Polymerase  
(2-3 U/µl) 
     Extension 2:00 72 
2.0 µl DMSO Final extension 10:00 72 
31.5 µl  UltraPureTM distilled water    
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3.2.15.5 PCR Setup for Expression Analysis by qPCR 
SYBRGreen fluorescence signal was monitored using a qPCR cycler (Realplex2 S). Since 
the CT-value is proportional to the logarithm of the initial concentration of the target gene 
in the sample, samples measured in parallel can be compared relative to each other. The 
use of the unspecific fluorescence dye SYBRGreen, instead of gene-specific probes as well 
as exertion of ubiquitous reaction terms allowed the high-throughput detection of different 
target sequences, as like this qPCR specificity was determined only by selection of the 
particular primer sequences.  
To optimize qPCR conditions, different template and primer concentrations for the target 
genes were tested initially in parallel. The sizes of the resulting PCR products for each 
primer pair were also verified by gel electrophoresis (appendix: 9.2). Furthermore, 
efficiencies of reference gene primers coding for GAPDH and β-actin were determined by 
dilution curves. Both reference genes were detected, but β-actin transcript was expressed 
slightly more stably and therefore chosen for these analyses.  
Extraction of mRNA was carried out from the brain areas frontal cortex, striatum and 
hippocampus of 3 month old animals. It was essential that the obtained mRNA was free 
from genomic DNA. Therefore, a DNAse digest was accomplished before extraction was 
carried out. Integrity of the mRNA was verified through the presence of the two discreet 
18S and 28S rRNA bands on agarose gels (appendix: Figure 45). After extraction and 
purification of total RNA (Methods, 3.2.13), cDNA was synthesized from RNA prior to 
qPCR reaction (Methods, 3.2.14). Data obtained from ProT -/-- and ProT +/+-genotypes were 
finally normalized by the reference gene β-actin. 
The efficiencies for the primers used for analyses of the genes of interest were not 
determined explicitly, and were assumed to be amplified with 100% efficiency for 
calculation (amplification-coefficient was set at 2). 
Reaction Mixture Program 
2.0 µl cDNA-template (3.2.14)  Time Temperature 
1.0 µl Respective "sense" primer, 10 pmol  [min] [°C] 
1.0 µl Respective "antisense" primer,  
10 pmol 
Initial denaturation 
40 cycles of 
10:00 95 
 
5.0 µl Jump-Mix (Sigma)      Denaturation 0:30 95 
1.0 µl dNTP-Mix, 2.5 mM each      Hybridization 0:30 59 
2.0 µl UltraPureTM distilled water      Extension 0:30 72 
  Final extension 10:00 72 
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3.2.15.6 PCR Setup for RT-PCR Analysis 
Reaction Mixture Program 
2.0 µl cDNA-template (3.2.14)  Time Temperature 
1.0 µl "Sense" primer, Ex5 Forward 100 µM  [min] [°C] 
1.0 µl "Antisense" primer, Ex9 Reverse resp. 
Beta-Actin, 100 µM 
Initial denaturation 
30 cycles of 
2:00 95 
 
5.0 µl 5x GoTaq PCR buffer (Fermentas)      Denaturation 0:30 94 
1.0 µl dNTP-Mix, 10 mM      Hybridization 0:30 55 resp. 58  
(β-Actin) 
0.3 µl GoTaq Flexi® DNA Polymerase 
(Fermentas)  
(2-3 U/µl) 
     Extension 0:45 70 
1.0 µl DMSO Final extension 2:00 70 
12.7 µl  UltraPureTM Distilled water    
 
3.2.15.7  PCR Setup Genotyping 
Presence of wild-type allele was proven by an amplicon of 354 bp, whereas the occurrence 
of modification of ProT gene was shown by the appearance of a PCR product of 430 bp. 
Reaction Mixture Program 
1.0 µl Isolated genomic DNA (3.2.3)   Time Temperature 
0.5 µl Respective "sense" primer, 20 µM  [min] [°C] 
0.5 µl Respective "antisense" primer, 20 µM Initial denaturation 
30 cycles of 
2:00 95 
 
5.0 µl 5x Taq buffer (Fermentas)      Denaturation 0:30 95 
2.0 µl MgCl2      Hybridization 0:30 59 
1.0 µl dNTP-Mix, 10 mM       Extension 0:30 72 
0.3 µl GoTaq Flexi® DNA Polymerase 
(5U /µl, Fermentas) 
   
1.0 µl DMSO Final extension 1:00 72 
13.7 µl  UltraPureTM distilled water    
 
3.2.16  Preparation of Plasmamembrane-Enriched Polypeptide-Fractions  
(P2-Fractions) 
Respective brain area samples were transferred into 900 µl of ice-cold sucrose-lysis-buffer 
(0.32 M Sucrose, 1 mM EDTA, 10 mM Hepes-Tris, pH 7.4) and homogenized with a 
dounce-type glass homogenizer (20 strokes) on ice. Afterwards, suspensions were spun 
down (6100 x g, 5 min) at 4°C, the supernatants were transferred in new reaction-tubes and 
centrifuged (16000 x g, 30 min, 4°C) again. Pellets became resuspended in 500 µl buffer 2 
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(125 nM NaCl, 5 mM KCl, 1.2 mM CaCl2, 1.3 mM MgSO4, 10 mM Glucose and 25 mM 
HEPES-TRIS, pH 7.4) and spun down (16.100 x g, 30 min, at 4 °C). Resulting pellets were 
resuspended in 80 µl of buffer 3 (5 mM Tris/ 1 mM EDTA). Afterwards, suspensions were 
frozen and stored at –80°C. 
3.2.17  Determination of the Protein Content of P2-Fractions 
Protein concentrations of P2-Samples were determined based on the method of Bradford 
with minor modifications (Bradford 1976). In brief, 2 µl of samples were diluted (1:20) with 
0.1 M NaOH. A bovine serum albumin (BSA calibration) standard (0 µg/µl - 10 µg/µl 
BSA) was prepared. 200 µl Bradford Reagent were added to each sample (10 µl/well, 
triplicates, 96 well plates), and the absorbance was measured after 5 min by use of an 
ELISA microplate reader (Sunrise-Basic Tecan) at 595 nm. Subsequently, the protein 
concentrations were calculated according to the calibration graph. 
3.2.18  SDS-Polyacrylamide-Gel-Electrophoresis (SDS-PAGE) and Western-Blot 
Analysis 
P2-fraction samples were separated in 6% - 12% SDS-polyacrylamide gels based on the 
method of Laemmli with minor modifications (Laemmli 1970). In brief, NuPage Sample 
Reducing Agent (Invitrogen) was added to the sample buffer (NuPage, Invitrogen), and 
500 µl NuPage Antioxidant (Invitrogen) were added to the running buffer. Samples  
(40 µg of protein) were heated 10 minutes at 70°C. 5 µl prestained Kaleidoscope standard 
(Bio-Rad) and 2.5 µl Magic Marker standard (Invitrogen) were used as molecular weight 
markers.  
The gels were transferred to nitrocellulose membranes (2.13) using a blotting module 
(XCell II Blot Module, Invitrogen) for 90 min at 30 V in NuPage Transfer Buffer 
(including 20 % methanol). Nitrocellulose filters were rinsed in PBS (2.6), blocked in Roti 
Block (2.5) for 1 h at room temperature, and incubated with the respective antibodies in 
Roti Block, over-night at 4°C. Afterwards, membranes were washed three times (5 min) 
with washing buffer (PBS + 0.1 % Tween 20). Thereafter, nitrocellulose filters were 
incubated with the respective secondary antibodies diluted in Roti Block (1h at RT). For 
detection, enhanced chemoluminescence reagent (GE Healthcare) was used according to 
the manufactures recommendations, and nitrocellulose filters were scanned by use of 
DeVision DBOX Detection-System (Decon). 
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3.2.19  Stripping of Nitrocellulose Filters 
Antibodies binding to nitrocellulose filters were removed (stripped) by rotating them in 
buffer (62.5 mM TRIS-HCl pH 6.8, 2 % SDS, 100 nM ß-mercaptoethanol) at 50°C for  
30 minutes. Afterwards, they were washed 6 times (5 min each) in washing buffer (PBS + 
0.1 % Tween 20) and subsequently blocked with Roti Block (60 min, RT).  
3.2.20  Southern-Blotting 
Screening of mouse embryonic stem cell clones for homologous recombination was done 
by the method of Southern blotting. Digested (BamHI) DNA was separated by 
electrophoresis through 1% agarose gels, and subsequently depurinated (2.7) for 10 min in 
the gel, followed by denaturation (2.7), and neutralization (30 min each, 2.7). Blotting 
transfer to nylon membranes was performed in 10x SSC (2.7) over-night as capillary blot. 
Via UV-crosslinking, the DNA was immobilized on nylon membranes before hybridization 
with denatured radio-labeled probes at 62°C overnight. Unspecific binding was avoided by 
prehybridisation with herring sperm DNA (Invitrogen). Thereafter, membranes were 
incubated once for 10 min in 2x SSC/0.1% SDS at room temperature, followed by final 
washes in 0.2x SSC/0.1% SDS at 58°C (2 x 10 min). Afterwards, membranes were 
equilibrated in maleic acid buffer. The results were detected by exposure to a hyperfilm 
(Amersham Pharmacia) for up to over-night. 
3.2.21  L-[3H]-Proline Uptake 
After preparation of synaptosome-suspensions [protocol according to preparation of  
P2-fractions 3.2.16, with the exception that final pellets were resuspended in Krebs-Ringer-
Hepes solution (125 mM NaCl resp. LiCl, 5 mM KCl, 1.2 mM CaCl2, 1.3 mM MgSO4,  
10 mM glucose, 25 mM Hepes-Tris, pH 7.4)] aliquots of 20 µl were preincubated for 2 min 
at 37°C. Accumulation of L-proline was initiated by addition of 80 µl of Krebs-Ringer-
Hepes solution containing 0.063 µM radiolabeled and 2.437 µM unlabeled L-proline (final 
concentration 2 µM L-proline), and suspensions were incubated for 2 min with gentle 
agitation at 37°C. Afterwards, the uptake reaction was terminated by addition of 9 ml of ice 
cold Krebs-Ringer-Hepes solution, and the suspensions were rapidly filtrated onto 
nitrocellulose (HAWP02500, 0.45 µm, Millipore). The resulting filters were placed into 
vials, and radioactivity was determined by scintillation spectrometry.  
3.2.22  Nissl Staining 
Slides with brain sections were passed through a sequence of baths to obtain cresyl violet 
stained tissue. First, the slides became incubated for 15 min in 95% ethanol, followed by  
1 min of incubation in 70% ethanol and a subsequent bath in 50% ethanol. Afterwards, the 
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sections were washed twice for 2 min in UltraPureTM distilled water, before they were 
stained by incubation in cresyl violet solution (1.25 g of cresyl violet acetate, 0.75 ml of 
glacial acetic acid in 250 ml distilled water) for 2 min. Subsequently, the slides were washed 
1 min in 50% ethanol, then 2 min in 70% ethanol, and afterwards 2 min in 95% ethanol. 
Finally, the sections were washed in ethanol absolute, incubated 5 min in roticlear® (Roth) 
and covered with moviol and cover-slips. 
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3.3 Experimental Methods with Animals 
Behavioral experiments were conducted at the animal facility “Haus für experimentelle 
Therapie (HET)”of the University´s Medical Center and at the animal facility of the Max 
Planck Institute for Brain Research of the University of Frankfurt. The microinjection 
service of the HET was utilized for the reimplantation of positively targeted ES cells into 
pseudopregnant foster animals to obtain chimeric mice. The S1 (Sicherheitsstufe 1, §§4-7 
GenTSV) animal facilities provided standardized climatic conditions and a 12/12-h 
light/dark cycle (lights were turned on 7:00 a.m. and off 7:00 p.m., respectively. The 
described animal experiments and the animal housing were approved by the „Landesamt 
für Natur, Umwelt und Verbraucherschutz“(LANUV) in NRW. All experimental protocols 
were performed in compliance with existing national regulations and guidelines 
(Tierschutzgesetz v. 18.5.2006 (BGBl. I S. 1206, 1313), g v. 18.12.2007 (BGBl. I S. 3001; 
2008, 47)). Food and drinking water was supplied ad libitum. In case of any behavioral 
experiment, mice were brought to the testing room and allowed to acclimate for at least 
15 min prior to the respective test. 
3.3.1 Generation of Chimeric Mice 
Chimeric mice were obtained by the method of blastocyst injection. For this purpose cells 
of a targeted SV129 ES cell line proven by Southern-blot were injected into blastocysts 
maintained from superovulated 4-6 week old C57BL/6J mice (Charles River). Blastocysts 
were afterwards retransferred to pseudo-pregnant foster mice. Chimeric animals were 
assessed by coat color and crossed with the C57BL/6J mouse strain.  
3.3.2 Preparation of Nervous Tissue 
Mice were sacrificed via cervical dislocation, the skulls were opened and the required brain 
areas were removed rapidly as described previously (Glowinski et al. 1966) and immediately 
shock-frozen in liquid nitrogen. Tissue samples were stored at –80°C until further usage.  
3.3.3 Hot Plate Test 
Sensitivity to thermal nociception was investigated by use of a commercially available hot 
plate analgesia meter (TSE-Systems), with a metal plate that could be heated to a constant 
temperature. In the experiments performed in the scope of this thesis, the surface of the 
plate was heated to a temperature of 50°C, and latency to respond was defined as the time 
between the moments that the mouse was placed onto the plate and that it started to move 
away or licked a paw.  
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3.3.4 Open Field Test 
The open field test is an evaluation used to ascertain general activity levels, locomotor 
activity, and exploration habits of rodents. Confrontation to a novel environment usually 
implies stress to the animals. Therefore, the explorative behavior of an animal gives 
information about how well this animal can adapt to a novel situation. The behavioral 
forces are the curiosity to explore the novel situation opposed by the fear about the new 
situation, which influences the outcoming behavior coincidently. Assessment took place in 
a square arena (45 x 45 cm). This arena was mounted within specially designed sound 
attenuating shells. A mouse was placed in one corner of the open field arena and allowed to 
freely move for 15-30 minutes while being tracked by an automated infrared-tracking 
system (Actimot, TSE Systems GmbH) recognizing horizontal as well as vertical activity. 
Hyperactivity threshold was set to 20 cm /s. At the end of each trial the surface of the 
arena was cleaned with 70% ethanol. The open field test was conducted with two different 
illumination conditions, depending on the desired behavioral parameter. With an 
illumination intensity of 2 lux basic exploration behavior of the mice was studied. By 
intensive illumination (250 lux intensity) the open field test was additionally used to study 
emotionality of the mice, since normal behavior in mice is to seek the protection of the 
periphery (Archer 1973). To minimize the influence of anxiety on spontaneous locomotor 
activity level, animals were monitored under sound-attenuated conditions without the 
experimenter being visible. Mice were always placed individually in the arena.  
3.3.5 Y-Maze Test 
Spontaneous alternation behavior was assessed in a symmetrical Y-shaped runway made of 
white plastic with walls 28 cm high and open top. Each arm was 48 cm long and 12 cm 
wide. Mice were tested randomly by placing them individually at the end of one arm of the 
maze. Animals were allowed to move freely in the three arms of the maze during an 
observation time of 5 min. The maze was wiped clean with 70% ethanol before another 
mouse was tested. The sequence of arm entries (with all four feet into any of the arms) was 
recorded visually. Alternation was defined as multiple entries into different arms on 
overlapping triplet sets. Percentage of spontaneous alternation was calculated via entries 
into a new arm, thus by the ratio of the possible alternations, as shown by the following 
equation:  
Alternation (%) = (number of alterations/total arm entries – 2) * 100 
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3.3.6 Forced Swimming Test 
The forced swimming test (FST) is a test to investigate depression like behavior in mode of 
„behavioral despair“. This paradigm was developed and established 1977 by Porsolt and 
colleagues and examines the behavior of a mouse in a cylinder filled to the half with water 
(Porsolt et al. 1977). Usually, confrontation with this aversive situation first induces 
escaping behavior that later on changes to immobility, whereas the mice let themselves 
float in the water. The time period mice spent in immobility is called the “depression like 
condition”. This immobility time can be drastically reduced in favor of the escaping 
behavior e.g. by prior application of antidepressant drugs to the mice. The test was carried 
out in a cylinder (high 35 cm, diameter 18 cm) filled with water (25°C) to the half, so that 
the mouse was not able to touch the bottom nor to escape from the cylinder. Time of 
immobility was monitored over 5 minutes and calculated in percentage of total time.   
3.3.7 Prepulse Inhibition (PPI) 
Prepulse inhibition (PPI) is an indicator of sensorimotor gating, a process that is important 
for filtering irrelevant sensory information and allows attention to be focused on a given 
stimulus. PPI is determined with a weak acoustic noise that inhibits the reaction to a 
subsequent strong startling one. To measure PPI the startle reflex measurement system 
(TSE-Systems) was used. The test was started by placing a mouse into a small cage, which 
was put in a sound-attenuated chamber onto a balance to record the startle response 
elicited by the sound-stimuli. First, the mouse was left undisturbed for 5 min to habituate 
to the new situation. Background noise level of the chamber was set at 60 dB. The prepulse 
sounds (0, 65, 70, 75, 78, 80 and 85 dB) of 20 ms were presented for 120 ms before the 
startle stimulus (110 dB for 40 ms) was given. All pulse combinations were presented in a 
randomized order. The PPI percentage was calculated using the following equation: 
(1 - Average of startle amplitude in trail with prepulse/ 
Average of startle amplitude in trails without prepulse)*100 
 
3.3.8 Determination of Body Weights 
Determination of the body weights was carried out by scaling the mice in a carton on a 
laboratory balance (Sartorius). 
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3.3.9 Rotarod Test 
The rotarod test was carried out with a rotarod device (TSE-Systems). This test is designed 
to evaluate motor coordination and balance skills of the mice. Therefore, a mouse was 
placed on a rotating (5 rpm) rod in orientation opposite to that of its rotation, and the rods 
accelerated to 25 rpm gradually over 75 seconds. This rotating rod was placed 35 cm above 
the floor to induce locomotion of the mice by avoidance to fall down. Falling down 
latencies of the mice were recorded automatically.  
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4 Results 
4.1 Generation of  ProT-Knockout Mice 
In the present section, all experiments related to the generation of the high affinity sodium-
dependent L-proline transporter (PROT) deleted mouse line will be described. This 
comprises the experimental design concerning the strategy of targeting the ProT gene, as 
well as the procedure of creating the artificial DNA construct.  
4.1.1 Targeting Strategy 
The target gene (ProT) encoding the murine PROT (SLC6A7) is located on chromosome 
18 and encompasses 14 coding exons (www.ensemble.org), distributed over a genomic 
DNA-stretch of 18.82 kb (Figure 4). Transcription of this gene originates mRNA with a 
length of 3362 bp (NCBI acc. no. NM 201353.1), and the translated protein consists of 637 
amino acids (NCBI acc. no. NP 958741.1).  
The strategy for generating the ProT gene deleted mouse strain is outlined in Figure 4. A 
region of 1158 bp containing the reading frames for exons 6 and 7 was selected as target 
for the deletion of ProT. This area encodes the central region of the murine PROT, 
including the transmembrane domain 5, the extracellular loop 3 and the transmembrane 
domain 6. The transmembrane domain 6 is located in the core of the protein and essential 
for the transport action of amino acid antiporters (Chang et al. 2010). Therefore, removal 
of this central region (1158 bp) of the ProT gene was thought to disrupt the expression of 
ProT mRNA through disturbance of the gene locus and to break down functionality of the 
transporter. This deletion should be achieved by replacing the region of 1158 bp with a 
neomycin resistance gene (neo) of 1826 bp under the control of the phosphoglycerate 
kinase (PGK) promoter. 
Ex1 Ex2 Ex3 Ex4 Ex5 Ex6 Ex7 Ex8 Ex9
Ex10
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Ex12
Ex13 Ex14
1158 bp
wild-type ProT gene locus
Ex13 Ex14Ex3 Ex4 Ex5 Ex8 Ex9
neo
Ex1 Ex2
1826 bp
Ex10
Ex11
Ex12targeted ProT gene locus
  
Figure 4 Knockout strategy of ProT showing wild-type ProT locus and the targeted allele 
At the top, the murine wild-type ProT gene locus is pictured with exons represented as blue arrows, and the 
target region for deletion containing exons 6 and 7 (1158 bp) is indicated with a grey arrow. At the bottom, 
the targeted ProT gene locus after effective homologous recombination is depicted. The locus contains the 
neomycin resistance gene (1826 bp) pictured as a green block (neo) instead of the target region (1158 bp).  
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4.1.2 Isolation of the ProT Gene 
A mouse genomic bacterial artificial chromosome (BAC) library was virtually screened 
(using NCBI clone finder; http://www.ncbi.nlm.nih.gov/projects/mapview) for the 
genomic sequence of the ProT gene (SLC6A7), previously gained from ensembl data base 
(http://www.ensembl.org). Three identified recombinant E. coli clones containing ProT 
genomic DNA were delivered from the Children´s Hospital Oakland Research Institute 
(CHORI), seeded on LB plates and grown to recover BAC DNA. Southern blot analysis 
confirmed the presence of the full length SLC6A7 DNA in the three clones (Figure 5).  
 
BAC3 (RP24-211A8) BAC5 (RP24-243J21) BAC7 (RP24-285G11)
A . B. C. D. A . B. C. D.A . B. C. D.
18 kb
6.8 kb
10.8 kb
 
Figure 5 Southern-blot analysis of DNA from BAC clones to prove presence of the full length 
ProT genomic DNA 
Pictured are BAC clones 3, 5 and 7 confirming presence of SLC6A7 DNA after cleavage with KpnI (A.), 
BamHI (B.), EcoRI (C.) as well as double digest with EcoRI and BamHI (D.). A DNA sequence homologous to 
exons 3 and 4 was used as a probe. Presence of ProT should result in appearance of a fragment of 10.8 kb 
after KpnI cleavage, digestion with BamHI would give rise of a 6.8 kb fragment, EcoRI restriction should give 
an 18 kb fragment and BamHI/EcoRI cleavage would result in a fragment of 6.8 kb. As shown, all analyzed 
BAC clones could be verified containing SLC6A7 DNA as expected. 
 
4.1.3 Construction of the ProT Targeting Vector 
The next step was the generation of a targeting vector for homologous recombination. 
Toward this goal, a 7.3 kb genomic DNA sequence of the murine ProT gene, which 
includes exons 2 to 9, and the XpPNT-vector (appendix: Figure 41), containing a gene 
encoding for neomycin resistance (neo) as well as a herpes simplex virus thymidine kinase 
gene (HSV-TK; 1127 bp), were used.  
Insertion of the neo gene into the genomic locus of the ProT gene was expected to be 
achieved by homologous recombination in embryonic stem (ES) cells. Therefore, the 
targeting vector contained DNA sequences, which were 5´ and 3´ homologous to the 
targeted 1158bp-ProT-region that was anticipated to be removed. 
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For the 5’ homologous region, a 5028 bp-fragment from the end of exon 2 up to the 
beginning of exon 6 (including exons 3, 4 and 5) was chosen. The 3’ homologous area 
comprised an 1131 bp-fragment from the beginning of exon 8 up to the beginning of exon 
10 (Figure 6). PCR reactions were performed to amplify the 5´ and 3´ homologous region 
respectively, applying appropriate oligonucleotide primers and the BAC clone RP24-243J21 
(BAC5) as genomic DNA template (further information concerning PCR-conditions: 
3.2.15.1 and appendix: Figure 42). Each fragment was subcloned into pBluescript-vector 
(pBS) and verified by restriction analysis (appendix: Figure 43 A and Figure 43 B) and 
sequencing. The 3’ homologous fragment was first inserted into the XpPNT-vector 
between the neo and the HSV-TK genes by using BamHI and EcoRI. Afterwards, the  
5’ homology fragment was introduced by NotI and XhoI into the XpPNT-vector.  
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neo HSV-TK
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Figure 6 ProT-knockout-strategy showing the wild-type ProT locus, the cloned targeting construct 
and the targeted allele  
At the top, the murine wild-type ProT gene locus is pictured with exons represented as blue arrows. The 
fragment representing 5’ homology (5028 bp, Ex2-Ex6) to the targeting construct, the target region for 
deletion (1158 bp, Ex6-Ex7) and the fragment representing 3’ homology (1131 bp, Ex8-Ex10) are indicated 
with grey arrows. In the center, the targeting construct containing the 1826 bp neomycin resistance gene for 
positive selection (neo), pictured as a green block and the truncated herpes simplex virus thymidine kinase 
gene fragment for negative selection, embodied as a red block (HSV-TK), are shown. At the bottom, the 
targeted ProT gene locus after effective homologous recombination is depicted, showing the exchange of 
1826 bp neo gene (neo) for the target region (1158 bp).  
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4.1.4 Transfection of Mouse Embryonic Stem Cells and Screening by Genomic 
Southern Blot-Analysis 
Next, the targeting vector was linearized at the single NotI restriction site previous to 
transfection by electroporation in HM1-ES cells derived from agouti colored 129/Sv mice 
(Magin et al. 1992). Electroporated cells were grown in selective media containing the 
neomycin analog antibiotic G418 and the nucleoside analogue FIAU (3.1.4) in order to 
select resistant colonies indicative for the presence of the neomycin resistance gene as well 
as absence of the HSV-TK gene, thus identifying those cells that underwent homologous 
recombination. Upon selection, 106 cell clones were harvested and examined by Southern-
blot analysis for proper insertion of the neo gene at the ProT gene locus. The Southern-blot 
analysis strategy is described in Figure 7.  
Finally, out of the 106 harvested cell clones, 10 homologous recombinant ES cell clones 
were obtained. Exemplary results from Southern-blot analysis for six ES clones after 
BamHI-cleavage are outlined in Figure 8. In clones 40, 93, and 105 proper homologous 
recombinations occurred, as confirmed by the expected genomic DNA restriction patterns. 
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Figure 7 Strategy of Southern-blot analysis of genomic ES cell DNA 
The murine wild-type ProT gene locus and the ProT-deleted locus are indicated, with exons represented as 
blue arrows. Binding sites for the hybridization probe are outlined in red and sizes of the restriction 
fragments after BamHI-cleavage are indicated as grey arrows. Expected fragment sizes with this probe are 5.8 
kb for the wild-type allele (top) and 3.1 kb for the targeted allele (bottom). 
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+/+      +/- +/+      +/- +/+      +/-
5.8 kb
3.1 kb
36               40             68               93               98              105
 
Figure 8 Southern-blot analysis of genomic DNA from ES cells to verify homologous 
recombination  
After cleavage of the genomic DNA with BamHI, Southern-blot analysis was carried out using a probe 
binding 3´ of the knockout-locus (3´-probe, indicated in Figure 7). Results of clones 36, 40, 68, 93, 98 and 
105 are shown as exemplary to demonstrate correctly targeted heterozygous ES cells (+/-) and ES cells 
exhibiting a randomly integrated targeting construct (+/+), respectively. The presence of a single 5.8 kb 
fragment displays attendance of two wild-type alleles (+/+), and presence of a 5.8 kb and a 3.1 kb fragments 
indicates attendance of one wild-type allele as well as one ProT-deleted allele (+/-), thus reporting a 
successfully targeted ES cell clone. 
 
4.1.5 Generation of a ProT Knockout Mouse Line and Genotyping  
Five of the ten positive ES cell clones containing one ProT-deleted allele were expanded, 
injected into blastocysts derived from C57BL/B6J mice and reimplanted into 22 pseudo 
pregnant foster mice. The independent injection of ES cells derived from clone 105 into six 
foster animals led to the birth of two highly chimeric male mice (Figure 9) out of 11 
offsprings (F0 generation).  
 
 
Figure 9 Highly chimeric mice 
Chimeric mice were generated by injection of recombinant ES cell clone 105 (agouti colored 129/Sv) in 
blastocysts obtained from C57BL/6J mice.  
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The degree of chimerism was assessed by coat color, as the injected ES cell line was 
derived from agouti colored 129/Sv mice in contrast to the blastocysts generated from 
black C57BL/B6J animals. One chimeric male was fertile and further bred with 
C57BL/B6J females. The agouti coat color of the offspring (F1 generation) indicated the 
germline transmission. 
Next, to prove that the ProT-deleted allele was transmitted to the germline, genomic DNA 
was prepared from small tail biopsies of the F1 generation litters 4 weeks after birth and 
subjected to genotype analysis by PCR. The organization of the wild-type and ProT-deleted 
alleles as well as alignment of the PCR primers for the genotype analysis are shown in 
Figure 10 A. To determine the genotypes of the animals, two separate PCRs were used. 
Each PCR was designed to cover the region containing the insertion site of the neomycin 
resistance gene. This resulted in PCR fragments of different lengths for the wild-type  
(430 bp) and ProT-deficient (354 bp) allele.  
The analyzed F1 offspring generation displayed mice heterozygous for the mutated allele as 
well as wild-type mice consistent with the Mendelian rules predicting 50% probability. Mice 
heterozygous for the ProT mutant allele (ProT +/-) showed undisturbed development and 
fertility. 
Finally, to create mice homozygous for ProT-deficiency, heterozygous F1 mice were bred 
with each other. After genotyping, these matings resulted, as well in agreement with the 
Mendelian rules, in 50% mice heterozygous for the mutated allele, 25% wild-type mice and 
25% homozygous ProT-deficient mice, thus indicating that there was no increased 
embryonic mortality in the mutant animals. An example of the PCRs used in genotype 
analysis is shown in Figure 10 B. 
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Figure 10 Genotyping of the ProT knockout mice 
A. Organization of wild-type (top) and ProT-deleted (bottom) alleles with alignment of the particular PCR 
primers. Amplification with primer pair WTSIII 5´ (annealing in Ex7) and WTAS 3´ (annealing in Ex8) 
results in a 354 bp fragment revealing the presence of the wild-type allele and amplification with the primer 
pair neoS 5´ (annealing in the neo gene) and WTAS 3´ results in the formation of a 430 bp fragment, showing 
attendance of a targeted allele. B. Agarose gel electrophoresis of PCR products derived from F2 mice. 
Appearance of a single 430 bp amplicon (-/-) indicates the presence of a knockout animal (left). The 
attendance of a 430 bp fragment as well as a 354 bp amplicon reveals the presence of a heterozygous (+/-) 
animal (middle). Appearance of a single 354 bp fragment (+/+) displays the attendance of a wild-type animal 
(right). For detailed information about PCR conditions refer to materials and methods section 3.2.15.7. 
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4.2 Verification of  the ProT-Knockout in Mutant Mice 
To confirm that the expression of ProT gene is turned off in the knockout mice, PCR and 
Western blot analysis were performed.  
4.2.1 Analysis of the ProT mRNA Expression by RT-PCR & qPCR 
Examination of mRNA levels by reverse transcription polymerase chain reaction (RT-PCR) 
and quantitative real time polymerase chain reaction (qPCR) are the most sensitive 
techniques for detection and quantification of the transcription of a selected gene.  
Total mRNA was extracted (see 3.2.13) from different regions of the brain (olfactory bulb, 
frontal cortex, striatum and hippocampus) of 3 month old animals, and cDNA was 
synthesized (3.2.14). RT-PCR primers were designed to amplify a specific ProT cDNA 
fragment of 280 bp. The sense primer attaches to exon 7, which is expected not to be 
present in the deleted allele, and the antisense primer binds to exon 8. RT-PCR results of 
ProT in wild-type (+/+) as well as heterozygous (+/-) and knock-out (-/-) mice are 
depicted in Figure 11.  
Presence of the ProT mRNA was verified in heterozygous and wild-type mice. Its absence 
in homozygous mutants clearly demonstrates that in these animals transcription of the ProT 
gene does not take place. The lack of detectable ProT mRNA is not due to a poor RNA 
extraction from the different brain regions of the knockout mice, since equal amounts of  
β-Actin transcript were found in all analyzed tissues of the different genotypes. 
Similar results were obtained by qPCR (see 3.2.15.5), showing specific expression levels of 
ProT in different brain regions in wild-type mice, but never in knockout animals  
(Figure 12). 
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Figure 11 RT-PCR analysis of ProT expression in various brain areas 
ProT transcript (280 bp) is detected in wild-type animals (+/+) and slightly reduced also in heterozygous mice 
(+/-), but not in knockout animals (-/-) within all analyzed brain areas, confirming truncation of ProT 
transcription in the knockout mice. As control, β-Actin transcripts (193 bp) could be detected in all cases. (For 
detailed information about PCR conditions, see section 3.2.15.6.) 
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Figure 12 qPCR analysis of ProT expression in mutated versus wild-type mice 
The diagram shows the expression levels as arbitrary units (au) of ProT mRNA in the frontal cortex (FC), 
striatum (Str) and hippocampus (HC) of wild-type versus knockout mice. mRNA levels were gained from  
CT-values of ProT transcripts upon normalization with β-actin transcripts. Note the absence of ProT transcripts 
in knockout animals. Analyzed animals were 3 month of age. Data are given as means ± SEM (n = 3 for each 
genotype). Asterisk indicates significantly different expression levels of knockout mice from wild-type mice, 
p < 0.001 (Student´s t-test). (For detailed information about qPCR conditions and cDNA synthesis, please 
refer to section 3.2.15.5). 
 
4.2.2 Verification of the Absence of PROT Protein in Knockout Mice 
In order to confirm the presence or absence of PROT-expression at protein level in all 
mouse genotypes, a Western blot analysis was performed. Plasma membrane enriched 
brain homogenates (P2-fractions) from 2 different brain areas were separated on  
SDS-polyacrylamide gel electrophoresis, transferred to nitrocellulose and probed with 
antibodies specifically recognizing the C-terminal domain of PROT (Materials, section 2.2). 
As shown in Figure 13, Western blot analysis showed strong immunoreactivity in samples 
prepared from wild-type mice (+/+), and reduced immunoreactive labeling in 
heterozygous animals (+/-), but failed to exhibit immunoreactive polypeptide in PROT-
knockout mice (-/-), thus confirming the lack of the PROT protein in the homozygous 
mutants. 
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Figure 13 Western blot analysis of PROT polypeptide in hetero- and homozygous PROT-deficient 
mice and wild-type controls 
P2-fractions (60 µg protein/lane) of frontal cortices (A.) and hippocampi (B.) were separated by 8% SDS-
polyacrylamide gel electrophoresis, transferred to nitrocellulose and probed with antibodies which specifically 
recognize the C-terminal domain of PROT. Compared to wild-type mice, expression of PROT was reduced 
in heterozygotes (+/-) and completely abolished in homozygous (-/-) knockout mice. MagicMark® ladder 
was applied for size estimations and sample number was n = 3. (For detailed information about Western-blot 
procedure, refer to section 3.2.18.)  
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4.3 Analysis of  the PROT-deficient Mice 
In this section experiments concerning the first analysis of the ProT deleted mouse line are 
illustrated.  
4.3.1 Contribution of PROT to the Sodium-dependent High Affinity L-Proline 
Uptake in Brain 
To reveal the functional consequences of ProT gene deletion on high-affinity  
Na+-dependent uptake of L-proline, crude synaptosomal preparations (P2-fractions) from  
different brain areas, namely frontal cortex, striatum, hippocampus and olfactory bulbs, 
were prepared and incubated with L-[3H]-proline for 2 minutes (3.2.21).  
Two-way ANOVA revealed that there was an effect of the brain area on L-[3H]-proline 
uptake (F3,23 = 30.74; p-value < 0.001) as well as a strong effect of the genotype on  
L-[3H]-proline uptake (F2,23 = 122.96; p-value < 0.001). In addition, there was an effect of 
the interaction between genotype and brain area (F6,23 = 9.43; p-value < 0.001). 
As shown in Figure 14, L-[3H]-proline uptake was significantly reduced, by ≥50% in the 
olfactory bulbs (OB) and ≥75% in the hippocampus (HC), frontal cortex (FC) and striatum 
(Str) of PROT−/− mice, as compared to wild-type littermates. P2 membrane fractions from 
heterozygous animals showed intermediate L-[3H]-proline uptake values, consistent with a 
clear gene dosage effect of PROT expression. 
Incubation of membrane fractions from wild-type animals with 2.5 mM sarcosine, an 
inhibitor of PROT (Fremeau et al. 1992), decreased the uptake of L-[3H]-proline in 
fractions from wild-type animals to values comparable to the transport activity measured in 
the PROT-knockout membranes (Figure 15). These results indicate that PROT-mediated 
L-[3H]-proline is totally abolished in the homozygous mutants.  
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Figure 14 Determination of high-affinity sodium dependent L-[3H]-proline in membrane 
preparations from different brain areas 
Uptake was determined in frontal cortex (FC), striatum (Str), hippocampus (HC) and olfactory bulb (OB) of 
wild-type, heterozygous and knockout mice. Accumulation of L-[3H]-proline was reduced by half in 
synaptosomal preparations of heterozygous animals and further reduced in knockout mice. Data are given as 
means ± SEM (n = 3 for each genotype). Asterisk indicates significant difference from wild-type mice, with 
p < 0.05: *, p < 0.01: **, p < 0.001: *** (Student´s t-test). (For detailed information about assay procedure 
refer to section 3.2.21.) 
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Figure 15 Investigation of Na+-dependent accumulation of L-[3H]-proline in two brain areas 
employing the PROT-specific inhibitor sarcosine (2.5 mM)  
Sodium-dependent L-[3H]-proline accumulation of synaptosomal preparations of striati and hippocampi 
from knockout mice displays a comparable level to L-[3H]-proline uptake from wild-type mice in the 
presence of the PROT inhibitor sarcosine. Asterisk indicates significantly different from wild-type mouse 
controls, with p < 0.01: **, p < 0.001: *** (Student´s t-test). (For detailed information about assay procedure, 
refer to section 3.2.21.) 
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4.3.2 Analysis of Expression Levels of L-Proline Metabolizing Enzymes 
It was observed that the deletion of neuronal PROT protein impairs L-proline clearance 
capacity (4.3.1), thereby suggesting both an increase of the extracellular L-proline 
concentration at the synapsis and a decrease of this amino acid intracellularly. Therefore, it 
was examined whether metabolic turnover of L-proline could be affected by alterations of 
L-proline levels in PROT-deficient brains, analyzing the transcriptional levels of enzymes 
involved in its metabolic pathways. Expression of the enzyme P5C-synthase (Pycr) that 
catalyzes the NADPH-dependent conversion of ∆1-pyrroline-5-carboxylate to L-proline, 
and expression of proline dehydrogenase (PRODH), which catalyzes the first step in  
L-proline catabolism by converting L-proline to ∆1-pyrroline-5-carboxylate, were 
determined by qPCR. 
Transcriptional levels of Pycr were found to be weakly increased in the brains of PROT-
deficient animals, but without statistical significance (Figure 16). Similarly, expression of  
L-proline degrading PRODH was not found to be significantly changed (Figure 16). The 
investigation of the expression levels of L-proline controlling enzymes demonstrates that 
neither adaptive enhancement nor reduction of L-proline turnover developed in the 
knockout animals. This demonstrates that synthesis and degradation of L-proline remains 
constant in the mutated animals compared to wild-type controls.  
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Figure 16 Relative mRNA expression profiling of L-proline metabolizing enzymes  
Determination of pyrroline-5-carboxylate reductase (Pycr) and proline dehydrogenase (PRODH) expression as 
deduced from the amount of mRNA in different brain areas of ProT-deficient mice and wild-type controls 
revealed no significant differences. Analyzed animals exhibited 3 months of age. Data were normalized to  
β-actin and represent means ± SEM (n = 3 for each genotype).  
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4.3.3 Determination of Body Weights  
Although PROT-deficient mice were normal in appearance, monitoring of body weights of 
2-3 months old male mice detected a significant genotype-effect on the growth of mutant 
mice in contrast to wild-type controls. Body weights of PROT-/- animals were 15% 
significantly lower (21.6 g ± 0.5; n = 20, p-value < 0.01) than body weights of PROT+/+ 
mice (25.35 g ± 0.42; n = 20) of the same age (Figure 17). This outcome is surprising 
because the high affinity L-proline transporter is exclusively expressed in brain and 
therefore not thought to be involved in L-proline accumulation serving for protein 
synthesis. Nevertheless, a reduced body weight is a frequent finding of knockout mice 
strains (Reed et al. 2008) and has been reported as well for other neuronal transporter 
knockout mice and PRODH-deficient mice formerly (Giros et al. 1996; Xu et al. 2000). 
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Figure 17 Determined body weights of PROT-deficient and wild-type mice, respectively 
PROT-/- mice of 3 months exhibited statistically significant decreased body weights versus wild-type controls. 
Data are given as means ± SEM (n = 20 for each genotype). Asterisk indicates significantly different from 
wild-type mice (p < 0.01 by Students t-test). 
 
4.3.4 Histological Analysis for Detection of Abnormalities in the Brain 
In animal experimental models of hyperprolinemia, histological studies revealed 
degenerative alterations in their brains (Shanti et al. 2004). Because of the broad expression 
of PROT throughout the CNS, it was required the investigation whether PROT deletion 
induces gross morphological changes in the knockout brains. Macroscopic comparison of 
cresyl violet-stained brain sagittal sections of PROT-/- mice versus PROT+/+ animals 
detected no obvious differences, as shown in Figure 18. 
A. B.
 
Figure 18 Cresyl-violet stained sagittal sections of wild-type (A.) and knockout (B.) mice 
No gross morphological alterations were detected in PROT-deficient mice compared to their wild-type 
littermates. (For detailed information about staining procedure, refer to section 3.2.22.) 
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Furthermore, detailed analyses of brain areas that are known to exhibit a high PROT 
expression, namely the hippocampal formation, striatum and the cerebral frontal cortex, 
revealed no obvious defects in the number of cells and organization of brain anatomy 
(Figure 19). Therefore, it was concluded that PROT-deficient mice display normal 
morphological architecture of brain structures. Beyond this observation, PROT-deficient 
mice were normal in appearance and showed, comparable to their wild-type and 
heterozygous counterparts, undisturbed development and fertility. 
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Figure 19 Light microscopy of cresyl-violet stained sagittal sections of frontal cortices (A. and B.), 
striati (C. and D.) and hippocampal formations (E. and F.) from knockout (A., C., E.) and wild-type 
(B., D., F.) mice 
No alterations in the cellular appearance and tissue formation were observed in PROT-deficient mice 
compared to wild-type controls. Magnification factor was 10x. (For detailed information about staining 
procedure, refer to section 3.2.22.) 
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4.4 Behavioral Phenotyping of  PROT-deficient Mice 
Given that PROT is a neuronal protein, a comparative investigation of general behaviors of 
PROT-deficient mice and wild-type controls would be a beneficial way to get insights into 
putative alterations produced by this mutation. Toward this goal, different behavioral 
patterns have been examined, including sensorimotor tasks (rotarod and open field), as well 
as schizophrenia related alterations (PPI-test) and the analysis of nociceptive abilities (hot 
plate test). All analyses were carried out with 2-3 month old animals.  
4.4.1 Nociception - Hot Plate Test  
It has previously been proposed that PROT and L-proline might play a role in analgesia, 
due to the fact that application of enkephalins selectively inhibits transport function of 
PROT in transfected cells as well as in prepared synaptosomes (Fremeau et al. 1996; Galli 
et al. 1999). Therefore, it was of interest to study if pain perception is changed in PROT-
deficient mice. With the hot plate test sensory, defects in basic pain reception to a thermal 
stimulus were investigated. For this purpose, the surface of the test plate was heated to a 
constant temperature of 50°C, mice were then placed on the hot plate, and the latency was 
measured until the animals started licking a paw or tried to escape. Upon analysis, PROT-/--
mice did not demonstrate any genotypical effect with respect to their nociceptive ability’s 
when compared to wild-type control animals. In average, PROT-/- mice displayed a reaction 
to the thermal stimulus after 2.77±0.1 seconds, whereas PROT+/+ mice revealed in mean a 
reaction time of 2.78±0.07 seconds (n = 20, Figure 20). Thus, this result demonstrates that 
PROT-/- mice have normal sensory capabilities regarding pain perception. 
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Figure 20 Investigation of sensitivity to nociception 
No significant differences were detected in a hot plate test with respect to mean escape latencies for PROT-
deficient mice versus wild-type controls. Data are given as means ± SEM (n = 20 for each genotype).  
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4.4.2 Locomotor Skills - Rotarod Test 
It was of interest to examine the locomotor skills of PROT-deficient animals, as it has 
previously been reported that animals with reduced proline oxidase activity and high 
plasma L-proline levels exhibit sluggish behavior (Kanwar et al. 1975; Hayward et al. 1993). 
Therefore, PROT-deficient mice were subjected to the rotarod test, which is an animal test 
for locomotion skills such as coordination and balance. The animals were placed onto a 
rod, rotating with an initial speed of 5 rpm that gradually accelerated over 75 seconds to a 
final speed of 25 rpm. The rotation speed at which the mice could no longer handle 
walking on the rod was recorded. No significant genotypic effect on the ability of the mice 
to stay on an accelerating rod was observed (Figure 21). In average, the analyzed male 
PROT-/- mice withstood the forced motor activity to 13.01 ± 1.19 rpm versus on PROT+/+ 
mice that achieved an average performance of 12.62 ± 0.81 rpm. To examine whether 
locomotor learning was affected by the mutation, both mouse strains were examined 5 
minutes later, showing similar increased performance. Here, mutants achieved 14.86 ± 0.84 
rpm, compared to PROT+/+ mice, achieving 14.28 ± 0.99 rpm (Figure 21). In summary, 
the conducted rotarod analyses demonstrate that PROT-/- mice exhibit normal 
coordination and balance skills.  
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Figure 21 Rotarod analysis of mutants (KO) versus on wild-type (WT) mice 
Results are shown from two trails, with the second trail being performed 5 minutes after the first to measure 
additional locomotor learning abilities. No statistically significant difference in rotarod performance was 
detected for PROT-/- mice. Data are given as means ± SEM (n = 20 for each genotype). For detailed 
information about the rotarod protocol used, please refer to section 3.3.9. 
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4.4.3 Motor Activity - Open Field Test 
It was concerned whether PROT might play a role in affecting locomotion, since 
behavioral studies revealed that mice bearing a mutation in the gene that encodes proline 
oxidase display high plasma L-proline levels and altered locomotor activity (Moreira et al. 
1989; Paterlini et al. 2005). For this reason an analysis of the explorative behavior of the 
PROT-knockouts was conducted.  
The open field test is a standard paradigm to screen for general motor activity and 
spontaneous explorative behavior, both quantitatively and qualitatively. In this paradigm, 
mice were individually placed into an open arena and monitored without the experimenter 
being visible. Then, the distance traveled during 30 minutes under 2 lux illumination 
intensity was investigated. Total traveled distances of the mutant animals were significantly 
lower (248.44±14.87 m, n = 14) than those of their wild-type counterparts (313.6±14.94 m,  
p-value < 0.05), as represented in Figure 22 A, hence demonstrating a diminished basic 
locomotor activity of the PROT-deficient animals. Time course analysis of the traveled 
distances revealed that PROT-knockout mice were less active during the first 20 minutes of 
the total 30 minutes observation period (Figure 22 B). Two-way ANOVA showed an 
effect of the genotype on distance moved (F(1,120) = 8.24; p < 0.01) and an effect of the time 
period on distance moved (F(5,120) = 16.84; p < 0.001).  
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Figure 22 Motor activity test of wild-type and knockout mice  
Total distance traveled (A) under 2 lux illumination during 30 minutes revealed decreased locomotor activity 
of PROT-/- mice versus wild-type mice in a novel environment. Time course analysis of total distance 
traveled (B) is presented in intervals (5 min) and displays significantly decreased locomotor activity of  
PROT-/- mice particularly in the habituation phase to a novel environment. Data are given as means ± SEM 
(n = 14 for each genotype). Asterisk indicates significant different from wild-type mice, p < 0.05 (Student´s  
t-test). 
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Figure 23 Analysis of time periods spent in hyperactivity  
A. Time spent in hyperactivity in a novel environment displays significantly decreased periods for PROT-/- 
mice particularly in the habituation phase to a novel environment. B. Time block analysis in 5 minute 
intervals display significantly decreased time periods spent in hyperactivity for PROT-/- mice as well 
particularly in the habituation phase to a novel environment.. Non aversive illumination conditions of 2 lux 
were used to investigate basic exploration behavior. Data are given as means ± SEM (n = 14 for each 
genotype). Asterisk indicates significant difference from wild-type mice, with p < 0.05: *, p < 0.01: ** 
(Student´s t-test).  
 
Analysis of time periods in which mice were hyperactive additionally revealed that PROT-/- 
mice spend in average 368.21±27.39 seconds in hyperactivity versus on PROT+/+ mice 
spending 466.44±22.69 seconds (n = 14, p-value < 0.05; Figure 23 A). This decrease in 
high velocity locomotor activity indicates a better attention of the PROT-deficient mice. 
Furthermore, it shows in agreement to data from the analysis of total traveled distances a 
lower activity of the mutants in the novel environment. Two-way ANOVA of time course 
analysis showed an effect of the genotype on time spend in hyperactivity (F(1,120) = 7.67;  
p < 0.05) and an effect of the time period spent in the novel environment on time spend in 
hyperactivity (F(5,120) = 17.26; p < 0.001). Block analysis (Figure 23 B) revealed that the 
significant difference is only based on the beginning of the open field test and disappears 
after 20 minutes measurement suggesting as well that the PROT-mutants are more rapidly 
familiar with the novel environment and therefore exhibit a higher ability to habituate to 
the test chamber than wild-type controls. 
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4.4.4 Prepulse Inhibition Test and Acoustic Startle  
Prepulse inhibition (PPI) is an indicator of sensorimotor gating both in humans and 
rodents, a process that is important for filtering irrelevant sensory information and allows 
attention to be focused on a given stimulus. PPI is determined with a weak acoustic noise 
(prepulse) that inhibits the reaction to a subsequent strong startling one (pulse). It was of 
interest to examine the PPI responses of PROT-deficient animals, as mice with an 
inactivated PRODH gene, and thereby exhibiting elevated L-proline levels, show 
abnormalities in sensorimotor gating (Gogos et al. 1999). Furthermore, it is known that in 
humans, hyperprolinemia is a risk factor for schizophrenia (Clelland et al. 2011). The PPI 
test is widely used as a trait marker to diagnose schizophrenia in humans or animals 
because sensorimotor gating deficits occur in this disease as manifested by a reduction in 
PPI.  
First, an acoustic startle (AS) test was used as a pre-screen for PPI. The acoustic startle 
response is a protective response, elicited by a sudden and intense acoustic stimulus. Facial 
and skeletal muscles are activated within a few milliseconds, leading to a whole body flinch 
in rodents. AS trials were performed to check whether mice were unable to respond to 
weak prepulse tones whereas they reacted to loud tone pulses. As expected, wild-type and 
PROT-deficient mice showed no reaction in the presence of the different prepulses 
presented alone. Interestingly, PROT-/- mice displayed a tendency for higher startle 
amplitudes, although not statistically significant, than those observed in wild-type animals 
Figure 24. This observation might be due to either better sensory abilities towards acoustic 
stimuli or an increased anxiety phenotype in PROT-deficient animals.  
Notably, a statistically significant genotypical effect showing a higher PPI on prepulse 
stimuli of 65 db, and 70 db was observed for PROT-/- mice compared with PROT+/+ 
controls (n = 6, p-value < 0.05; Figure 25). Prepulse stimuli of 75 db as well revealed a 
higher degree of PPI but without statistical significance. This indicates that PROT-deficient 
animals have slightly better sensorimotor gating abilities that could be caused by an 
enhanced glutamatergic neurotransmission. Based on these results, it can be concluded that 
PROT-deficiency leads to neuronal adaptions giving rise to better attention abilities. 
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Figure 24 Acoustic startle amplitudes of PROT-knockout mice and wild-type controls.  
For PROT mutant mice slightly increased startle amplitudes were observed in comparison to wild-type 
controls. Data are given as means ± SEM (n = 6 for each genotype, p-value = ns).  
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Figure 25 Prepulse inhibition (PPI) of acoustic startle responses of knockout and wild-type mice  
Analysis of PPI was conducted at 3 different prepulse intensities as indicated. PPI is expressed as % 
inhibition of the acoustic startle produced by the main pulse alone. Data are given as means ± SEM (n = 6 
for each genotype). Asterisk indicates significant different from wild-type mice, p < 0.05 (Student´s t-test). 
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4.5 Biochemical Analysis of  PROT-deficient Mice  
According to literature reports, different knockout experiments point out that inactivation 
of one gene can modify the expression of related genes. For example, neuronal transporter 
knockout mice exhibit up- or down-regulations of related synaptic proteins (Xu et al. 
2000). To discover the role of PROT protein in neurotransmission in detail and to 
investigate if its inactivation causes brain biochemical alterations, an examination of the 
transcriptional expression of several genes by qRT-PCR studies, which are potentially 
associated with PROT-function, and the quantification of the expression levels of their 
corresponding polypeptides by Western blotting has been accomplished.  
4.5.1 Determination of the Influence of PROT-deficiency on glutamatergic 
synaptic Biochemistry 
As mentioned above (Introduction, 1.3), it is known that PROT is localized primarily at 
glutamatergic synapses where L-proline produces complex electrophysiological actions. 
Therefore, it was of interest to investigate possible changes in the expression levels of 
specific components of glutamatergic neurotransmission, putatively appearing upon 
deletion of PROT which is thought to increase L-proline concentration in the synaptic 
cleft.  
4.5.1.1 Examination of Possible Alterations Regarding Expression of the Kainate-
Receptor 
It has been published that high concentrations of L-proline can activate the kainate-
subtype of glutamate-receptors in brain slices (Henzi et al. 1992). Furthermore, application 
of the kainate-receptor inhibitor CNQX was reported to block responses triggered by  
L-proline (Takemoto 2005). Therefore, in the scope of this thesis, it was investigated 
whether the absence of PROT has an influence on the expression of kainate-receptors. The 
amounts of polypeptide expressed in synaptic terminals (P2-fractions) were analyzed by 
Western-blot, quantified densitometricly (Methods, 3.2.18) and normalized to the reference 
gene β-tubulin. Due to possible irregular transfer rates over the membrane area, wild-type 
and knockout samples were loaded alternately.  
Upon analysis of the brain universally expressed regulatory KA2 subunit of the kainate-
receptor (Herb et al. 1992), no altered expression was observed in frontal cortices of 
PROT-mutant mice versus wild-type littermates (Figure 26). Expression of the 
presynaptically localized GluR7 subunit was as well detected not to be modified in frontal 
cortices of PROT-knockout mice (Figure 26).  
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Western-blot analysis of hippocampi revealed a significantly moderate increased expression 
of GluR7 (+18.9±6.1%, p<0.05) and KA2 (+30.9±6.6%, p<0.01) levels in PROT-deficient 
mice versus wild-type controls (Figure 27). This adaptive increase in expression of KA2 
and GluR7 in the hippocampal formation suggests a potentially enhanced sensitivity of 
neurons containing kainate-receptors towards the transmitter glutamate. 
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Figure 26 Expression level determination of KA2 and GluR7 subunits in frontal cortices  
Left panel: Western-blotting analyses in synaptosomal preparations from frontal cortices of knockout (ko) 
and wild-type (wt) mice at the age of 3 months. Right panel: Corresponding densitometric quantification of 
relative GluR7 and KA2 levels in frontal cortices of PROT-knockout and age-matched wild-type animals. 
Data are given as means ± SEM (n = 4-5 for each genotype).  
 
 
 
Figure 27 Changes in expression of KA2 and GluR7 subunits in hippocampus  
Left panel: Western-blotting analyses of GluR7 and KA2 levels in synaptosomal preparations from 
hippocampi of knockout (ko) and wild-type (wt) mice at the age of 3 months. Right panel: Corresponding 
densitometric quantification of relative GluR7 and KA2 levels in hippocampi of PROT-knockout and age-
matched wild-type animals. Data are given as means ± SEM (n = 4-5 for each genotype). Asterisk indicates 
significantly different from wild-type mice, with p < 0.05: *, p < 0.01: ** (Student´s t-test). 
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4.5.1.2 Analysis of potentially induced Alterations on NMDA-Receptor Expression 
Initial examination on the mRNA expression levels of NMDA-receptor components was 
carried out in mouse samples from frontal cortex, hippocampus and striatum. Analysis was 
focused on the NMDA-receptor anchoring protein PSD95 and on the NR2A subunit, 
which is the major regulatory NMDA subunit present in the adult neocortex and 
hippocampus, regions where as well high PROT expression levels can be found.  
Notably, removal of ProT significantly induced expression changes of the regulatory NR2A 
subunit. ProT -/- mice exhibited a significantly raised expression of NR2A mRNA in frontal 
cortex (+56.8±18.6%, p<0.05) and hippocampus (+72.9±18.7%, p<0.05), whereas no 
significant alteration was detected in striatum (Figure 28). Interestingly, no expression 
change was detected on the mRNA levels of the NMDA-receptor anchoring protein 
PSD95 in any of the analyzed brain areas (Figure 28). 
To verify that the detected adaptive modifications of mRNA levels upon ProT-deletion 
corresponded to a concomitant increase in the expression of NMDA-receptor polypeptides 
in synaptic terminals, P2 fractions were prepared and analyzed by Western-blotting. 
Extraction of proteins was carried out from frontal cortex and hippocampus, previously 
found by the qPCR analyses to be the brain areas comprising major alterations. In 
agreement with the mRNA analysis, verification of the NR2A subunit expression by 
Western-blot analysis detected a significantly, although moderate, increased expression in 
frontal cortices (+19.7±6.8%, p<0.05; Figure 29) as well as a dramatic upregulation in 
hippocampi (+76.4±7.9%, p<0.01, Figure 30) of PROT-/- mutants. In addition, Western-
blot analysis also comprised the functionally obligatory NR1 subunit and the regulatory 
NR2B subunit, which represents the second major NR2 subunits present in the adult 
neocortex and hippocampus. Investigation of the membrane enriched fractions detected 
significantly increased levels of the NR1 subunit in frontal cortices (+28.0±4.1%, p<0.05), 
whereas no significant change in expression was observed in hippocampi, as represented in 
Figure 29 and Figure 30.  
Surprisingly, NR2B expression analysis in PROT-mutant mice revealed an elevation with a 
sharp increase of this subunit in frontal cortices (+86.3±15.8%, p<0.05; Figure 29). 
Moreover, a significantly upregulated expression of NR2B was observed in hippocampi of 
PROT-deficient animals (+36.8±10.3%, p<0.01; Figure 30). Confirming the qPCR 
analysis, no genotypical effect was present concerning expression of the NMDA-receptor 
anchoring protein PSD95 in any of the analyzed brain areas (Figure 29 and Figure 30). 
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Figure 28 Relative mRNA expression profiling of NMDA-receptor components NR2A and 
PSD95  
Data were normalized to β-actin and represent means ± SEM (n = 3 for each genotype). Asterisk indicates 
significant difference from wild-type mice, p < 0.05 (Student´s t-test). 
 
 
 
Figure 29 Validation of NMDA-receptor subunit level and -related PSD95 expression in frontal 
cortices of PROT-knockout and wild-type mice 
Left panel: Western-blotting analyses of NR1, NR2A, NR2B and PSD95 levels in synaptosomal preparations 
(P2-fractions) from frontal cortices of knockout (ko) and wild-type (wt) mice at the age of 3 months. Right 
panel: Corresponding densitometric quantification of relative levels in frontal cortices of PROT-knockout 
and age-matched wild-type animals. Data are given as means ± SEM (n = 4-5 for each genotype). Asterisk 
indicates significant difference from wild-type mice, p < 0.05 (Student´s t-test). 
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Figure 30 Composition of NMDA-receptor complex in hippocampi of PROT-knockout and wild-
type mice 
Left panel: Western-blotting analyses of NR1, NR2A, NR2B and PSD95 levels in synaptosomal preparations 
from hippocampi of knockout (ko) and wild-type (wt) mice at the age of 3 months. Right panel: 
Corresponding densitometric quantification of relative subunit levels in hippocampi of PROT-knockout and 
age-matched wild-type animals. Data are given as means ± SEM (n = 4-5 for each genotype). Asterisk 
indicates significant different from wild-type mice, p < 0.01 (Student´s t-test).  
 
In summary, analysis of NMDA-receptor subunits disclosed that expression levels of 
subunits were changed after ablation of PROT, thus suggesting a possible alteration in the 
subunit composition and total number of NMDA-receptors, which could result in changed 
glutamatergic signaling performance at these brain regions. 
 
4.5.1.3 Investigation of Putative Changes in AMPA-Receptor Expression 
AMPA receptors colocalize with NMDA-receptors in many brain areas, and activation of 
both is necessary to express long-term potentiation (LTP), a molecular basis of learning 
(for review see Nicoll 2003). As an increase of the NMDA subunits was detected in 
PROT-knockout mice, and being aware of the fact that application of L-proline at high 
concentrations activates AMPA-receptors in brain slices (Henzi et al. 1992), it was also of 
interest to investigate AMPA-receptor expression in ProT-deficient mice. 
Initial examination of mRNA expression of the ubiquitary expressed Gria1, coding for the 
GluR1 subunit, and Gria3, which encodes for the GluR3 subunit, displayed no alterations 
in both Gria transcript levels from PROT-knockout when frontal cortex, hippocampus and 
striati were analyzed (data not shown).  
To investigate whether the Gria2 gene expression is adaptively modified upon PROT-
deficiency, polypeptide expression of the corresponding GluR2 subunit in plasma 
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membrane enriched fractions of frontal cortices and hippocampi were analyzed by 
Western-blotting. Similar to Gria 1 and Gria 3, polypeptide expression of the GluR2 subunit 
displayed no change in the cerebral frontal cortex. However, a significantly moderate 
increase (+20.5% ±4.0 %, p<0.05) was observed in the hippocampal formation  
(Figure 31), thus suggesting a changed glutamatergic excitability by AMPA receptors in 
this brain region. 
Taken together, deletion of PROT induces adaptive changes on glutamate-receptor 
expression levels in PROT-knockout brains, particularly in hippocampus where expression 
increase of the regulatory KA2 subunit of the KA-receptor, the regulatory NR2A and 
NR2B subunits of the NMDA-receptor and the GluR2 subunit of the AMPA-receptor 
could be observed. Since the hippocampus is a brain area involved in memory function 
(Milner and Penfield 1955-1956), and activation of AMPA- as well as NMDA-receptors are 
required for the formation of LTP (O'Connor et al. 1995), these data suggest that PROT-
knockout animals might exhibit the prerequisite for better learning abilities in relation to 
those of wild-types. 
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Figure 31 Changes of GluR2 subunit expression in PROT-knockout and wild-type mice 
Left panel: Western-blot analysis of GluR2 levels in P2 fractions from frontal cortices and hippocampi of 
knockout (ko) and wild-type (wt) mice at the age of 3 months. Right panel: Corresponding densitometric 
quantification of relative GluR2 levels in frontal cortices and hippocampi of PROT-knockout and age-
matched wild-type animals. Data are given as means ± SEM (n = 4-5 for each genotype). Asterisk indicates 
significantly different from wild-type mice, p < 0.05 (Student´s t-test). 
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4.5.2 Examination of Allosteric NMDA-Receptor Modulators 
To gain further insights into how PROT-deficiency affects glutamatergic 
neurotransmission, it was investigated whether expression of genes controlling the 
allosteric NMDA-receptor modulators glycine and D-serine were changed. It could be 
envisaged that L-proline could help NMDA-receptors reaching their activated 
conformation due to the binding to an allosteric site. Evidence came from the observation 
that high concentrations of L-proline inhibit the binding of [3H]-glycine to the strychnine-
sensitive site of NMDA-receptors at the NR1 subunit (Ortiz et al. 1997). If L-proline as 
well acts as an allosteric enhancer of NMDA-receptor activation, it may be suggested that 
the level of the other positively allosteric modulating molecules, glycine and D-serine, are 
adaptively downregulated to protect against increased activation. Therefore, mRNA levels 
of the D-serine facilitating enzyme serine racemase (SR) and the extracellular glycine 
concentration controlling protein glycine-transporter 1 (GlyT1) were studied by qPCR-
analysis. As shown in Figure 32, no significant decreases in the expression of the mRNA 
levels of serine racemase or glycine-transporter 1 were detected. The absence of adaptions 
in the expression of these proteins, controlling the level of allosteric NMDA-receptor 
modulators, suggests that L-proline does not activate NMDA-receptors by an allosteric 
mechanism via the NR1 subunit.  
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Figure 32 Relative RNA expression profiling of serine racemase (SR) and glycine-transporter 1 
(GlyT1) of PROT-knockouts and wild-type mice 
Data were normalized to β-actin and represent means ± SEM (n = 3 for each genotype).  
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4.5.3 Investigation of Components of Dopaminergic System 
It is known that NMDA-receptors modulate the extracellular levels of dopamine in brain 
(Araneda and Bustos 1989). Consequently, dopaminergic neurotransmission could be 
affected as NMDA-receptors are altered in PROT-deficient animals (4.5.1.2). 
Determination of the expression of the enzyme catechol-O-methyltransferase (COMT) 
mRNA in frontal cortices of ProT-deficient animals revealed no significant changes  
(Figure 33). Similarly, no significant change in COMT expression was observed in striatum 
and hippocampus. Examination of the dopamine synthesizing enzyme tyrosine hydroxylase 
(TH) revealed a dramatic, statistically significant upregulation of 144.7±32.6% in frontal 
cortex of PROT-deficient mice (Figure 33). Even though PROT-deficient animals 
exhibited a moderate upregulation of the dopamine-receptor 1 (DRD1) mRNA in frontal 
cortices of 76.0±20.9 %, it was not statistically significant due to a high variance  
(Figure 33). However, the most potent adaptions on mRNA expression within the 
dopaminergic system were found for the dopamine-receptor 2 (DRD2). Frontal cortices of 
PROT-deficient mice exhibited a more than six fold increase in DRD2 mRNA 
(+573.4±120.5%), and a more than three-fold expression (+241.3±74.0%) of DRD2 
mRNA in hippocampi (Figure 33).  
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Figure 33 Relative mRNA expression profiling of proteins involved in dopaminergic 
neurotransmission of PROT-knockouts and wild-type mice 
Data were normalized to β-actin and represent means ± SEM (n = 3 for each genotype). Asterisk indicates 
significantly different from wild-type mice, with p < 0.01: **, p < 0.001: *** (Student´s t-test). 
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In summary, deletion of PROT results in changes on the expression levels of components 
of the dopaminergic system, thus suggesting a dysregulation of dopaminergic 
neurotransmission probably mediated by the persistent glutamatergic alteration previously 
observed in PROT-knockout mice. Interestingly, a mechanism to enhance working 
memory has been proposed to be mediated through activation of hippocampal DRD2-
receptors (for a review, see Liggins JTP, 2009). Therefore, DRD2 increase in PROT-
knockout mice strongly suggests improved performance in memory trials for these animals 
compared to wild-type mice. 
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4.6 Further Behavioral Analysis of  PROT-Knockout Mice 
The finding that PROT-knockout animals displayed an altered expression of synaptic 
components involved in glutamatergic and dopaminergic neurotransmission prompted us 
to further investigate potential behavioral abnormalities in these mice. Activation of 
glutamate-receptors is the molecular basis controlling several behavioral patterns, such as 
affective and cognitive tasks. Therefore, open field by intensive illumination, forced swim 
and Y-maze tests were examined next. 
 
4.6.1 Anxiety - Zone Analysis Test 
The fact that NR2A knockout mice display reduced anxiety-like behavior (Boyce-Rustay 
and Holmes 2006), in connection with the NR2A upregulation observed in PROT-
deficient animals, proposed an altered anxiety-like behavior in PROT-mutants. In order to 
prove this hypothesis, open field test analyses with aversive illumination conditions were 
conducted. By intensive illumination instead of very dim light, the open field test can be 
used to study emotionality of mice, as normal behavior of mice is to seek the protection of 
the periphery (Archer 1973). Interestingly, the distances that mice traveled into the center 
of the open field revealed a significant genotypical effect using 250 lux illumination 
intensity: PROT-/- mice covered only a small distance of 0.66±0.03 meters compared to 
PROT+/+ animals that traveled 2.0±0.12 meters into the center (Figure 34). Although 
PROT-/- mice exhibit a lower basal locomotor activity, which accounts for a reduction of 
20%, the disparity of the traveled distance in the center composes 67% reduction. 
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Figure 34 PROT-knockout mice exhibit increased anxiety-like behavior compared to wild-type 
animals.  
PROT-knockout mice traveled significantly less far into the center area of the open field (A) as compared to 
wild-type controls. Furthermore, PROT mutants made significantly less entries into the center of the open 
field (B) and spent significantly less time in the center area (C). Data are given as means ± SEM (n = 20 for 
each genotype). Asterisk indicates significant different from wild-type mice, p < 0.05 (Student´s t-test). 
 
Consistent with the results concerning traveled distances into the center, there was a 
significant genotypical effect for the total number of visits to the center of the open field: 
PROT-/- animals entered the center significantly less often (5.18±1.08, p-value < 0.05) than 
PROT+/+ control mice (13.65±3.46, n = 17) as represented in  
Figure 34. Accordingly, the average of time PROT-/- mice spend in the center, was 
7.09±1.56 seconds versus 17.04±3.52 seconds for PROT+/+ controls (n = 17, p < 0.05; 
Figure 34). In summary, zone analysis data, using aversive illumination conditions, 
indicates an increased anxiety phenotype of the mutant mice, by uncovering increased 
avoidance behavior with respect to numbers of visits to, distance traveled into, and time 
spend in the center of the open field. 
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4.6.2 Depression - Forced Swim Test   
The increase observed in biochemical analysis with respect to GluR7 expression gave rise 
to examine depression related behavior, since GluR7 is known to be associated with 
recurrent major depressive disorder (Schiffer and Heinemann 2007). Additionally, being 
aware of the finding that PROT-deficient mice exhibit a changed emotionality, namely an 
increased anxiety-like behavior (4.6.1), further analysis of affective behaviors was 
accomplished by examining the animals in a forced swim test. The forced swim test, also 
referred to as Behavioral Despair test, is used to investigate depression related behavior in 
animals. Mice were put in a cylinder from which they could not escape, and which was 
filled with water forcing the mice to swim. Information about emotionality is gained from 
the duration of immobility (or vice versa from the time of swimming). Usually, 
confrontation with this aversive situation firstly induces escaping behavior that later on 
changes to immobility, where the mice let themselves float in the water.  
Interestingly, a significant genotypical effect on the time period of immobility could be 
assigned to PROT-/- mice, which spent less time (60.89 ± 6.97 s resp. 20.3 ± 2.3%) 
immobile over a 5 minute period compared to PROT+/+ mice (127 ± 11.41 s resp. 42.3 ± 
3.8%), indicating a behavioral correlation with either positive mood or increased fear due 
to enhanced escaping behavior (Figure 35).  
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Figure 35 Immobility in the forced swim test of knockout and wild-type mice.  
PROT-knockout mice significantly behaved less immobile than wild-type control animals. Data are given as 
means ± SEM (n = 10 for each genotype). Asterisk indicates significantly different from wild-type mice,  
p < 0.0001 (Student´s t-test). 
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4.6.3 Short Term Memory - Y-Maze Test 
It was reported by Bavaresco et al. that chronic hyperprolinemia causes memory deficits 
(Bavaresco et al. 2005). In addition, biochemical investigations of the present thesis 
revealed a change in the expression levels of NMDA-receptor subunits of the knockout 
animals (section 4.5.1.2). On the basis of these findings, it was supposed that the long-term 
potentiation (LTP) is altered, affecting memory formation in the mutant mice.  
To examine this, PROT-/- mice as well as wild-type controls were studied for spontaneous 
alternation behavior in a Y-maze test. This paradigm is considered to reflect spatial 
working memory, which belongs to the short term memory. It was monitored whether 
these animals alternate between the “arms”, reflecting if they remember which “arm” they 
entered last. 
Interestingly, a significant genotypical effect was disclosed by the investigation of the 
spontaneous alternation behavior (Figure 36). PROT-/- mice outperformed wild-type 
controls by entering significantly more often a new “arm” (75.06 ± 2.05 % of the total 
entries versus on PROT+/+ mice, 55.47 ± 2.8 % of the total entries; n = 8, p-value  
< 0.001). This result indicates that PROT-deficient mice exhibit an enhanced spatial 
working memory due to the observed better performance in this test.  
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Figure 36 Analysis of spontaneous alternation behavior in the Y-maze test of PROT-knockout and 
wild-type mice.  
PROT-knockout mice performed significantly better in this cognitive task compared to wild-type controls. 
Data are given as means ± SEM (n = 8 for each genotype). Asterisks indicate significantly different from 
wild-type mice, p < 0.001 (Student´s t-test). 
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Taken together, these results indicate that the alterations detected in synaptic components 
of PROT-knockout mouse brains are associated with enhanced reaction to aversive stimuli, 
as demonstrated by two anxiety-related test paradigms, and modifications in memory 
formation. Our behavioral data are in agreement particularly with the expression increase 
of NMDA-receptor subunits and DRD2 in hippocampus of PROT-deficient mice, as this 
brain region is primarily involved in learning and memory, and anxiety-related responses 
are thought to be mediated by the septohippocampal system in both humans and animals. 
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4.7 Analysis of  Mature PROT-Knockout Mice 
Aging is known to influence many physiological processes in the brain, including 
expression of neurotransmitter receptors, thus resulting in modulation of 
neurotransmission functionality and behavioral patterns (Clayton et al. 2002a; Clayton et al. 
2002b). To discover whether the observed behavioral alterations of PROT-deficient mice 
increase during the aging process, further analyses were carried out with mature mice. 
4.7.1 Behavioral Analysis 
4.7.1.1 Open Field Analysis 
In agreement with the experimental data gained from the analysis of 3 months old mice, 
mature 8 months old PROT-/- mice as well covered significantly lower traveled distances 
(205.44±12.17 m, n = 18) in the open field compared to PROT+/+ mice (278.77±13.82 m, 
p-value < 0.001, Figure 37 A). Time course analysis of the traveled distances revealed that 
PROT-deficient mice were less active during each 5-min interval of the total 30 minutes 
observation period (Figure 37 C). Two-way ANOVA showed a significant effect of the 
genotype on distance moved (F(1,180) = 15.55; p < 0.001) and of the time period on distance 
moved (F(5,180) = 38.76; p < 0.001). Therefore, PROT-mutants exhibit a higher ability to 
habituate to the test chamber than wild-type controls, possibly due to changed signaling 
abilities of glutamate receptors leading to enhanced long-term-potentiation. For 
specification, this enhanced effect on locomotor activity with respect to the genotype was 
observed to be stronger in mature PROT-deficient animals, thus indicating that the 
adaptive effects of the mutation increase upon aging of the laboratory animals.  
In addition to the analysis of the horizontal activity, an even stronger genotypical effect was 
ascertained with mature 8 months old PROT-/- mice by examination of the time that was 
spent in hyperactivity. In average, PROT-mutants exhibited significantly lower hyperactive 
time periods (281.93±19.22 s) in comparison to wild-type controls (420.89±24.23 s,  
n = 18, p-value < 0.001, Figure 37 B). Block analysis confirmed this result by displaying 
that PROT-knockouts spent less time in hyperactivity during each 5-min interval of the 
total 30 minutes observation period (Figure 37 D). Two-way ANOVA of time course 
analysis revealed an effect of the genotype on the time spend in hyperactivity (F(1,180) = 19.6; 
p < 0.001), and additionally an effect of the time period spent in the novel environment, on 
the time spend in hyperactivity was disclosed (F(5,180) = 35.33; p < 0.001). Via this observed 
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improved habituation abilities, it could be concluded that PROT ablation induces adaptions 
that ameliorate attention and learning deficits occurring upon aging. 
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Figure 37 Motor activity test of 8 months old wild-type and knockout mice  
A. Investigation of total covered distances (q.v. 4.4.3) revealed a statistically significant decreased locomotor 
activity of mature PROT-/- mice in a novel environment. B. Determination of periods spent in hyperactivity 
after exposure to a novel environment by 8 months old knockout and wild-type mice shows a significant 
genotypical effect. Total time spent in hyperactivity over 30 minutes display significantly decreased 
hyperactivity-time for PROT-/- mice versus control animals under non aversive conditions (2 lux illumination 
intensity). C. Time course analysis of total covered distance shown in intervals of 5 min revealed a particular 
decreased locomotor activity of PROT-/- mice in the first half phase (habituation phase) of the test. D. Block 
analysis of time spent in hyperactivity in 5 minute intervals (B) display significantly decreased observed 
hyperactive time periods for PROT-/- mice versus control animals Illumination conditions of 2 lux were used 
to investigate basal exploration behavior. Data are given as means ± SEM (n = 14 for each genotype). 
Asterisk indicates significantly different from wild-type mice, with p < 0.05: *, p < 0.01: **, p < 0.001: *** 
(Student´s t-test). 
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4.7.1.2 Y-Maze Test 
To investigate retentivity of mature PROT-deficient mice, they were subjected to a Y-maze 
test. In agreement with the observations obtained by analyses of 3 months old mice, also  
8 months old PROT-/- mice entered significantly more frequently a new “arm” of the maze 
(71.42 ± 2.34 %, n = 8) than PROT+/+ controls (51.39 ± 2.31 % of the total entries,  
p-value < 0.001) of this age (Figure 38). These data show that mature PROT-deficient 
mice display a significantly improved spatial working memory in relation to wild-type 
controls of the same age.  
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Figure 38 Examination of spontaneous alternation behavior of mature mice in a Y-maze test.  
PROT-knockout mice were shown to perform significantly better in this cognitive task than wild-type 
controls. Data are given as means ± SEM (n = 8 for each genotype). Asterisk indicates significant different 
from wild-type mice, p < 0.001 (Student´s t-test). 
 
4.7.2 Analysis of NMDA-Receptor Composition in Mature Mice 
Aging is known to be associated with a selective decrease in the expression of NR1, NR2A 
and NR2B subunits of the NMDA-receptor (Clayton and Browning 2001; Sonntag et al. 
2000). To investigate whether the detected alterations in NMDA-receptor expression of 
PROT-deficient mice vary during aging of the animals, further Western-blot analyses were 
carried out.  
Surprisingly, and in discrepancy to the results from the behavioral analysis of  
8 month old PROT-deficient animals, investigation of the amounts of polypeptides 
expressed in synaptic terminals of 11 months old mice led mainly to the observation that 
no differences in expression of NMDA-receptor subunits were detectable (Figure 39, 
Figure 40). The only exception was the expression of the NR2B subunit in hippocampi, 
which was still significantly increased in ProT-deficient animals (Figure 40). These results 
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indicate a counter regulation to the observed adaptions in the expression of NMDA 
receptor subunits found for PROT-deficient mice at the age of 3 months. 
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Figure 39 Validation in NMDA-receptor subunit level and -related molecule PSD95 expression  
Left panel: Western-blot analyses of NR1, NR2A, NR2B and PSD95 levels in synaptosomal preparations 
(P2-fractions) from frontal cortices of 11 months old knockout (ko) and wild-type (wt) mice. Right panel: 
Corresponding densitometric quantification of relative subunit levels in frontal cortices of PROT-knockout 
and age-matched wild-type animals. Data are given as means ± SEM (n = 4-5 for each genotype). Asterisk 
indicates significant different from wild-type mice, p < 0.05 (Student´s t-test). 
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Figure 40 Composition in NMDA-receptor complex in hippocampi of mature PROT-knockout 
and age-matched wild-type mice 
Left panel: Western-blot analyses of NR1, NR2A, NR2B and PSD95 levels in synaptosomal preparations 
from hippocampi of 11 months old knockout (ko) and wild-type (wt) mice. Right panel: Corresponding 
densitometric quantification of relative subunit levels in hippocampi of PROT-knockout and age-matched 
wild-type animals. Data are given as means ± SEM (n = 4-5 for each genotype). Asterisk indicates significant 
different from wild-type mice, p < 0.01 (Student´s t-test) 
. 
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5 Discussion 
Within the scope of this thesis the generation of a new mouse model was described. In the 
generated mouse strain, the expression of a functional murine ProT gene was abolished 
(knockout strain). Furthermore, this mouse strain was analyzed and initial experiments 
were accomplished. The data derived from these studies will be discussed in this chapter. 
5.1 Generation and Validation of  the PROT-deficient Mouse Strain 
The aim of this thesis was the generation of a mouse line with a mutated ProT gene locus 
and, as a result, the ablation of the expression of a functional PROT protein. This was 
achieved through the use of established knowledge in genetics and cell biology. Fragments 
of mutated genomic DNA are introduced into mouse mammalian embryonic stem (ES) 
cells and can recombine with endogenous homologous sequences via crossing-over events 
(Thomas et al. 1986). These targeted ES cells can then be used to transfer the manipulated 
gene into the mouse germline to create a chimeric animal (Robertson 1991). This chimera 
can then be used to create a manipulated mouse strain through breeding, in case the 
mutation is not lethal.  
In this thesis, a targeting construct was created and subsequently transferred into HM1-ES 
cells from SV129 origin to mutate the murine ProT locus (4.1.3 & 4.1.4). Selection for 
targeted ES cell clones was performed upon culture in G418 and FIAU containing media. 
Homologous recombination of the targeting construct was successfully verified by 
Southern-blot analysis (4.1.4) and yielded ten homologously recombined ES cell clones. 
The frequency of homologous recombination observed in this experiment was higher 
(9.4%) in relation to earlier reported homologous recombination frequencies of 1–3% 
(Capecchi 1989). An exponential relationship has been described between the size of the 
homologous region and the targeting frequency (Capecchi 1989), meaning that an increase 
in homology leads to highly elevated recombination frequencies. Moreover, the possibility 
of a homologous recombination also depends on the state of compaction of the targeted 
genomic DNA locus (Hasty et al. 1991). As our targeting vector contained DNA sequences 
comparable in size to other targeting constructs previously used to generate different 
knockout mouse lines, the high frequency of homologous recombination observed in our 
experiment could be due to the possibility that the murine ProT gene locus is highly 
accessible for recombination events in ES cells.  
The reimplanted blastocysts gained upon injection of the ES cell clone 105 led to the birth 
of chimeric male mice that were used to transmit the mutation to progeny. It was 
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successfully verified by PCR analysis that the offspring generated by mating the chimera 
with C57/B6 mice exhibited the mutation according to the ratios described by Mendel. 
Similarly, it was confirmed by RT-PCR and by qPCR (4.2.1) that the mutation of the  
ProT gene locus led to decreased ProT transcript in heterozygous animals and to total 
abortion of ProT mRNA expression in homozygous mice. Moreover, a decreased PROT 
polypeptide content in isolated synaptosomes could be determined in preparations of 
heterozygous PROT-knockouts and the analysis of homozygous PROT-deficient mice 
proved the complete absence of PROT polypeptide (4.2.2). Taken together, the generation 
of the PROT-knockout mouse line could be therefore successfully verified.  
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5.2 Characterization of  PROT-deficient Mice 
PROT-knockout mice were normal in appearance and showed, similar to their wild-type 
and heterozygous counterparts, undisturbed development and fertility. In addition, they 
display normal morphological architecture of brain structures (4.3.4). Furthermore, no 
significant expression differences of the L-proline metabolizing enzymes were detected, 
indicating unchanged L-proline metabolism. Therefore, the PROT-deficient mouse strain 
represents a valuable tool for the analysis of PROT-function in vivo. 
5.2.1 Contribution of PROT to Sodium-dependent High Affinity L-Proline Uptake 
in Brain 
Synaptosomal preparations of PROT-deficient mice compared to wild-type animals 
revealed a significant reduction in high-affinity Na+-dependent uptake of L-proline of 
different brain areas. The contribution of PROT to the total Na+-dependent high affinity 
L-proline uptake was observed to be more than 80% in hippocampus, 54% in olfactory 
bulbs, ~70% in frontal cortex, and ~80% in striatum (4.3.1). These results are consistent 
with the expression pattern of PROT determined by Northern-blot analysis, which 
displayed high expression levels in hippocampus, lower in cortex, and low expression levels 
in olfactory bulb (Fremeau et al. 1992). The discrepancy between the observations that 
striatum exhibit high levels of L-proline transport (Figure 14) but only low levels of ProT 
mRNA (Figure 12) is possibly due to the fact that PROT is synthesized in glutamatergic 
pyramidal cells in frontal cortex and transported to axon terminals of descending pathways 
into the striatum. 
Addition of sarcosine, an inhibitor of PROT (Fremeau et al. 1992), decreased the uptake of 
L-proline in synaptosomal preparations of wild-type to similar levels as in the knockout 
mice (4.3.1). Notably, sodium-dependent L-proline accumulation in knockout mice was 
also further slightly inhibited by the addition of sarcosine. Thus, this inhibited L-proline 
accumulation in the knockout mice might be due to any transporter different from PROT, 
for instance, a low affinity metabolic amino acid transporter like the v7-3 transporter 
(Drgonova et al. 2007). Taken together, these experiments revealed that PROT mainly 
contributes to the high-affinity Na+-dependent L-proline uptake in brain. Therefore, it can 
be concluded that a physiologically effective knockout of the ProT gene is present in the 
PROT-knockout mouse strain. 
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5.2.2 Influence of PROT-Deletion on Glutamatergic Neurotransmission 
Previous studies have revealed that application of L-proline to brain slices can activate 
glutamate-receptors of the NMDA-, KA-, and AMPA-type (Henzi et al. 1992; Martin et al. 
1992), thus suggesting that PROT is involved in glutamatergic neurotransmission. In 
addition, it is known that other neuronal transporter knockout mice display molecular 
adaptive mechanisms, up- or down-regulating related synaptic proteins (Xu et al. 2000). 
Given that the neuronal L-proline transporter is absent upon embryogenesis in PROT-
deficient mice, it could be envisaged that similar compensatory conditions could also occur 
in these animals, modifying the expression profile of glutamate-receptors. 
Within the scope of this thesis, densities of the KA-receptor subunits, KA2 and GluR7, 
have been found to be upregulated in hippocampus of PROT-knockout mice (4.5.1.1). 
Since the presynaptic action of KA-receptors is lost in GluR7-knockout mice (Pinheiro et 
al. 2007), this subunit is suggested to exhibit an exclusively presynaptic localization. On the 
other hand, the KA2 subunit is mainly localized at postsynaptic sites (Darstein et al. 2003). 
Thus, KA-receptors are localized pre- and postsynaptically, and are able to regulate 
transmission of information and excitability in a synapse-specific manner (Lerma et al. 
2001). The size of postsynaptic KA-receptor-mediated currents is 10-fold smaller than 
AMPA-mediated currents, but exhibits a longer duration with a consequently longer 
integration time (Lerma et al. 2001). Therefore, the adaptive increase in expression of KA2 
in the hippocampal formation could result in enhanced sensitivity to the transmitter 
glutamate. Altogether, the increased expression of both pre- and postsynaptic subunits 
suggests a different arrangement of KA-receptors in PROT-deficient mice, which could 
result in altered glutamatergic signaling. 
Upon analysis of the expression of the AMPA-receptor subunits, moderate upregulation of 
GluR2 polypeptide was also observed in the hippocampal formation of PROT-knockout 
mice (4.5.1.3). AMPA-receptors are heterotetramers composed of maximum two different 
subunits, with GluR2 being a key subunit for the formation of functional receptors 
(Mansour et al. 2001). The GluR2 subunit is localized at postsynaptic elements (Hampson 
et al. 1992). A change in synaptosomal GluR2 therefore likely reflects an alteration in 
AMPA-receptor availability in dendritic spines, which would result in changed 
glutamatergic neurotransmission in PROT-deficient hippocampus. 
In addition, it was ascertained that PROT-deficient mice exhibit an increase in NMDA-
receptor expression compared to wild-type control animals (4.5.1.2). In hippocampus, 
Western-blot analysis showed a significant high expression increase of the NR2A and 
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NR2B subunits (+76.36±7.93% and +36.84±10.32%, respectively). Similarly, frontal 
cortices also displayed an increase of NR2A and NR2B subunit levels (+19.7±6.8% and 
+86.3±15.8%, respectively). Moreover, a significant upregulation of the NR1 subunit was 
likewise observed in frontal cortex of PROT-knockout animals. These data suggest that an 
altered composition (subunit-shift) of the different NMDA-receptor subunits could be 
present in the postsynaptic density of these particular brain areas. At first sight, these 
findings could appear controversial as the obligatory NR1 subunit was not observed to be 
upregulated in the same extend as the NR2 subunits. However, the NR1 subunit has been 
shown to be highly expressed, allowing a considerable dynamic range in the formation of 
functional NMDA-receptors (Zhong et al. 1994). 
NMDA-receptors are tetramers composed of one NR1-dimer and two NR2 subunits 
(Laube et al. 1998; Schorge and Colquhoun 2003). Although the NR1 subunit exhibits all 
properties of the NMDA-receptor channel complex, the assembly of NR2 subunits with 
the NR1-dimer potentiates or rather ascertains the receptor mediated currents. NMDA-
receptors containing NR2B as a partner for NR1 exhibit a prolonged duration of channel 
opening time compared with receptors built of NR1 and NR2A (Vicini et al. 1998). 
Therefore, NR2A containing NMDA-receptors mediate faster neurotransmission than 
those containing NR2B (Cull-Candy et al. 2001). The observed upregulation of NR2A 
subunits in the hippocampus of PROT-deficient mice could be explained as a counter 
regulation to the totally increased NMDA-receptor density, attenuating the putatively 
enhanced NMDA-receptor transmission by shortening the duration of the channel opening 
time. Thereby, the hippocampal formation would be protected from glutamatergic 
excitotoxicity arising by an increased glutamate release.  
Taken together, our analyses in PROT-knockout mice showed a modified expression 
profile for several glutamatergic receptor subunits, particularly in hippocampus, which is 
the brain area primarily involved in learning and memory. The expression elevations of the 
KA2 and GluR7 subunits of the KA-receptors, GluR2 subunit of the AMPA-receptor, and 
the regulatory NR2 subunits of the NMDA-receptor strongly indicate changes in 
hippocampal glutamatergic neurotransmission. 
According to the literature, activation of NMDA-receptors increases the surface expression 
of AMPA-receptor subunits (Li et al. 2009), what is consistent with the detected increase of 
GluR2 expression in PROT-deficient mice. Activation of AMPA- and NMDA-receptors 
are required for the formation of long-term potentiation (LTP), a molecular basis of 
learning (Nicoll 2003), and activity-dependent synaptic maturation (O'Connor et al. 1995). 
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Therefore, the present data indicate that ablation of PROT induces adaptive changes that 
might give rise to molecular basis for better learning abilities. 
Further investigations are required to verify the mechanism that PROT utilizes to 
contribute to NMDA-receptor transmission. The amount of NMDA-receptors localized 
on the cell surface should be analyzed into more detail to ensure that despite the observed 
total increase, an increased number of receptors are ready to effect signal transduction. 
Furthermore, it should be determined, e.g. by electrophysiological investigations, whether 
the overexpression of the NMDA-receptors in PROT-knockout mice translates into 
enhanced NMDA-receptor mediated synaptic currents.  
5.2.3 Contribution of PROT on Dopaminergic Neurotransmission 
In this work it was studied if the detected upregulations of glutamate-receptors in  
PROT-deficient mice leads to a secondary dysregulation of the dopaminergic 
neurotransmission. Evidence came from the observation that NMDA-receptors regulate 
the release of dopamine (Araneda and Bustos 1989). Assuming that PROT-deficient mice 
have enhanced glutamatergic neurotransmission (5.2.2), secondary alterations within the 
dopaminergic neurotransmission were considered to be possible as well. Moreover, 
PRODH-knockout mice lacking the L-proline metabolizing enzyme proline-dehydrogenase 
(PRODH) display increased levels of L-proline in the brain and exhibit adaptive changes in 
the expression of proteins involved in dopaminergic neurotransmission (Paterlini et al. 
2005). Since ablation of ProT gene is also expected to result in increased levels of L-proline 
in brain synapses, adaptions in expression of genes belonging to the dopaminergic system 
were anticipated. Paterlini et al. found a 25% upregulation of the enzyme catechol-O-
methyltransferase (COMT) in a cohort of frontal cortices of PRODH-deficient mice. 
COMT inactivates biologically active catechols, including the neurotransmitters dopamine, 
noradrenaline and adrenalin, which are suggested to be involved in physiological as well as 
pathophysiological processes (Levy 2009). In contrast to the literature, frontal cortices of 
PROT-knockouts, examined in the present thesis, exhibited no significant expression 
change of COMT mRNA. Furthermore, Paterlini et al. reported that PRODH-deficient 
mice exhibit a significant downregulation (~35%) of dopamine-receptor D1 (DRD1) 
mRNA in frontal cortices (Paterlini et al. 2005). However, no significant changes in DRD1 
expression were detected in PROT-deficient animals. The most striking adaptions on 
mRNA expression within the dopaminergic system of PROT-knockout mice were found 
for dopamine-receptor D2 (DRD2), which was shown to have a slightly reduced expression 
in PRODH-deficient animals (Paterlini et al. 2005). In contrast, here it was shown that 
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frontal cortices of PROT-deficient mice exhibited a six-fold increase in DRD2 mRNA, 
whereas a three-fold increase was also ascertained in hippocampus. Furthermore, in frontal 
cortices the dopamine synthetizing enzyme tyrosine hydroxylase (TH) was dramatically 
upregulated, indicating an elevation in dopamine synthesis and thereby suggesting also an 
increased release of dopamine in frontal cortices of PROT-deficient animals.  
The observed alterations within these components of the dopaminergic system are 
suggested to be due to the elevated NMDA-receptor expression found in PROT-knockout 
mice (4.5.1.2), since it was demonstrated that NMDA-receptor activation can control 
dopamine release (Jedema and Moghddam 1996; Del and Mora 2001). It has previously 
been reported that dopamine transporter (DAT) knockout mice display increased 
extracellular levels of dopamine, leading to compensatory decreased expression levels of 
TH- and dopamine receptors in order to dampen dopaminergic responsiveness (Jaber et al. 
1997; Jaber et al. 1999). Therefore, it can be suggested that the detected upregulation of 
TH and dopamine receptors in PROT-deficient mice indicates adaptive changes in 
dopaminergic neurons in attempt to increase dopaminergic responsiveness, in order to 
compensate a putative decreased extracellular level of dopamine.  
Taken together, the analysis of PROT-knockout mice displayed no comparable adaptions 
like those of PRODH-knockouts, which counterfeit the disease hyperprolinemia, probably 
due to different compensatory mechanisms in the dopaminergic system aroused in these 
different knockouts. Thus, the phenotype of PROT-deficient mice is not comparable to 
hyperprolinemia. However, in order to completely understand the contribution of PROT 
on dopaminergic neurotransmission, further more detailed studies are necessary. 
5.2.4 PROT-Deficient Mice Exhibit Changed Behavioral Profiles 
5.2.4.1 Altered Locomotor Activity in PROT-Deficient Animals 
In the course of this work it was shown that PROT-deficient animals display a significantly 
reduced locomotor activity when they are exposed to a novel environment in the open field 
test (4.4.3). These lower levels of exploratory locomotor activity of PROT-knockout mice 
were especially prominent during the first 20 min of the 30-min-test and disappeared by the 
end of the test session.  
Rotarod analysis of PROT-knockout mice confirmed that the detected hypolocomotion is 
not due to motor impairments of these animals, as PROT-mutants did not exhibit 
differences in this task compared to wild-type littermates (4.4.2). A second explanation for 
the decreased locomotion would be due to nonspecific locomotor hypoactivity. However, 
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the observation that PROT-deficient mice in general possess a significant reduced 
locomotor activity mainly in the first 20 min of the test (4.4.3) argues against this 
consideration. In fact, it seems more likely that the reduced locomotor activity arises from 
an improved ability to judge the familiarity of the recently visited spatial locations, so this 
paradigm gives information about how well the animals can adapt to a novel situation. 
Within the open field test two different and opposite forces govern the behavioral pattern 
of the animals. These forces are on the one hand the curiosity to explore the novel 
situation, which is on the other hand opposed by the fear about the new situation. The 
outcoming behavior is thereby influenced coincidently. In order to reduce the fear-like 
behavior, open field test analyses with non-aversive illumination conditions were 
performed. Therefore, the reduced explorative behavior of the PROT-knockout mice 
indicating a reduced curiosity maybe due to an increased positive mood and better learning 
abilities in these animals. This would be consistent with the data gained by examining the 
learning performance of these mice (4.6.3) as well as with the biochemical investigations 
exhibiting upregulated NMDA-receptor densities in hippocampus (4.5.1.2), suggesting 
changed signaling abilities, and possibly causing enhanced long-term-potentiation (LTP). 
Interestingly, it has been reported that NR2A-knockout mice exhibit an opposite 
phenotype compared to PROT-knockouts when studied in the open field test, with 
increased locomotor activity compared to wild-type littermates (Boyce-Rustay and Holmes 
2006). The biochemical analysis of PROT-deficient animals displayed adaptive elevated 
NR2A protein levels. This leads to the consideration that the expressed amount of NR2A 
subunits correlates with this behavioral condition. The concluding hypothesis that an 
enhanced NMDA-receptor transmission leads to the observed hypolocomotion of PROT-
deficient mice is further supported by a study investigating the effects of D-amino acid 
oxidase (DAO) knockout mice (Almond et al. 2006). These animals display elevated  
D-serine levels with consequently enhanced NMDA-receptor transmission, demonstrated 
by enhanced LTP and improved spatial learning abilities. Moreover, this mouse model 
exhibits as well a reduced locomotor activity when studied in the open field test. The 
authors hypothesize that an increased glutamatergic neurotransmission augments tonic 
GABAergic inhibition of nucleus accumbens dopamine release. This could be considered 
as well to happen in PROT-deficient animals. A decreased dopamine release with 
subsequent lowered activation of dopamine-receptors is known to result in a decreased 
locomotor activity (Beaulieu and Gainetdinov 2011; Jackson and Westlind-Danielsson 
1994; Jackson et al. 1994) and could thereby contribute to the hypolocomotion of PROT-
knockout mice. This hypothesis would be consistent with the data gained by examining the 
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expression of key proteins involved in dopaminergic neurotransmission within PROT-
knockout mice (4.5.3), since the increased expression of tyrosine hydroxylase and 
dopamine-receptors suggests a compensatory response to reduced dopamine release.  
Clearly, it would be interesting to perform further experiments. Clarification of the 
contribution of NMDA-receptors to the observed differences in locomotor activity of 
PROT-knockouts and wild-type animals would be beneficial. Application of NMDA-
receptor antagonists before examining the performance of PROT-knockout mice in an 
open field tests, would be also valuable. Thereby, it could be examined if PROT-lacking 
animals are at least partially protected from the locomotion enhancing effects of NMDA-
receptor antagonists. 
5.2.4.2 Increased Learning Abilities of PROT Mutant Mice 
Within the scope of this thesis, it could be shown by analysis of spontaneous alternation 
behavior that PROT-deficient mice display a significantly improved spatial working 
memory (4.6.3). This result demonstrating better learning abilities of PROT-lacking animals 
is in agreement with the open field analysis (4.4.3) that detected better habituation 
performances to a novel environment, since habituation represents non-associative 
learning.  
One possible reason for the better learning abilities of PROT-deficient mice could be the 
observed increase in glutamate-receptor density (4.5.1). It has been shown that NMDA-
receptor antagonists reduce spontaneous alternation behavior (Rubaj et al. 2003). 
Furthermore, it is well established that glutamate-receptors are important for long-term 
plasticity of synaptic transmission, which represents a cellular basis of learning processes 
(Martin et al. 2000). NMDA-receptors are critical for the induction of both long-term 
depression (LTD) and long-term potentiation (LTP) (Dudek and Bear 1992; Clayton et al. 
2002b). NMDA-receptors containing NR2B as partner for NR1 exhibit a prolonged 
duration of channel opening time compared with receptors built of NR1 and NR2A (Tovar 
et al. 2000). Consequently, the density of NMDA-receptors built with NR2B subunits is 
important for a better spatial working memory, what could be impressively verified with 
conditional NR2B-knockout mice showing reduced level of spontaneous alternation 
behavior, thus demonstrating a short-term spatial working memory deficit for recently 
visited places (von Engelhardt-Jakob et al. 2008). In addition, improved learning abilities in 
mice overexpressing NR2B clearly indicate the important role of this NMDA-receptor 
subunit in spatial learning (Tovar et al. 2000; Tang et al. 1999). PROT-knockouts in young 
as well as in mature age display enhanced NR2B levels within the hippocampus, a structure 
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important for learning processes (MILNER and PENFIELD 1955-1956). Therefore, it 
could be concluded that the detected upregulation of the NR2B subunit is responsible for 
the significantly improved spatial working memory of PROT-deficient mice.  
Furthermore, the increased learning abilities of PROT-knockouts could be partially due to 
the significantly increased GluR2 expression detected in the hippocampal formation. 
According to literature, spatial and non-spatial learning performance was disrupted in 
GluR2-mutant mice (Gerlai et al. 1998). Moreover, activation of AMPA-receptors is 
required for the formation of LTP, besides the activation of NMDA-receptors (O'Connor 
et al. 1995). Thus, it seems likely that augmentation of GluR2 expression, reflecting an 
increased AMPA-receptor number, and NR2B expression in PROT deficient mice 
facilitates the formation of improved LTP as a molecular basis for increased learning 
abilities.  
Taken together, the present results strongly suggest that PROT plays an important role 
within learning, possibly by regulating NMDA-receptors, which are the key receptors 
underlying synaptic plasticity. Therefore, it could be considered that PROT function is 
important for synaptic plasticity, which is relevant to behavioral and cognitive alterations 
with respect to learning abilities. 
5.2.4.3 Improved Sensorimotor Gating in PROT-Knockout Mice 
In the present work it was determined that PROT-knockout mice exhibit improved 
prepulse inhibition (PPI). PPI is an indicator for sensorimotor gating abilities, a process 
important for filtering irrelevant sensory information from the environment and thereby 
allowing attention to be focused on a given stimulus. This process is mediated by a 
neuronal system in which the brainstem receives modulatory input from the nucleus 
accumbens that in turn is innervated by the frontal cortex and hippocampus (Schmajuk and 
Larrauri 2005).  
Mice with an inactivated PRODH gene and thereby harboring elevated L-proline levels 
showed abnormalities in sensorimotor gating, ascertained by a ~15% lowered PPI  
(Gogos et al. 1999). Moreover, it is known that human hyperprolinemia is a risk factor for 
schizoaffective disorders (Jacquet et al. 2005). PPI is disrupted in patients suffering from 
schizophrenia or schizoaffective disorders (Grillon et al. 1992). Therefore, it was suggested 
that deletion of PROT could lead to a comparable phenotype of PRODH-knockout 
animals and moreover to a schizophrenia-related phenotype. However, the improved PPI 
of PROT-deficient mice (4.4.4) seems to be in discrepancy to the observations gained with 
PRODH-knockout animals. Assuming that the better PPI performance of PROT-mutants 
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is not due to improved auditory abilities caused by PROT-deficiency, variations in synaptic 
L-proline levels of PRODH- and PROT-knockout mice, which would lead to different 
compensatory mechanisms, could be responsible for this divergent PPI behavior.  
Another aspect to be considered is the common association of lowered PPI performance 
with schizophrenia. It could be envisaged that inhibition of PROT function could be an 
effective treatment of the schizophrenic disorder. To prove this hypothesis, it would be 
interesting to study the effects on PPI deficits induced by NMDA-receptor antagonists in 
PROT-deficient animals compared to wild-type controls. Thereby, it could be examined if 
PROT-lacking animals are at least partially protected from the PPI disrupting effects of 
NMDA-receptor antagonists.  
Taken together, the surprising finding of increased PPI in PROT-knockouts indicates that 
these animals display a slightly better attention performance than wild-type mice. Another 
conclusion, as mentioned above (5.2.3), is that although PROT-deficient mice and 
PRODH-knockouts are expected to exhibit increased L-proline levels in brain, both mice 
strains do not display similar phenotypes. 
5.2.4.4 Altered Emotionality in PROT-Knockout Mice 
The analysis of PROT-deficient mice in an open field test using aversive conditions gave 
evidence for an increased anxiety-like phenotype of the PROT mutants (4.6.1). By intensive 
illumination, the open field test can be used to study emotionality of the mice  
(Archer 1973), as normal behavior in mice is to seek the protection of the periphery, 
suppressing the locomotion enhancing curiosity-drive to explore the novel environment. 
Therefore, the reductions in time spent in the center, in distances traveled in the center 
area, and in number of visits to the center of the open field by PROT-knockouts, indicate 
an increased response to the anxiety-related component of the intensive illuminated open 
field test. This finding is supported by the outcome of the acoustic startle test (4.4.4) used 
as prescreen for the PPI-analysis. The tendency in PROT-knockouts to a higher reaction 
caused by a loud tone suggests that these animals exhibit increased anxiety-like behavior.  
Anxiolytic-like effects have been demonstrated through application of AMPA-receptor 
antagonists (Kotlinska and Liljequist 1998), as well as reduced anxiety was reported for 
GluR2-knockout mice (Mead et al. 2006). Moreover, NR2A-knockout mice also exhibit 
anxiolytic-like effects (Boyce-Rustay and Holmes 2006). Upon biochemical analysis of 
PROT-deficient mice, it was observed that these animals display an adaptive increase of 
NR2A and GluR2 protein levels. Therefore, this receptor upregulations in PROT-deficient 
mice could be a reasonable molecular basis for their detected increased anxiety-like 
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behavior. Indeed, mediation of emotion by NMDA neurotransmission is a growing body 
of evidence and discussed in several studies. Supporting evidence comes from studies 
where NMDA-receptor antagonist treatment showed also anxiolytic effects in rodents 
(Martinez et al. 2002; Wiley et al. 1995). 
In the scope of this thesis, it was observed that PROT-mutants display significantly 
reduced time of immobility in the forced swimming test (FST), also referred to as 
behavioral despair test (4.6.2), indicating antidepressant-like or positive mood behavior. 
The reduced time of immobility in the FST was not due to a generalized increase in 
activity, as indicated by the lower basic locomotor activity of the mutants in the standard 
open field test (4.4.3). It is known that forced swimming causes stress, which is reflected in 
altered neurotransmitter release and changed cellular signaling (Sakakibara et al. 2005). 
Central administration of L-proline attenuates induced stress in chicks (Hamasu et al. 
2010), which is quenched by co-injection of the NMDA-receptor antagonist MK-801, 
giving further evidence for the impact of NMDA-receptor density upon emotional state. 
Interestingly, it has been demonstrated that radio-ligand binding to NMDA-receptors is 
altered in suicide victims (Nowak et al. 1995), what is consistent with the hypothesis that 
NMDA-receptors are furthermore involved in the pathophysiology of depression (Trullas 
and Skolnick 1990). Therefore, the observed NMDA-receptor upregulation in PROT-
deficient mice could be a reasonable molecular basis for the decreased behavioral despair 
upon FST analysis. In addition, it is also known that during stress dopamine release is 
reduced by activation of glutamate-receptors (Del and Mora 2001), which results in 
increased expression levels of DRD2. Likewise, consistent with the interpretation that 
increased swimming times indicate antidepressant-like behavior is the observation that 
PROT-knockout mice display elevated expression of DRD2 mRNA (4.5.3), as chronic 
antidepressant treatment increases DRD2-signaling (Collu et al. 1997). Therefore, it seems 
possible that PROT-deficient mice, in contrast to their wild-type counterparts, experience 
less stress in the FST leading to subsequent decreased behavioral despair. 
In summary, PROT-deficient mice display altered emotionality that could be explained by 
adaptive changes in glutamate-receptor expression. Nevertheless, future experiments are 
necessary to precisely analyze PROT mechanisms governing emotionality. 
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5.2.5 Alterations in Mature PROT-Knockout Mice 
In general, aging is known to be associated with increased glutamate release (Freeman and 
Gibson 1987), decreased expression of NMDA-receptors (Clayton and Browning 2001) 
and deficits in activity dependent NMDA-receptor cell surface regulation (Clayton et al. 
2002a), consequently resulting in a decreased synaptosomal plasticity. The investigation of 
mature PROT-deficient mice revealed that these animals exhibit significantly lowered 
spontaneous locomotion in an novel environment (4.7.1.1) and outperforming spatial 
learning abilities (4.7.1.2), confirming the results gained by the analysis of 3 months old 
PROT-knockouts (4.4.3 and 4.6.3). However, analysis of the NMDA-receptor expression 
revealed no expression differences comparing PROT-mutants with age-matched wild-type 
controls apart from the significantly increased expression of the NR2B subunit in 
hippocampus (4.7.2). As mentioned above, analysis of conditional NR2B-knockout mice as 
well as mice overexpressing NR2B gave evidence that particularly the NR2B subunit plays 
an important role in spatial learning (Tovar et al. 2000; Tang et al. 1999). Interestingly, it 
has been reported that a knock-down of the NR2B subunit expression, especially in the 
hippocampus, can mimic age-related changes in LTP and spatial learning  
(Clayton et al. 2002b). The better spatial learning abilities of mature PROT-deficient mice 
could be thereby due to the observed increased expression of NR2B in hippocampus 
(4.7.2). In addition, as previously discussed, a reduced locomotor activity could arise from 
an improved ability to judge the familiarity of the recently visited spatial locations. This 
would as well implicate better learning abilities of the mutant mice and could also be due to 
the increased hippocampal NR2B expression in the mature PROT-deficient animals.  
 
Additionally, the open field analysis displayed a stronger behavioral phenotype for 8 
months old PROT-deficient animals (4.7.1.1) compared to 3 month old mutants (4.4.3), 
although within these young mice more adaptive changes in protein expression were 
present (4.5). Thus, the stronger behavioral phenotype of the 8 months old PROT-
deficient mice could be a result of increased receptor function in addition to the increased 
NR2B expression. Enhancement of NMDA-receptor function is known to be mediated by 
protein kinase C (PKC) and tyrosine kinase activation, which leads to rapid recruitment of 
NMDA-receptors to the cell surface (Huang et al. 2001; Lu et al. 1999). Furthermore, 
phosphorylation is known to regulate trafficking of NMDA-receptors (Chung et al. 2004). 
Therefore, the phosphorylation state of the respective NMDA-receptors subunits and their 
plasma membrane location levels should be determined in further experiments. Moreover, 
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to clarify the role of the increased expression of NR2B on synaptic transmission, additional 
comparative electrophysiological investigations of 8 month old PROT-deficient mice and 
wild-type littermates would be valuable.  
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5.3 Benefits from the PROT-Knockout Mouse Line  
The generation and analysis of mice lacking the expression of a functional PROT-protein 
clearly provided deeper insights into the in vivo modulatory role of the high affinity 
transport of L-proline by PROT. The question how L-proline and PROT influence 
glutamatergic neurotransmission within the normal brain will be further outlined and 
discussed here. Even though only speculative, some evidence about the physiological 
relevance can be hypothesized. 
First, L-proline has been shown to enhance NMDA-receptor transmission in low 
concentrations (Cohen and Nadler 1997b). Why should this not be due to the binding to 
an allosteric site and thereby cause facilitation of NMDA-receptors to reach their activated 
conformation? In the present thesis it could be shown that the expression level of proteins 
controlling the allosteric NMDA-receptor modulators glycine and D-serine were not 
changed in PROT-deficient animals (4.5.2). If L-proline additionally facilitated NMDA-
receptor activation through binding to an allosteric site, it could be concluded that the level 
of the other positively allosteric modulating molecules glycine and D-serine should be 
adaptively downregulated to protect against increased activation. Therefore, these data 
would reason against the hypothesis that L-proline is as well a positive allosteric modulator 
of NMDA-receptors. Moreover, since it was reported that L-proline in high concentrations 
can activate NMDA-, AMPA- and KA-receptors (Henzi et al. 1992), it could be envisaged 
that L-proline binds, maybe with low affinity, to orthosteric sites of these receptors and 
thereby causes their activation. This hypothesis cannot be ruled out, since it is not known 
whether some glutamate-receptors, with a specific subunit combination, may exhibit an 
affinity for L-proline. However, it has to be concerned that if glutamate-receptors are 
activated to a great extent, the physiological problem of glutamate-receptor excitotoxicity 
arises, and therefore evolution would not favor such a “second low affinity agonist” for 
glutamate-receptors.  
Albeit specific sodium-independent binding of radiolabeled L-proline to rodent brain 
synaptic membranes was reported (Greene et al. 1986; Cordero et al. 1991), so far no 
specific high-affinity receptor has been found for L-proline. However, some orphan 
receptors exist for which no ligand has been described in the literature so far. Since PROT 
is expressed in glutamate pathway fibers (Nadler et al. 1992), it can be suggested that a 
high-affinity L-proline specific receptor would be localized in their adjacency. This 
hypothetical receptor could be expressed by glutamatergic neurons in order to depolarize 
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the respective cells upon activation via L-proline and thereby simulate the reported 
potentiation of glutamatergic neurotransmission by L-proline (Cohen and Nadler 1997b).  
 
It is a common knowledge that the number of receptors present at the postsynaptic 
membrane determines the response to the neurotransmitter released from the presynaptic 
terminal. How can modulation of the expression of glutamate-receptors upon PROT-
knockout be explained? The neurobiological reasons of these alterations are only 
speculative, but some evidence can be hypothesized.  
It is well known that glutamate-receptor amounts can be modulated by chronic increase or 
decrease of agonist activation (Resink et al. 1996; Follesa and Ticku 1996). Chronic 
treatment with agonists and subsequent stimulation of the receptor can lead to 
downregulation of the corresponding receptor through an increase of receptor degradation 
(Luttrell and Lefkowitz 2002). Agonist-induced downregulation has been reported for 
NMDA-receptors (Resink et al. 1996), AMPA-receptors (Feligioni et al. 2006), and KA-
receptors (Martin et al. 2008), suggesting that these glutamate-receptors are regulated by 
the same mechanisms. On the other hand, chronic exposure to antagonists can lead to a 
compensatory increase in glutamate-receptor density with a subsequent supersensitivity 
towards the corresponding agonist (Williams et al. 1992). It has been suggested that 
endogenous extracellular L-proline maintains NMDA-receptor containing synapses in a 
partially potentiated state, as application of L-proline to brain slices, in concentrations 
normally present in cerebrospinal fluid, potentiates NMDA-receptor transmission (Cohen 
and Nadler 1997b). Therefore, at least the upregulation of NMDA-receptor amounts could 
be explained as follows:  
Since L-proline is released in a Ca2+-dependent manner from neurons upon depolarization 
(Mulder and Snyder 1974), the ablation of PROT, which leads to a slower clearance of L-
proline (4.3.1), should permanently increases the extracellular level of  
L-proline (only low affinity transport of L-proline by metabolic carriers is still possible) in 
distinct synaptic clefts, where PROT usually is situated. According to the literature, 
enhanced extracellular concentrations of L-proline induce an inhibition of glutamate release 
(Cohen and Nadler 1997a). Moreover, it has been reported that treatment with NMDA-
receptor antagonists induces an upregulation of the density of NMDA-receptors in vitro and 
in vivo (McDonald et al. 1990; Williams et al. 1992). Therefore, it is possible that the 
respective glutamatergic cells react against the chronically lowered agonist-concentration in 
turn with an increased expression of the NMDA-receptors to maintain excitability of the 
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respective glutamatergic synapses. This regulation could be triggered by the same cellular 
mechanisms like chronically treatment with antagonists, which induces a compensatory 
upregulation of NMDA-receptors (McDonald et al. 1990; Williams et al. 1992).  
Alternatively, the increased NMDA-receptor expression is possibly due to increased 
NMDA-receptor activation in PROT-knockout mice. Ablation of PROT should lead to 
increased extracellular L-proline levels and, according to the literature, this amino acid 
should potentiate and, in high concentrations, activate NMDA-receptors, (Cohen and 
Nadler 1997b; Henzi et al. 1992; Martin et al. 1992). It has been reported that activation of 
NMDA-receptors increases the expression of both NMDA- and AMPA-receptors. 
Furthermore, it has been shown that induction of LTP (which prerequisites the activation 
of NMDA-receptors) does not alter AMPA-receptors, but also increases the expression of 
NMDA-receptors (Grosshans et al. 2002; Li et al. 2009). Therefore, enhanced NMDA-
receptor expression in PROT-deficient mice could be also explained by increased NMDA-
function and enlarged LTP.  
Besides these speculations, it should be mentioned that the different NMDA-receptor 
subunits are encoded by different genes (Monyer et al. 1994) and it is uncertain whether 
these genes are equally regulated upon PROT-knockout. Alterations in the neuronal 
biochemistry of PROT-deficient mice could lead to unspecific different regulations of the 
respective transcription factors or influence the promoter accessibilities.  
 
Knockout mice can be highly informative about the discovery of protein function. In 
addition, it has been shown previously that phenotypes of knockout mice correlate well 
with the therapeutic effects of a high number of best-selling pharmaceutical drugs 
(Zambrowicz and Sands 2003). Phenotypical screening of these animals can be used to 
delineate valuable new drug targets and furthermore help in the determination of the 
potential on-target side effects associated with a given target. Consequently, PROT-
knockout mice provide the advantage that they can be used to model the physiological 
significance of PROT-inhibitors in a therapeutically relevant manner. Typically, 
neurotransmitter transporters were thought to function only as terminators of synaptic 
transmission by active transport of the respective neurotransmitters back into neuronal 
cells (or into glial cells). However, the findings presented in this thesis indicate that the 
function of this transporter is more than pure reuptake of L-proline released upon 
depolarization. The present results show that absence of PROT affects glutamatergic 
synaptic components and causes behavioral alterations, suggesting that the in vivo 
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physiological role of PROT is, at least in part, to control glutamatergic synaptic 
transmission. Inhibitors of PROT could be used to ameliorate memory and attention, as 
well as to improve sensorimotor gating. Moreover, the adaptive changes in the expression 
of key proteins as well as manifested behavioral alterations observed in PROT-deficient 
mice within this thesis differ from the adaptive changes found within hyperprolinemia 
animal models. Therefore, the knockout of PROT is not comparable with the disorder 
hyperprolinemia. However, further experiments are required to elucidate more precise 
molecular and cell biological mechanisms to fully uncover the complete relevance of 
PROT within neurotransmission. 
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6 Conclusion 
The essential outcome of the present study was the successful generation of a mouse strain 
deficient in the expression of the murine ProT gene, encoding for the putative 
neurotransmitter transporter PROT. Successful deletion of PROT was demonstrated by 
Southern-blot on ES-cell level, and by PCR-analysis as well as Western-blot technique in 
the generated animals. Knockout mice were viable, displayed no morphological 
abnormalities in brain, and exhibited unchanged expression of L-proline metabolizing 
enzymes, indicating unaffected L-proline metabolism. Therefore, the PROT-deficient 
mouse strain represented a valuable tool for both elucidation of in vivo PROT-function and 
analysis of adaptive processes in the expression of CNS genes appearing upon PROT 
inactivation. First, it was shown that PROT contributes to a main extent to the high affinity 
sodium-dependent L-proline uptake in the brain regions hippocampus, cortex and striatum. 
Since PROT-function is assumed to affect CNS glutamate neurotransmission, putative 
alterations within associated elements of glutamatergic synapsis were investigated. For this 
purpose, expression levels of glutamate-receptor subunits were examined using Western-
blot technique and mRNA analysis by quantitative real time polymerase chain reaction. 
Within the scope of this thesis, significantly increased levels of the NMDA-receptor 
subunits, but unchanged PSD95 expression, were detected in different brain regions of 
PROT-knockout mice. A predominant upregulation of NR2B could be ascertained in 
frontal cortices and hippocampi, whereas predominantly increased NR2A levels were 
found only in hippocampi of PROT-lacking mice, suggesting region specific alterations in 
NMDA-receptor signaling. Moreover, raised expression of AMPA- and KA-receptor 
subunits was observed in the hippocampal formation of PROT-deficient animals. Taken 
together, these findings indicate that ablation of PROT induces adaptive changes in 
glutamate-receptor expression that could result in alterations of glutamatergic 
neurotransmission in these mutant animals. In addition, it was assumed that modulation of 
NMDA-receptor signaling could induce a secondary dysregulation in dopamine 
neurotransmission. Therefore, dopaminergic system associated proteins like catechol-O-
methyltransferase (COMT), tyrosine hydroxylase (TH) and dopamine-receptor D1 and D2 
(DRD1, DRD2) were also analyzed by qPCR-analysis, disclosing an upregulation of TH 
and DRD2 mRNA, which suggest far-reaching changes in general CNS neurotransmission 
in PROT-knockout mice.  
Finally, it was investigated whether PROT deletion has an impact on the behavior of 
PROT-deficient mice. It could be shown that these animals display significantly reduced 
106 6 Conclusion 
levels of exploratory locomotor activity and increased anxiety like behavior. Furthermore, a 
better performance of PROT-deficient animals compared to their wild-type littermates in 
memory test was observed. The detected alterations in glutamate-receptor levels might 
explain the changed behavioral phenotypes of PROT-knockout mice. Since augmented 
expression levels of NMDA-receptors previously have been associated with improved 
memory function, the observed increase of NMDA-receptor expression in PROT-deficient 
animals is consistent with their better performance in memory tests. Moreover, mediation 
of emotion by glutamatergic neurotransmission could also explain the altered emotionality 
in PROT-deficient animals. Increased glutamatergic neurotransmission is similarly 
associated with reduced locomotor activity, as also observed in PROT-/- mice. 
Collectively, these studies describe a mouse model that helps to clarify some particular 
physiological functions of PROT. Nevertheless, further experiments are required to 
elucidate more precise molecular and cell biological mechanisms to fully uncover the 
complete relevance of PROT within neurotransmission. Ongoing experiments using this 
new mouse model will provide new insights into the precise role of this exceptional 
transporter. 
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7 List of  Abbreviations 
ad (Lt.) up to 
bp Base pairs 
cDNA copy DNA 
C° Celsius 
CMV Cytomegalovirus 
CNS Central nervous system 
dH2O Demineralized water 
DMEM Dulbecco´s modified Eagel´s Medium 
DMSO Dimethyl sulfoxid 
DNA Deoxyribonucleic acid 
dNTP Deoxynucleotidetriphosphate 
E.coli Escherichia coli 
EDTA Ethylene diamine tetraacetic acid 
e.g. Exempli gratia (for example) 
ES cell Embryonic stem cell 
f.c. Final concentration 
FCS Fetal calf serum 
FIAU Fialuridine 
g Acceleration by gravity 
g Gram 
G418 Geneticin 
GABA γ-Aminobutyric acid 
h Hour(s) 
HBSS Hank´s balanced salt solution 
HEPES N-(2-Hydroxyethyl)piperazine-N-ethanesulforinic acid 
HET Haus für experimentelle Therapie 
HSV-TK Herpes simplex virus thymidine kinase 
IgG Immunoglobulin G 
KA Kainate 
kb Kilo base(s) 
LIF Leukemia inhibitory factor 
LTD Long term depression 
LTP Long term potentiation 
M Molar concentration (mol/liter) 
m Murine / mouse 
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MEF Mouse embryonic fibroblast 
min Minute(s) 
ml Milliliter 
mRNA messenger RNA 
ms Millisecond 
µl Microliter 
µM Micromolar 
n Number 
neo Neomycin 
nm Nanometer 
nM Nanomolar 
NMDA N-methyl-D-aspartic acid 
ns Non-significant 
N-terminus Amino terminus 
OD Optical density 
ORF Open reading frame 
PBS Phosphate buffered saline 
PCR Polymerase chain reaction 
RNA Ribonucleic acid 
rpm Rounds per minute 
RT Room temperature 
RT-PCR Reverse transcription polymerase chain reaction 
s Second(s) 
SDS Sodium dodecyl sulfate 
SEM Standard error of mean 
TE Tris EDTA 
TM Transmembrane 
Tris Tris(hydroxymethyl)aminomethane 
U Unit 
UTR Untranslated region 
UV Ultraviolet 
V Volt 
WT Wild-type 
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9.1 Targeting Vector Map and Generation of  the Targeting Vector 
The vector XpPNT (Figure 41) (Thomas et al. 1986) was developed for gene knock-out 
experiments in mammalian cells by double homologous recombination (Fiau and neo 
selection) and used for the construction of the targeting vector for homologous 
recombination of the murine ProT gene locus. Therefore, the plasmid contains a neomycin 
resistance gene (neo) of 1826 bp under the control of the mouse phosphoglycerate kinase 1 
(PGK) promoter, as well as a herpes simplex virus thymidine kinase gene (HSV-TK) of 
1127 bp. The neomycin resistance gene contains some modifications at the start region of 
the coding sequence as compared to the wild-type gene. As a third selection marker the 
plasmid contains an ampicillin resistance gene (amp) for featuring introduction and 
maintenance in bacterial hosts. The origin of replication from E. coli allows amplification of 
the plasmid.  
 
Figure 41 Vector-map of pPNT for gene knockout experiments in mammalian cells 
The depicted plasmid-map was designed by the use of the bioinformatics software Vector NTI. 
Indicated are:  
Mouse phosphoglycerate kinase 1 promoter (PGK1), neomycin positive selection marker (neo), 
replicon of E. coli plasmid ColE1 origin (ColE ori), ampicillin selection marker for amplification in 
bacteria (ampicillin resistance), negative selection marker (HSV-TK) as well as the endonuclease 
restriction sites used for cloning (NotI, XhoI, BamHI and EcoRI) and linearization (NotI). 
 
pPNT
7348 bp
HSV-TK
neo
ampicillin resistance
PGK
PGK
ColE ori Not I (56)
XhoI (62)
BamHI (1894)
EcoRI (1915)
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In order to achieve homologous recombination in ES cells the targeting vector had to 
contain homologous genomic DNA fragments, 5´ and 3´ to the ProT central region 
(1158 bp) that was anticipated to be removed. For the 5’ homology region a fragment of 
5028bp (long arm) from the end of exon 2 up to the beginning of exon 6 (including exons 
3, 4 and 5) were selected and the 3’ homology area (short arm) comprised a fragment of 
1131bp from the beginning of exon 8 up to the beginning of exon 10. In order to maintain 
this genomic DNA fragments PCR reactions were performed (Figure 42) to amplify the  
5´ and 3´ homologous regions by use of appropriate oligonucleotide primers and the BAC 
clone RP24-243J21 (BAC5) as DNA template. The primers used to amplify the  
5’ homologous DNA fragment were designed to add artificial endonuclease restriction sites 
to the amplicons next to amplification of the desired sequence (2.4). To the 5’ homologous 
DNA fragment 5´ a NotI site and 3´ an XhoI site were added in order to finally allow 
insertion into the XpPNT- vector by standard cloning techniques. Likewise, endonuclease 
restriction sites were added to the 3’ homologous DNA fragment. 5´ of the short arm a 
BamHI site and 3´ an EcoRI site were attached to finally allow insertion into vector. The 
amplification products of the PCR reactions (Figure 42), were purified by agarose gel 
electrophoresis and isolated by subsequent gel extraction. 
 
0.5 kb
1 kb
1.5 kb
2 kb
3 kb
100 bp
200 bp
300 bp
500 bp
1000 bp
 
Figure 42 Images of agarose gel electrophoresed PCR products displaying the 5’ homologous 
fragment (A.) and the 3’ homologous fragment (B.) detected by use of ethidium bromide under 
UV-light 
PCR amplicons were flanked by artificially introduced restriction sites to finally allow insertion into 
the vector XpPNT. 5´a NotI site and 3´ an XhoI site were added to the 5’ homologous DNA 
fragment (A.). The 3´homologous fragment maintained a 5´ BamHI site and a 3´ EcoRI site. For size 
estimations a 1kb DNA ladder (2.1) was applied.  
 
A. B. 
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Prior to insertion into the vector XpPNT both fragments were subcloned into the vector 
pBS in order to ensure the correct sequence. Verification was accomplished by restriction 
analyses (Figure 43 A. & Figure 43 B.) and sequencing (GATC Biotech AG, Konstanz).  
 
0.5 kb
1 kb
2 kb
3 kb
1.        2.       3.        4. 
0.5 kb
1 kb
2 kb
3 kb
1.      2.        3.       4.       5.       6. 
 
Figure 43 Agarose gel analysis of restriction endonuclease cleavages in order to verify 
introduction of the 3’ homologous fragment (A.) into vector pBS and the 5’ homology fragment 
(B.) in vector pBS envisaged with ethidium bromide under UV-light  
A. Restriction cleavage of the 3’ homologous fragment was confirmed by the expected 
genomic DNA restriction patterns:  
EcoRI cleavage (2.) was expected to result in a linearized DNA fragment of 4423 bp  
NheI and EcoRI treatment (3.) should reveale fragments of 3281 bp as well as 1142 bp 
(additionally partially cut fragment of 4423 bp is visible) 
SpeI cleavage (4.) shows the expected fragments of 3725 bp and 698 bp 
For size estimations a 1kb DNA ladder (1.) was applied. 
B. The 5’ homologous fragment was as well verified by the expected restriction patterns:  
Linearization at the single XhoI site (2.) resulted into the expected fragment of 8320 bp 
EcoRI and XhoI cleavage (3.) revealed fragments of 5110 bp as well as of 3210 bp 
BamHI and XhoI cleavage (4.) shows the expected fragments of 6690 bp and 1630 bp 
XbaI and XhoI cleavage (5.) was expected to result in the expected fragments of 5040 bp 
and 3280 bp 
A 1kb DNA ladder (1.) was applied for size estimations. 
 
Finally, the homologous sequences became inserted into the pPNT-vector to accomplish 
construction of the targeting vector for homologous recombination of the murine ProT 
gene locus. The 3’ homologous fragment was first inserted with BamHI and EcoRI between 
the neo gene and the HSV-TK gene. Afterwards the 5’ homologous fragment was 
introduced into the vector XpPNT by NotI and XhoI. The correctness of this vector was 
further proven by restriction enzyme analyses (Figure 44). 
 
A. B. 
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1000 bp
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10000 bp
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Figure 44 Gel electrophoresis of restriction mapping to confirm the final ProT-pPNT targeting 
vector 
Pictured are the expected restriction patterns after cleavage with the particular enzymes to verify the integrity 
of the final targeting construct. Applied enzymes and expected patterns were: (2) ProT-pPNT after NotI 
cleavage resulting in a linearized fragment of ~13.5 kb, (3) fragments of ~5 kb & ~8.5 kb after restriction of 
the targeting vector with NotI and XhoI, (4) ProT-pPNT after BamHI cleavage generating two fragments of 
~3.4 kb and ~10 kb, (5) 10 kb, 1.8 kb 1.6 kb fragments after XhoI & BamHI cleavage of ProT-pPNT, (6) 10.5 
& 2.9 kb fragments after HindIII restriction, (7) SpeI resulting in 10.5 & 2.2 & 0.8 kb fragments, (8) ProT-
pPNT after EcoRI cleavage resulting in 7.8 + 5.7 kb fragments, (9) 1.1 + 5.9 + 6.3 kb fragments after XbaI 
treatment, as well 1kb-ladder (1) 
 
9.2 qPCR-Setup 
Initially integrity of the extracted and purified mRNA was verified through presence of the 
two discreet 18S and 28S rRNA bands visible after agarose gel electrophoresis (Figure 45). 
It was essential that the obtained mRNA was free from genomic DNA. Therefore, a 
DNase digest was accomplished before the extraction was carried out. After purification 
cDNA was synthesized from the mRNA prior to qPCR reaction. To optimize the qPCR 
conditions, different template concentrations as well as different primer concentrations 
were tested in parallel.  
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Figure 45 Exemplary depiction of the control of mRNA integrity in a number of different areas 
of the brain by agarose gel electrophoresis, visible by use of ethidium bromide under UV-light 
Agarose gel electrophoresed RNA (each 0.5µg) displaying discrete 18S and 28S rRNA bands detected with 
ethidium bromide under UV-light. Loaded were: 
1 = frontal cortex knockout 1  10 = frontal cortex wild-type 2 
2 = striatum knockout 1   11 = striatum wild-type 2 
3 = hippocampus knockout 1  12 = hippocampus wild-type 2 
4 = frontal cortex wild-type 1  13= frontal cortex knockout 3 
5 = striatum wild-type 1   14 = striatum knockout 3 
6 = hippocampus wild-type 1  15 = hippocampus knockout 3 
7 = frontal cortex knockout 2  16 = frontal cortex wild-type 3 
8 = striatum knockout 2   17 = striatum wild-type 3 
9 = hippocampus knockout 2  18 = hippocampus wild-type 3 
 
Moreover, the sizes of the resulting PCR products for each primer pair have been verified 
by gel electrophoresis to ascertain fitting to their respective theoretical calculations  
(Figure 46 and Figure 47).  
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Figure 46 Agarose gel electrophoresis of PCR products displaying amplicons of the respectively 
indicated primer pairs detected by use of ethidium bromide under UV-light 
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Figure 47 Agarose gel electrophoresis of PCR products displaying amplicons of the respectively 
indicated primer pairs detected by use of ethidium bromide under UV-light 
 
Efficiencies of reference gene primers were determined by dilution curves. Both reference 
genes GAPDH as well as β-Actin were stably expressed, but β-actin was slightly better 
expressed and therefore chosen for the analysis. The efficiencies for the primer pairs used 
for analyses of the genes of interest were not determined and for calculation assumed to be 
100% efficient.  
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To permanently control amplification products and exclude false fluorescence signals 
(primer-dimer) of the respective reaction, a melting curve was recorded subsequently to 
each experiment (Figure 48).  
 
Figure 48 Representative melting curve analysis for control of amplification products exemplified 
by primer pair NR2B  
Data obtained from ProT-/-- and ProT+/+-genotypes were normalized by the reference gene 
β-actin and set in relation to each other. 
 
9.3 Manufacturer 
Agilent Technologies D-76337 Waldbronn 
Applichem D-64291 Darmstadt 
Applied Biosystems CA 92008, USA 
Berthold technologies D-75323 Bad Wildbad 
Bioplastics BV 6374 XW Landgraaf, NL 
Bio Rad CA 94547, USA 
Biozol D-85386 Eching 
Cayman Chemical Company MI 48108, USA 
Chemicon® (Millipore) MA 01821, USA 
Cisbio Bioassays BP 84175, France 
Corning® Incorporated NY 14831, USA 
CyBio D-07745 Jena 
Decon Science Tec GmbH D-37318 Hohengandern 
Enzo Life Sciences PA 19462-1202, USA 
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Eppendorf D-22339 Hamburg 
Fermentas D-68789 St. Leon-Rot 
Fisher Scientific Leicestershire LE11 5R6, UK 
Fluka D-21147 Hamburg 
Genex Lab Torquay TQ2 8JG, UK 
Gibco Paisley PA4 9RF, UK 
Gold Biotechnology MO 63132, USA 
GraphPad Software, Inc CA 92037, USA 
Greiner bio one 4550 Kremsmünster, Austria 
Grüssing GmbH Analytika D-26849 Filsum 
Heraeus D-63450 Hanau 
HLC BioTech D-37120 Bovenden 
Invitrogen™ D-64293 Darmstadt 
KMF Laborchemie Handels GmbH D-53785 Lohmar 
Labomedic GmbH D-53115 Bonn 
Leica D-35578 Wetzlar 
Merck D-64293 Darmstadt 
Mettler Toledo D-35353 Giessen 
Microsoft® Corporation D-85716 Unterschleißheim 
Moravek Biochemicals CA 92821, USA 
New England BioLabs® (NEB) MA 01938-2723, USA 
Olympus D-20097 Hamburg 
PerkinElmer Life Sciences MA 02451, USA 
Promega WI 53711, USA 
QIAGEN GmbH D-40724 Hilden 
Riedel-de Haen D-30926 Seelze 
Ritter GmbH D- 86830 Schwabmünchen 
Roth D-76231 Karlsruhe 
SAFC Supply Solutions MO 63103, USA 
Sarstedt D-51582 Nümbrecht 
Sartorius D-37075 Göttingen 
Sigma D-21147 Hamburg 
Thermo Fisher Scientific Germany Ltd. & Co. KG. D-53113 Bonn 
Tocris Bristol BS11 0QL, UK 
 
 
